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SUMMARY of dissertation by Alexander Chen entitled: 
The Engineering and Development of pH-Responsive 
Biopolymers for Drug Delivery Applications 
This dissertation describes experimental studies to understand the structure of 
biocompatible pH responsive polymers and their interaction with the biological system in 
order to design more effective entities for biomedical applications. A systemic approach 
was used to study the structure and biological interaction of pH responsive biocompatible 
poly (L-lysine iso-phthalamide) (PLP) polymer and its derivatives. 
 
Poly (L-lysine isophalamide) is a unique polymer that contains pendant carboxylate group 
and modification with phenylalanine was able to enhance the intracellular delivery 
efficiency of the polymer. However, the exact structure and mechanism of action remains 
mostly unknown. In this study, a variety of modifiers was used to synthesise new PLP 
derivatives in order to elucidate their effect on the polymer structure and other functional 
characteristics. New characterisation methods including circular dichroism and small 
angle neutron scattering were introduced to provide more detailed information on the 
polymer structure and evidence to explain the polymer-membrane interaction. It was 
determined that PLP adopted a helical structure in solution and that the ability of the 
PLP- derivative to from a lamellar structure in solution would lead to enhanced 
intracellular delivery effectiveness. 
 
Chirality of the PLP components and modifiers were also examined. Three PLP 
enantiomers and four phenylalanine modified PLP were synthesised and characterised. 
The polymers were determined to be chemically identical and had comparable 
functionalities. However, it was proven again that the ability for polymer to form lamellar 
structure would result in enhanced intracellular delivery efficiency. The structural and 
functional information was later used to better design a drug delivery system for the 
cryopreservation of mammalian cells. The approach was successful, as the resulting 
vitamin E modified polymer was able to achieve similar cryosurvival rate with trehalose 
as cryoprotectant compared the gold standard DMSO protocol. The success marked the 
importance of application-specific design and understanding of drug delivery systems. 
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This section explores the motivation of using pH-responsive biocompatible poly (L-lysine 
iso-phthalamide)-based polymers as a delivery platform for therapeutic agents. The 
chapter begins with an overview of biocompatible polymers and how they advanced the 
field of medicine. Followed by background on pathophysiology of cells and transportation 
machineries that interact with polymers. Subsequently, a summary of poly (L-lysine iso- 
phthalamide)-based polymers and their successful applications. The section concludes 




1.2 Overview of Synthetic Materials in Biomedical Applications 
1.2.1 Synthetic Materials for Biomedical Application 
 
 
The field of medicine had been extremely successful in drug development and controlling 
diseases in the past century. These developments partially contributed to the increase of 
approximately 30 years in life expectancy in western Europe, the US, Canada, and New 
Zealand (Christensen et al., 2009). However, the need for more efficient and effective 
treatments is ever-expanding, especially with the rapidly increasing world population with 
prolonged lifespans (Christensen et al., 2009). New materials and disciplines have been 
created to satisfy these needs in forms such as drug delivery system (DDS) and 
biocompatible scaffolds for regenerative medicine as the field of polymer chemistry 
continued to advance throughout the past decade (Wilczewska et al., 2012; Mura, 
Nicolas and Couvreur, 2013). Biopolymer-based drug delivery systems developed in the 
later 1990’s alone, were responsible for over $10 billion of annual sales (Langer, 1998). 
Which did not even account for the rising demand in synthetic replacement for biological 
tissues, smart medicine and advance diagnostics. 
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Biocompatible polymers are macromolecules that, when in contact with the biological 
system, do not elicit adverse effects such as immune or necrotic responses. These 
materials can be either naturally occurring or artificial. Artificial polymers are more 
structurally diverse and versatile compared to their naturally occurring counterparts 
(Duncan, 2003). Early synthetic polymers were commonly taken from areas of science 
and technology outside of medicine. The lack of understanding for the pathophysiology 
of the biological system when exposed to these materials created inherent problems such 
as polyetherurethanes used in artificial hearts causing thrombogenesis or polysaccharide 
such as arginate causing inflammatory responses (Bernacca and Wheatley, 1998; 
Langer and Tirrell, 2004; Jones, 2008). Therefore, for synthetic materials to achieve their 
full potential in medical applications, the biological parameters similar to the 
effectiveness should be integrated in the initial design. The applications and development 
of biocompatible polymers will be further discussed in the following sections. 
 
 
1.2.2 Selected Biomedical Applications of Biopolymers 
 
 
Biopolymers were the basis of a wide range of biomedical applications including drug 
delivery, polymer therapeutics, diagnostics and regenerative medicine (Langer and 
Tirrell, 2004). The main focus of this review will be on drug delivery and polymer 
therapeutics due to the scope of this thesis. 
 
Polymers can be used as an active delivery vehicle or an inert linker between active 
therapeutics and targeting agents depending on their functionality. In many cases, 
polymers were incorporated to favorably modify the solubility, systemic toxicity, 
pharmacokinetics, and promote targeted delivery (Duncan, 2003; Swierczewska, Lee 
and Lee, 2015). For example, polyethylene glycol (PEG) is one of the most commonly 
used polymers to increase protein solubility, prolong plasma half-life and reduce 
immunogenicity (Delgado, Francis and Fisher, 1992; Lee, Na and Bae, 2005; 
Swierczewska, Lee and Lee, 2015). PEGylation has become the most established half-
life extension technology with over 20 PEGylated therapies approved for different 
medical indications in the US and Europe (Swierczewska, Lee and Lee, 2015). 
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Another well-established polymer that has been applied for biomedical use is N-(2-
hydroxypropyl) methacrylamide (HPMA). The biodegradable polymer was first 
synthesised in 1973 and reported to be an effective modifier for insulin and 
chymotrypsin in 1977 (Johnson, Kopečková and Kopeček, 2009; Yang and Kopeček, 
2017). The polymer was later conjugated to doxorubicin and further modified to produce 
a series of derivatives. The strategy was proven advantageous as it increased the 
maximum tolerated dose of doxorubicin (expressed in drug equivalent) (Lee, Na and 
Bae, 2005; Kopeček, 2013; Wu et al., 2017). Additional modifications of the polymer-
drug conjugate were made by incorporating short peptide targeting sequences or 
antibodies to construct target specific therapeutics (Shiah et al., 2001; Lu et al., 2003). 
HPMA-drug conjugate demonstrated anti-cancer activity in vivo and reached clinical 
development with a second generation of these constructs in development (Yang and 
Kopeček, 2017). 
 
In addition to using polymer as a carrier for traditional therapeutics, drug-free 
macromolecular therapeutic applications of biopolymer conjugates are becoming an 
emerging field. Johnson et al. designed a HPMA co-polymer with fragments of anti-CD20 
antibody that crosslinked CD20 receptors to induce receptor clustering effect in B cells 
(Johnson, Kopečková and Kopeček, 2009; Johnson, Kopečková and Kopeček, 2012). 
The construct was able to induce apoptosis in five different CD20-expressing cells and it 
was effective against human non-Hodgkin’s lymphoma (NHL) Raji B cells (Chu, Yang 
and Kopeček, 2012). These cases demonstrated the promising future of biopolymers 




1.3 Cell Membrane Structure and Intracellular Delivery 
 
 
The mammalian cell is the basic structure of a functional organism (Figure 1-1). The 
interior content of the cell is separated by the cell membrane which is a lipid bilayer 
incorporating various molecules and proteins. The phospholipids in the cell membrane 
create a hydrophobic barrier for hydrophilic molecules preventing most molecules from 
 21  
freely diffusing through the membrane. Channels spanning across the cell membrane 
constitute of membrane proteins allow selected molecules to enter the cell regardless of 
their hydrophobicity. Additionally, cells have transportation mechanisms for 
macromolecules and membrane impermeable particles. Why these structures are 
important, how cells transport foreign molecules and how they interact with amphiphilic 












1.3.1 Cell Membrane Structure 
 
 
Phospholipids are molecules containing hydrophilic, commonly charged, head groups 
and hydrophobic fatty acid tails. These lipids self-assemble into an enclosed bilayer 
structure, where the hydrophobic groups were stacked towards each other, in 
physiological conditions, separating the exterior environment from the interior component 
(Figure 1-2). As mentioned in the previous section, the hydrophobic core of the bilayer 
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membrane structure prevents hydrophilic molecules from crossing. Larger molecules, 
such as proteins or nucleic acids, are also impermeable to the plasma membrane. 
 
Typical plasma membranes are simple bilayer in nature, however, membranes in the 
biological systems are composed of hundreds of different phospholipids, 
polysaccharides, and membrane proteins (van Meer, Voelker and Feigenson, 2008; 
Sampaio et al., 2011). In fact, 50% by weight of the membrane in a typical mammalian 
cell is consist of protein (Holthuis and Menon, 2014). The lipids are in a disordered liquid 
state which enables movement of membrane components, but the lateral mixing is 
highly non- uniform (Singer, S.J.; Nicolson, 1972; Spector and Yorek, 1985). The fluidity 
and non-homogeneous structure have important implications for many crucial cellular 
processes such as protein trafficking, membrane fusion, and signalling transduction 
(Helmreich, 2002; Holthuis and Menon, 2014). 
 
 
Figure 1-2: Illustration of cell membrane structure and membrane components, reproduced from 
Totora and Nielson, 2011. 
 
 
In fact, certain lipids along with certain functional proteins to form ‘lipid rafts’ or ‘micro 
functional domains’ with increased cholesterol and sphingolipid concentration that are 
segregated from membrane (Pralle et al., 2000; Allen, Halverson-Tamboli and 
Rasenick, 2007). Common proteins found on lipid rafts include 
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glycosylphosphatidylinositol (GPI)-anchored proteins, doubly acylated proteins, such as 
G-proteins, cholesterol-linked and palmitoylated proteins such as the Hedgehog 
signaling proteins, and transmembrane proteins (Brown and London, 1998; Hooper, 
1999; Resh, 1999; Rietveld et al., 1999). These proteins play major roles in cell 
signaling as they transmit information from the extracellular space such as hormones or 
cytokines and modify the cell behaviour. For example, histamine could act by binding to 
G-protein coupled receptors (GPCR) and induce cells to exhibit inflammatory responses. 
Other cell functions involving membrane proteins, specifically, transportation of foreign 
molecules into the cell and how the pathway affected the field of medicine will be 
discussed in the following section. 
 
 
1.3.2 The Role of Intracellular Delivery 
 
 
In nature, cells have mechanisms to transport molecules across the cell membrane to 
acquire essential nutrients and communicate across cells and organs. For example, 
glucose, the essential fuel for cells to produce energy and maintain cell function, could 
diffuse through sugar-specific membrane channels without being blocked by the cell 
membrane. For larger molecules or molecules without membrane channels, cells utilise 
a process called endocytosis, where cells internalise molecules from the extracellular 
environment. Endocytosis can be further categorised into four groups defined by the 
volume or membrane proteins involved (Figure 1-3). 
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The first category involves active engulfment of large unselected volumes. Some 
examples are phagocytosis and marcopinocytosis observed in macrophages, a type of 
mobile white blood cell, scavenging apoptotic cells and foreign pathogens (Swanson, 
2008). The second type is clathrin-mediated endocytosis (CME), which utilises the 
triskelion-shaped scaffold clathrin protein to form transport vesicles. It is a selective 
process involving receptor-mediated recruitment of clathrin and formation of membrane- 
bound vesicles that detach from the cell membrane. This process is highly conservative 
across mammalian cell types and utilised to internalise many well-studied ligands such 
as transferrin (Mousavi et al., 2004). The third type, caveolin- mediated endocytosis, 
depends on flask-shape caveolin-lipid membrane complexes namely caveolae. 
Caveolae, believed to be important in endocytosis and signal transduction, are typically 
50-80 nm in diameter and are co-localised with high cholesterol, sphingolipid, and 
signalling protein membrane regions (Anderson, 1998). The fourth type is the general 
cell internalisation process of small molecules without the facilitation of either clathrin or 
caveolin (Mayor and Pagano, 2007). 
 
The categorisations at times could be difficult to define as different types of endocytosis 
can be used to internalise the same ligand in different cells (Jones, Gumbleton and 
Duncan, 2003; Singh et al., 2003; Damm et al., 2005). Thus, it is crucial to determine 
the targeted cell type and recruit the correct internalisation motif for delivery systems that 
aim to utilise these native pathways (Varga et al., 2005). 
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Additionally, the fate of each pathway can be relatively different. Endocytosis vesicles 
can be recycled back to the cell surface or further develop into late endosomes. The 
latter development will result in the acidification of the vesicle lumen and subsequently 
result in the fusion with lysosomes. The pH in the vesicle lumen of early endosomes 
and late endosomes are 7 to 6 and 6 to 5 respectively. The fusion of late endosome 
with lysosome will lead to further decrease the pH to below 5.5 along with the 
introduction of degradative enzymes (Mukherjee, Ghosh and Maxfield, 1997). This 
process is similar to the human digestive system, where larger molecules are broken 
down and absorbed while ensuring foreign agents are neutralised. How the 
understanding of these native internalisation pathways is relevant to intracellular 
delivery would be discussed in the following section. 
 
 
1.3.2.1 Applications and Current Challenges in Intracellular Delivery 
 
 
The interest for intracellular delivery was sparked by the discovery that cell physiology 
could be manipulated by synthetic nucleic acid sequences (Seeman, Cheng and Iles, 
1973; Subbarao et al., 1987; Timothy E. McKnight et al., 2004; Villalobos et al., 2006; 
Wang et al., 2009). Transfection, which refers to the delivery of DNA or RNA into the 
cytosolic place, has nearly become synonymous with intracellular delivery in the past 
decade as is one of most studied and arguably the most important applications (Midoux 
and Monsigny, 1999; Han et al., 2007; Martin and Rice, 2007; Yue et al., 2011). 
Transfection was the core technology that enabled nucleic acid synthesis in bacteria, 
therapeutic protein production in immortalised cell lines, and selective 
inhibition/expression of proteins in cells for biomedical research. However, as previously 
discussed, macromolecules including nucleic acid were unable to cross the cell 
membrane intact. An array of techniques has been developed to transport molecules 
across the cell membrane. These techniques can generally be categorised into ones that 
utilise the previously discussed endocytosis pathways and other methods that do not 
involve endocytosis. The two types of intracellular delivery would be discussed in the 
following sections. 
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1.3.2.2 Endocytosis-Dependent Intracellular Delivery 
 
 
As introduced in the earlier section, the uptake of molecules through membrane-bound 
vesicles is broadly defined as endocytosis (Christie and Grainger, 2003). It was 
discovered as early as 1974 that cells selectively internalised lysosomotropic agents 
through lysosomes and this transportation mechanisms could be utilised as a solution to 
overcome the cell membrane barrier (de Duve, 1974). Viruses and bacteria which 
replicate within cells are perhaps the first entities to exploit the endocytosis pathway to 
introduce pathogenic materials into the intracellular space. Influenza virus, an enveloped 
RNA virus, contains surface viral protein hemagglutinin (HA) which contains a terminal 
sialic acid (SA) binding site (Weis et al., 1988). The virus initiates the infection process by 
attaching HA to cell surface receptors that contains terminal SA residues. Although these 
receptors are currently unknown, studies suggest that the binding of HA to these 
receptors trigger the endocytosis of the virion (Dou et al., 2018). The endocytosis can 
either occur through the clathrin-dependent process or micropinocytosis (Roy et al., 
2000; Rust et al., 2004; Chen and Zhuang, 2008). After the virus is transported to the 
endosome where the pH decreases, HA will go through a large conformational change 
and expose a fusion peptide domain (White, Helenius and Gething, 1982). As the fusion 
peptide would enable the viral membrane to merge with the endosomal membrane which 
resulted in the release of viral genome (Figure 1-4). The entry and membrane fusion are 
rapid processes and could occur in approximately 10 minutes (Dou et al., 2017). The viral 
entry of endocytosis pathway became the inspiration and basis of many intracellular 
delivery systems in the past decade. 
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Figure 1-4: A schematic Illustration of influenza virus entry into mammalian cell through 
endocytosis and the HA protein performing pH-dependent membrane fusion activity, reproduced 
and modified from Dou et al., 2018. 
 
 
One obvious intracellular delivery system is modified viruses that carry nucleic acid 
encoding the desired protein constructs. For example, adeno-associated virus (AAV), a 
non-pathogenic small (~4.7 kb) single strand DNA virus, is a commonly used vector to 
deliver specially designed genome sequences for the generation of T-cell therapies 
(Mays and Wilson, 2011; Maeder and Gersbach, 2016). The viral vectors are still 
considered one of the most effective and efficient intracellular delivery systems. 
 
Synthetic transfecting agent, such as polyethyleneimine (PEI), also mediates the delivery 
of DNA by utilising the endocytosis pathway. The polymer first forms complexes with 
DNA, internalised by cells into the endosome, and disrupts the lysosome through the 
“proton sponge effect” (Boussif et al., 1995; Forrest and Pack, 2002). The amine groups 
on PEI have buffering effect in acidic endosomes and induce osmotic imbalance and 
passively rupture the membrane vesicle (Boussif et al., 1995; Behr, 1997). This process 
enables the payload to be released from the lysosome into the cytosol. 
 
The two above-mentioned examples demonstrated the importance of the endocytosis 
pathway as a route for intracellular delivery systems. Systems or techniques that are 
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independent of endocytosis were also well developed and contributed to the 
advancement of various advancement in the medical field. These developments would 
be discussed in the following section. 
 
 
1.3.2.3 Endocytosis-Independent Intracellular Delivery 
 
 
Intracellular delivery techniques that do not involve the endocytosis pathway generally 
target the cell membrane directly by causing holes, pores or defects to enable the 
passage of certain agents. These techniques could be physical or biochemical and can 
be categorised as membrane penetration or permeabilization (Stewart, Langer and 
Jensen, 2018). 
 
Membrane penetration strategies use conduits or vehicles to puncture the cell 
membrane and create passages for the cargo. Techniques including microinjection, 
ballistic particles, and nanoneedles are common examples. Microinjection was the first 
method to be invented as a direct penetration intracellular strategy (Korzh and Strähle, 
2002). This technique disrupts the cell membrane with a miniaturised pipette-like 
element, which subsequently injects the payload directly into cells in a controlled 
manner. It could, however, be limited by the size of the injection needle, the precision of 
the pump that ejects the payload, and number of experiments at a given time. 
Nanoneedles utilise a similar penetration principle except that they typically consist of 
finer fabricated structures for penetration and are more modifiable (Melechko et al., 
2003; Shalek et al., 2010). The payloads are usually loaded on the nanoneedle 
structures and designed to be released after they came into contact with the cytosolic 
space. All these delivery techniques would cause puncture of the cell membrane and the 
target cells would require repair of the cell membrane and other cellular structures. 
 
Membrane permeabilisation, on the other hand, makes the plasma membrane temporarily 
permeable to cargo present in the extracellular environment. The permeability of the 
membrane for the cargo would depend on the size and the duration of the transient 
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channels. Thus, depending on the property of the cargo, the permeabilisation strategy 
would have to be designed accordingly. The membrane disruptive events could be 
achieved physically or biochemically (Stewart, Langer and Jensen, 2018). Physical 
methods could range from mechanical, electrical, thermal, and laser-based. These 
techniques usually allow better control over the intensity and duration of membrane 
disruptive events (Hapala, 1997; Meacham et al., 2014). However, these techniques 
would not be further discussed as it is out of the scope of this study. 
 
Biochemical agents that could disrupt the cell membrane includes detergents, 
surfactants, organic solvents, peptides, and numerous proteins. As an example, 
detergents and organic solvents are commonly used to disrupt the cell membrane and 
extract certain lipophilic components (Karande et al., 2005). Various peptides and 
proteins created by organisms ranging from bacteria to mammals has the ability to 
impact the membrane integrity. Pore-forming proteins (PFPs) including colicins 
produced by E. coli and the C9 protein of the human immune system are one example 
(Bischofberger, Iacovache and van der Goot, 2012). An array of membrane-active 
peptides has been known to be able to interact with and disrupt the plasma membrane 
(Sun, Forsman and Woodward, 2015). One type of membrane-active peptides is 
antimicrobial peptides (AMP), which are usually amphiphilic and cationic with the ability 
to induce pore formation at critical concentration (Zasloff, 2002; Brogden, 2005). 
Although only a small amount of the over 5,000 AMPs were studied for their mechanism 
of action, a universal feature of these peptides is the ability to adopt different 
conformations when it came into contact with lipid bilayers (Zasloff, 2002). More 
specifically, the peptides are able to form two distinctive peptide-lipid states. The peptide 
initially forms an inactive surface-bound state that adsorbs onto the lipid membrane outer 
surface and then rearranges into formation that supports stable pores across the lipid 
bilayer (Sengupta et al., 2008). Of note that these peptides, such as melittin, often adopt -
helix secondary structure in their active state. Although there are currently many 
theories attempt to characterise the exact mechanism of how AMPs disrupt the cell 
membrane, the overall prerequisites for AMP-mediated formation appears to be a critical 
concentration of peptides in solution and the ability to aggregate in the lipid
Layer (Sengupta et al., 2008). The understanding of how AMP and related cell-
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penetrating peptides could disrupt the plasma membrane forms the basis of intracellular 
delivery applications. One such synthetic polymer delivery system will be discussed in 
the following section. 
 
 
1.4 pH-Responsive Polymers as a Drug Delivery System 
 
 
Poly (L-lysine iso-phthalamide) was developed by Eccleston et al. in the late 1990’s 
(Figure 1-5). Inspired by the influenza hemagglutinin protein, the polymer was designed 
to be biodegradable, easily synthesised and amphiphilic (Eccleston, Slater and Tighe, 
1999). Eccleston synthesised a range of pH-responsive polymers with iso-phthalic acid 
and diamines of various carbon chain lengths to develop intracellular delivery systems in 
vitro (Eccleston et al., 2000). After extensive experimentation, PLP was determined to be 




Figure 1-5: Illustration of reaction scheme for PLP synthesis and systemic metabolic breakdown. 
The chemical structure of PLP is shown on the upper right-hand corner. PLP can be broken down into 
biocompatible metabolic products L-lysine and iso-phthalic acid. 
 
 
The linear polymer has a free carboxylic acid group in each subunit that can be ionised 
at physiological pH range. It is believed that while the carboxylic acid is at physiological 
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pH, it holds a negative charge which cause each subunit to be expanded. As the pH 
decreases, the polymer loses the negative charges and hydrophobic interaction between 
the subunits becomes the dominant force. Subsequently, PLP forms hydrophobic globular 
structures and aggregate in aqueous solution (Chen, 2007). To note, these were 
hypotheses from previous studies intended to explain the pH-responsive and polymer- 
membrane interaction of PLP. The pendant carboxylic acid groups are not only an 
important part of the pH responsive character of PLP. The reactive carboxylic acid groups 
are suitable for conjugation and modification. The modifier and amount of grafting can be 
easily controlled to produce various derivatives (Chen et al., 2009; Khormaee et al., 
2010). How these modifications were achieved and how modifications affect PLP 
characteristics would be discussed in the following section. 
 
1.4.1 Modification of PLP 
 
 
Hydrophobic amino acids including L-valine, L-leucine, and L-phenylalanine were first 
used to modify the PLP property and successfully enhanced the intracellular delivery 
efficiency of membrane impermeable molecules in mammalian cells (Chen et al., 2009). 
It was previously shown that incorporating L-phenylalanine at 75% molar ratio to 
carboxylic acid groups resulted in the most effective PLP-based intracellular delivery 
(Chen et al., 2009). This result led to the belief that hydrophobicity of the modifying 
amino acid would determine the intracellular delivery efficiency of the resulting polymer. 
 
However, the positive relationship of hydrophobicity of the modifying amino acid and 
delivery efficiency of the polymer came into question when Khormaee et al. compared L- 
phenylalanine grafted PLP to L-tyrosine grafted PLP and found the effectiveness of the 
two polymers are comparable. The overall hydrophobicity of phenylalanine and tyrosine 
are significantly different, but the study concluded that aromatic structure may be the key 
for the improved intracellular delivery efficiency of the modified PLP polymers (Khormaee 
et al., 2010). Identifying the key factors that are crucial to enhance membrane interaction 
and disruption are important as the overall effectiveness and solubility of PLP-based 
polymers are heavily affected by the hydrophobic modifier. 
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Inspired by the idea of membrane affinity and polymer therapeutics proposed by Langer 
et al. that polymers could have dual function as a drug carrier and active agent, modifiers 
beyond amino acids were further explored in this study (Langer and Tirrell, 2004). 
Biologically active hydrophobic molecules such as cholesterol, sphingolipids and 
hydrophobic vitamins, were studied as potential hydrophobic modifiers in this study. 
These modifications may provide PLP with enhanced membrane interactive property, at 
the same time, biological function to improve the overall effectiveness of the polymer 
drug delivery system. 
 
 
1.4.2 Biomedical Applications of PLP-based Polymers and Future Developments 
 
 
The post-genomic era has enhanced our understanding in the pathophysiology of the 
biological system. Macromolecules such as antibodies and nucleotides are often applied 
as therapeutics. The target of a large portion of these drugs is within the cell, therefore, 
carriers enabling these therapeutics to access the intracellular component are of crucial 
importance. Small interfering RNA (siRNA) was discovered as an effective way to achieve 
protein knockout. However, the commonly used PEI and lipofectamine based delivery 
systems for nucleotide were immunogenic and toxic at higher doses. In a study, 
Khormaee et al. showed that PP-75 was biocompatible and a suitable delivery system for 
siRNAs. Stathmin siRNA-conjugated PP-75 was able to supress stathmin expression in 
U-251 human glioblastoma cell line in vitro at a comparable level to stathmin siRNA 
delivered by lipofectamine. Additionally, stathmin siRNA-conjugated PP-75 was able to 
suppress U-251a tumor growth in vivo by suppressing tumor stathmin level which 
subsequently reduced the tumor drug resistance towards chemotherapeutic treatment 
(Khormaee et al., 2013). In addition to the delivery of nucleic acid, PP-75 was also 
proven to be a suitable and effective delivery system for the membrane impermeable 
trehalose, a naturally occurring cryoprotectant. Lynch et al. showed that co-incubation of 
PP-75 and trehalose in erythrocytes mediated the uptake and increased the intracellular 
concentration of trehalose to 123 ±16 mM. The increase in intracellular trehalose 
concentration would translate into approximately 20% higher erythorocyte cryosurvival 
(Lynch et al., 2010). 
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The two examples proved that PLP-based polymers are effective intracellular drug 
delivery systems that are biocompatible and highly modifiable. As the PLP polymer is 
extremely versatile, further improvement and modifications could be made to enhance 
the delivery efficiency not only as a drug delivery system but also as a potential polymer 
therapeutics. How to increase the understanding of this polymer system and use the 
knowledge for a more intelligent design of the polymer would be explored in this thesis. 
 
 
1.5 Research Aims 
 
 
The aim of research conducted in this study was to investigate ways improve the 
intracellular delivery efficiency and effectiveness of pH-responsive polymers for the 
appropriate biological application. This was achieved by using various chemical 
modifications and synthesis of new pH responsive polymers to create a spectrum of 
similar polymers for comparison. The polymers were characterised by different 
techniques to determine the molecular composition, secondary structure, 
 
 
1.5.1 Understand the structure of PLP-based polymers 
1.5.2 Systemically study the effect of pendant group modifications on PLP 
1.5.3 Use amino acids with different chirality in PLP polymer backbone or as a modifier 
to study polymer structure and biological activities 
1.5.4 Explore other modifications and additional biomedical applications 
1.5.5 Discover potential replacement materials 
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1.6 Thesis Outline 
 
 
CHAPTER 1, LITERATURE REVIEW AND RESEARCH AIMS, explores the current 
landscape of functional polymers and intracellular delivery systems with specific focus on 
pH-responsive biocompatible polymers. 
 
 
CHAPTER 3, SYNTHESIS AND CHARACTERISATION OF PLP-BASED POLYMERS, 
outlines the syntheses and development of pH responsive and biocompatible polymer, 
PLP. The chapter further discussed new techniques used to unveil additional structural 
and functional insights of PLP. 
 
 
CHAPTER 3, THE EFFECTS OF CHIRALITY ON THE STRUCTURE AND 
FUNCTIONALITY OF PH-RESPONSIVE DELIVERY POLYMERS, describes how the 
chirality of the component for the syntheses of PLP-based polymers would affect the 
structure and functionality of the resulting polymer. Amino acids of different chirality were 




CHAPTER 4, THE SYNTHESES AND CHARATERISATION OF SECOND 
GENERATION PLP-LIKE POLYMERS, discusses whether using a different di-acid could 
result in a more biocompatible polymer while retaining the intracellular delivery capability 
of PLP. The chapter further explores whether modification with hydrophobic amino acids 
could successfully enhance the second-generation pH-responsive polymer. 
 
 
CHAPTER 5, SYNTHESIS AND CRYOPRESERVATION APPLICATION OF AN 
ANTIOXIDANT GRAFTED PLP, describes a new application-specific design using 
functional modifier to increase PLP delivery efficiency and introduce anti-oxidative 
function. The chapter outlines the rationale for the design of the polymer for 
cryopreservation and how it ultimately improved the survival of cells undergone 
cryopreservation. 
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CHAPTER 6, CONCLUSION AND FUTURE WORKS, presents the main finding of this 
work and outlines future studies that could lead to the further improvement of PLP as a 
drug delivery system. 
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2.1.1 Development of poly (L-lysine iso-phthalamide) 
 
 
Poly (L-lysine iso-phthalamide) (PLP), an amphiphilic polyamide with hydrophobic groups 
and pendant hydrophobic carboxylate groups, was first synthesised and characterised by 
Eccleston et al. as an intracellular delivery system (Eccleston et al., 2000). The 
development of PLP was inspired by the viral fusogenic peptide hemagglutinin (HA) that 
has membrane disruptive activity below physiological pH. It was previously suggested 
that PLP is membrane neutral at physiological pH and undergoes a conformation 
change once the carboxylate groups are protonated (Figure 2-1). The membrane lytic 
activity of PLP was measured by release of hemoglobin from red blood cells which was 
determined to lyse 20% of red blood cells at pH 4.5 (Eccleston et al., 2000). It was 
thought that the PLP polymer could facilitate the endosomal escape through enhanced 
membrane interaction and the proton sponge effect, where the positively charged protons 
absorbed onto the amine group of polymer result in osmic imbalance and eventual 
rupture of the endosomes, at a slightly acidic endosome environment in HeLa cells due 
to the formation of hydrophobic micro-domains and the carboxylate groups of the 
polymer (Chen et al., 2009) . 
 37  
 
Figure 2-1: Conformational change of poly (L-lysine iso-phthalamide) in solution at pH 7.4 and pH 
4.0. Simplified cartoon to depict PLP and negative charges arose from the carboxylate pendant group on 
the polymer at pH 7.4. 
 
 
PLP was initially assumed to be a flexible random coil in solution at pH 7.4, similar to 
typical polymer such as polystyrene (PS) in solution. The carboxylate group on the side 
chain generates ionic repulsion between the negatively charged groups making it an 
extended structure. As the pH decreases, the carboxylate groups are protonated and the 
ionic repulsion weakens so the polymer can adopt a more compact globular structure 
driven by hydrophobic association of the benzene rings on the polymer backbone 
(Chen, 2007; Khormaee, 2009). It was suggested that the globular form of PLP at low 
pH is membrane active and constitutes part of the membrane disruptive activity like the 
helical HA protein which adopts a more compact structure when protonated to facilitate 
membrane fusion. Additionally, the “proton sponge effect” was proposed to be the second 
mechanism for PLP to cause membrane disruptive activity. The proton sponge effect was 
first proposed by Behr et al. in 1997, where macromolecules with proton receiving 
functional groups can buffer the hydrogen ions pumped into the endosome and lead to 
transportation of additional protons and ions causing an osmotic imbalance of the 
endosome causing it to break (Behr, 1997; Benjaminsen et al., 2013). Both mechanisms 
were thought to be an important way PLP could escape the endosomal pathway. 
 
Despite PLP having membrane lytic activities and intracellular delivery capabilities, two 
main issues prevented PLP from becoming an efficient drug delivery system. First, the 
pH at which PLP is membrane active is considerably lower than the physiological pH of 
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7.4. The pKa of PLP occurs in the pH range of 4.5 to 5 and such values of pH only occur 
in the biological system in the late endosomal pathway. Any therapeutic material could 
be digested or destroyed that late into the endosomal process. Second, the hemolysis 
assay showed that the membrane disruption ability of PLP is weaker than natural 
occurring cell penetrating peptides (CPPs) (Eccleston et al., 2000). 
 
How different chemical modifications of PLP affect membrane disruption has been 
studied, however, direct evidence of the structure different pH environments and the exact 
delivery mechanism is yet to be unveiled. More extensive studies would enhance clarity 
on what factors would contribute to increasing the delivery efficiency and could further 




2.1.2 PLP Sidechain Modification 
 
 
Chen et al. first discovered that by grafting hydrophobic amino acids to the pendant 
carboxylate of PLP at different molar ratios through N,N'-Dicyclohexylcarbodiimide 
(DCC)-mediated amide formation, the polymer membrane disruptive activity could be 
significantly enhanced while raising the transition pH of the polymer (Chen, 2007). The 
amino acids used include valine (Val), leucine (Leu), and phenylalanine (Phe) to 
generate PV, PL and PP polymers respectively. It was initially thought that 
hydrophobicity of the polymer modifying amino acids was the sole factor for the 
improved delivery efficiency until Khormaee et al. reported that modification with an 
aromatic amino acid tyrosine (Tyr), an amino acid less hydrophobic than Phe, increased 
the intracellular delivery efficiency of PLP to a similar level to the Phe modification. Her 
paper suggested that the aromatic structure of the modifier was also an important factor 
that affects the overall polymer delivery efficiency (Khormaee et al., 2010). Various cell 
penetrating peptides have increased effectiveness after adding amino acids containing 
aromatic side chains such as tryptophan (Nakano and Okamoto, 2001). Aromatic amino 
acids are also commonly observed in transmembrane proteins such as G-protein 
coupled receptors (GPCR) that play crucial roles in physiological response like
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muscle movement or mood regulation (Kroeze, Sheffler and Roth, 2003). These findings 
indicated that multiple characteristics of how the modifier affects the overall membrane 
interactive and disruptive activity of PLP-derivatives. Thus, it is important to systematically 
identify the influence of modifiers to improve the overall effectiveness of PLP-based 
polymers. Additional amino acids were used to modify PLP and the resulting polymers 
were compared to PLP and Phenylalanine modified PLP. 
 
 
2.1.3 Polymer Characterisation Methods 
 
 
PLP-based polymers were previously characterised by standard physical methods 
including NMR, FTIR, GPC, and dynamic light scattering (DLS) (Chen, 2007). The 
results provided convincing evidence of the primary chemical structure of the polymer 
and the chemical modifications. Additionally, the transition pHs of polymers were 
characterised using UV spectroscopy and previously with pyrene-based assay at a 
range of pHs with phosphate and citrate buffers. The results indicated that the 
precipitation of PLP-based polymers at below physiological pH, or transition pH, is 
correlated with the formation of hydrophobic micro- domains and membrane disruptive 
activity. The intracellular delivery characteristic of the polymers was further evaluated by 
quantifying membrane impermeable fluorophore calcein in mammalian cells after 
incubation. It was determined that the closer the transition pH is to the endosomal pH of 
5.5, the higher the intracellular delivery efficiency in the calcein delivery assay. 
However, the overall conformational change and the mechanism of membrane 
disruption is yet to be fully elucidated. 
 
Attempts were made to capture the transition of the polymer using characterisation 
techniques such as DLS or atomic force microscopy (AFM). The challenge lies in the 
resolution and the experimental condition of methods such as DLS and AFM. DLS was 
commonly accepted as a good method to characterise polymer molecules in solution. 
However, it provides information on the theoretical hydrodynamic diameter of the 
molecule assuming it is globular. Additionally, the resolution is limited to around the 10 
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nm range. AFM on the other hand, provides a higher resolution, but a more 
complicated setup and lengthy data collection process. Only liquid AFM could provide 
information of polymers in solution. It will however, require a flat surface such as mica 
to deposit the sample, and a liquid chamber for polymer solution. With the advancement 
in characterisation methods, more detailed structural information could be obtained to 
further study of the PLP-based polymers. This includes secondary structures through 
characterising the optical activity of polymers by polarised light source and high-
resolution structural data in solution using small angle neutron scattering (SANS). 
 
Circular dichroism (CD) is the difference between the absorbance of left- and right-
handed circular polarised light and can more broadly refer to the spectroscopy of 
recording this difference (Langeveld-Voss et al., 1996). This method was commonly 
used to characterise natural and synthetic macromolecules that are optically active. 
Proteins and polypeptides, for example, are often determined through CD spectra by 
comparing the result with semi-empirical models to predict secondary structures such 
as  helices or  sheets. The most abundant optically active functional groups are 
amide bonds that generate CD signal in the far UV region. These signals are often 
affected by the secondary structure and, thus used to identify unique peptide 
formations. Other optically active groups including aromatic rings on the amino acid 
side chains with CD spectra in the near UV region. Since structurally, PLP is also a 
polyamide containing aromatic groups, CD could be applied to extract information on 
the overall orientation of optical active amide groups and aromatic group to gather 
information on the overall structure. 
 
Synthetic helical polymers were commonly characterized by CD to confirm their helical 
orientation after the 1950s. For example, optically active helical poly(phenylacetylene) 
bearing an L-alanine (L-Ala) residue with a long n-decyl chain as pendants was 
determined to adopt a helical structure by AFM while the sense of the helix formed by 
the polymer was determined by CD (Yashima et al., 2009). This method, however, has 
limitations on projecting the exact structure as models are mostly established semi-
empirically and without a comprehensive data base for synthetic polymers it is nearly 
impossible to predict the secondary structure with this method (Langeveld-Voss et al., 
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1996; Pasternack, 2003). Complementary methods such as X-ray diffraction are 
commonly used in parallel with CD to confirm the molecular structure for polymers with 
a defined crystal structure. In this study, CD was used to characterise PLP and its 
derivatives at different pHs in the presence or absence of lipid vesicles to study the 
polymer structure. X-ray diffraction data of PLP and its derivatives, however, could not 
be obtained with the experimental setup due to insufficient contrast. 
 
Another powerful technique to characterise macromolecular structures is SANS which 
utilises the neutron scattering pattern after penetration of the tested sample. The 
technique is able to probe the 3D structure of a material from 1 nm up to a few hundred 
nm and describe the object in detail. Typical quantifiable data that can be extracted 
from SANS could include shape, volume, gyration radius, mass, and fractal dimension. 
Additionally, how objects in the sample are organised within the media and interact 
between them could also be studied by SANS. The scattering data recorded from the 
technique is a 2-dimensional plot with intensity in the y-axis and scattering vector (q) in 
the x-axis. Intensity is measured as the differential scattering cross section per unit 
volume while the scattering vector could be mathematically calculated as 4𝜋𝜃/𝜆. The 
scattering angle (θ) is recorded during the experiment while the wavelength (λ) of the 
neutron beam, which is considered as a planar monochromatic wave, is selected for the 
experiment (Cousin, 2015). To summarise, the recorded scattering pattern could be used 
to calculate the macro- and micro-structures of the sample at high precision and 
resolution (Hammouda, 1995; Mondal Roy and Sarkar, 2011). Due to its non-
destructive nature and rapid data collection, the method was able to provide high quality 
structural data of macromolecules in solutions and change in structure in different 
environments. In this study, various polymers at different pHs were tested to generate 
crucial information for unveiling the structure of PLP and PLP-based polymers at 
different pH environments for the first time. 
 
In this chapter, new and existing PLP-based polymers were synthesised to study their 
overall structure, characteristics, and functionalities. CD and SANS were applied for the 
first time to characterise PLP and its derivatives at different pHs to supplement existing 
characterisation methods for portraying a more comprehensive picture of the polymer 
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structure and membrane interactive activity. The additional information would provide a 
more detailed structural and mechanistic understanding of the polymer and assist the 








Iso-phthaloyl chloride, potassium carbonate, N,N’-dicyclohexylcarbodiimide (DCC), 
concentrated hydrochloric acid, 4-dimethylaminopyridine (DMAP), N,N-
dimethylformamide (DMF), L-tryptophan methyl ester dihydrochloride, glycine methyl 
ester hydrochloride, potassium hydroxide, di-tert-butyl dicarbonate, sodium 
borohydride, N-hydroxysulfosuccinimide (Sulfo-NHS), N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC), sodium phosphate dibasic, sodium phosphate 
monobasic, phosphoric acid, deuterium hydroxide, dipotassium deuterium phosphate, 
potassium di-deuterium phosphate, phosphoric acid-d3 solution, acetone, methanol, 
dichloromethane, ethylene diamine, trifluoroacetic acid (TFA), chloroform, ethyl alcohol, 
diethyl ether, triethylamine, and trypan blue stain (4%) were purchased from Sigma- 
Aldrich, Gillingham, UK. L-lysine methyl ester dihydrochloride was obtained from Acros. 
L-phenylalanine methyl ester hydrochloride was purchased from Alfa Aesar, Heysham, 
UK. Sodium hydroxide, sodium carbonate and DMSO were purchased from Fisher 
Scientific, Loughborough, UK. Dulbecco phosphate-buffered saline was purchased from 
Life Technologies, Paisley, UK. Florisil Mesh was purchased from Material Harvest, 
Cambridge, UK. Chemicals were chemical grade and used as received without 
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2.2.2 Synthesis of poly (L-Lysine Iso-phthalamide) 
 
 
Poly (L-lysine iso-phthalamide) was synthesised according to the method of Eccleston 
et al., using single-phase polymerisation technique (Eccleston, Slater and Tighe, 1999). 
The reaction is depicted in Figure 2-2 below. 
 
Figure 2-2: Reaction scheme for the synthesis poly (L-lysine iso-phthalamide). The synthesis is a 
polycondensation of L-lysine methyl ester dihydrochloride and iso-phthaloyl chloride in Acetone/Water 
solution.
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In a typical reaction, L-lysine methyl ester·2HCl (0.15 mol, 0.2 M) and an acid acceptor, 
potassium carbonate (K2CO3 0.6 mol, 0.8 M), were dissolved in deionised water (750 
mL). The aqueous solution was placed in an ice bath and stirred with a Teflon-coated 
magnetic stir bar. A pre-cooled dry acetone (750 mL) solution containing iso-phthaloyl 
chloride (0.15 mol, 0.2 M) was added rapidly to the water solution. The reaction was 
allowed to proceed for 30 minutes, during which poly (L-lysine methyl ester iso- 
phthalamide) precipitated out of the solution. The polymer was transferred to a beaker 
containing deionised water (DI water) soaked for 3 hours. Fresh DI water was changed 
every hour while the polymer was gently massaged for 5 minutes during each water 
change. The raw material was dried overnight in a vacuum oven at 55 ºC. Dried poly (L- 
lysine methyl ester iso-phthalamide) was broken down and dissolved in DMSO. Same 
volume of 5 wt% NaOH solution in ethanol (2.5 molar equivalents to each poly (L-lysine 
methyl ester iso-phthalamide) subunit [MW = 276.3 Da], 1.25 M) was added slowly to the 
polymer solution. The hydrolysed polymer precipitated out in 2-3 minutes, and was 
collected by vacuum filtration and re-dissolved in DI water. 
 
The crude polymer solution was dialysed in Visking tubing membrane (MW cut-off 12 - 
14 kDa) against deionised water for 1 week to remove inorganic salts, residual organic 
solvents, and low molecular weight oligomers. Fresh DI water (3 L) was changed daily 
for the during the 1-week purification period. Solid impurities were removed by vacuum 
filtration. The pH of the clear solution was adjusted to 7.4 using 1M NaOH and lyophilised 
to yield the sodium form of poly (L-lysine iso-phthalamide). 
 
To prepare the neutral form, the purified sodium form polymer was acidified to pH 3.0 with 
1 M HCl. The precipitate was collected by vacuum filtration, washed 3 times with DI water 
and lyophilised to yield a fine white powder. 
 
The neutral form of the polymer was used for the structural characterisation and 
modification while the sodium salt form was used to prepare aqueous polymer solutions 
for other the physiochemical and biological property studies. 
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2.2.3 Synthesis of Amino Acid-Modified Poly (L-lysine Iso-phthalamide) 
 
 
The derivative of poly (L-lysine iso-phthalamide) grafted with amino acids includes, L- 
glycine, L-tryptophan and L-phenylalanine, were formed using standard DCC promoted 
amide-coupling chemistry as depicted in Figure 2-3 below (Haslam, 1980). 
 
 
Figure 2-3: Reaction scheme for the synthesis of Phenylalanine grafted poly (L-lysine iso- 
phthalamide). The reaction was achieved through standard DCC/DMAP coupling. The phenyl group is 
denoted as R and y varies by grafting percentage. 
 
 
In a typical synthesis for 50% amino acid grafted-PLP, poly (L-lysine iso-phthalamide) (3 
g, 10.87 mmole [COOH]), appropriate amount of L-glycine methyl ester·HCl, triethyl 
amine as an acid acceptor (1.2 molar equivalent to L-glycine methyl ester·HCl), and 
DMAP as a catalyst (0.6 g, 20 wt% of the polymer) were dissolved in a pre-cooled and 
anhydrous binary DMSO/DMF (1:3 V:V, 60 mL) solvent. A separate solution of DCC (3 
molar equivalent of L-glycine methyl ester·HCl) in DMF (20 mL) was prepared and added 
dropwise to the polymer solution. The reaction was allowed to proceed at room 
temperature for 60 hours. 
 
Solid impurities and side product dicyclohexylurea were removed by vacuum filtration and 
a 5 w/v NaOH in anhydrous ethanol solution (2.5 molar equivalent of each polymer 
subunit) was added to hydrolyse ester groups. Polymers with low grafting percentage (< 
25%) precipitated out directly in 2-3 minutes. For polymers with higher degree of grafting, 
the reaction was allowed for 3 hours and added rapidly to 5 volume of diethyl ether. The 
precipitate was collected by vacuum filtration and re-dissolved in DI water. The polymer 
was dialysed in Visking tubing membrane (Medicell, MW cut-off 12-14 kDa) against DI 
water for 1 week. Fresh DI water (1 L) was changed daily for the during the 1-week 
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purification period. The pH of the solution was adjusted to ~7.4 and lyophilised to 
produce a white powder. For the preparation of the neutral form, the dialysed solution was 
acidified to pH ~3 with 1 M HCl. The precipitation was collected by vacuum filtration, 
washed 3 times with DI water, and lyophilised to a fine white powder. 
 
The derivatives grafted with L-phenylalanine or L-tryptophan was prepared analogously 
except doubling the amount of triethyl amine for the starting material contains 2 molar 
equivalents of HCl instead of one. The degree of grafting was controlled by varying the 




2.2.4 Polymer Characterisation 
2.2.4.1 Nuclear Magnetic Resonance (NMR) 
 
 
Polymers were dissolved in DMSO-D6 and characterised by Bucker Advance 500 MHz 
NMR spectroscopy (Bruker Biospin GmbH, Germany). The H NMR spectrum were 
processed through peak picking and integration with MNova software (Mestrelab 
Research, Spain). The data was used to confirm polymer structure and calculate grafting 
percentage of modified PLP polymers. 
 
 
2.2.4.2 Fourier Transform Infrared Spectroscopy (FTIR) 
 
 
Attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) was 
used to determine the presence of benzene ring, amide group, and carboxylate group. 
Similar to other absorption spectroscopy techniques, FTIR uses a light source to excite 
chemical functional groups and extract unique emission patterns. FTIR shines 
polychromatic light of different frequencies to acquire absorption data and which can 
then Fourier transformed into an absorption spectrum. The advantage of this method is 
the higher signal-to-noise ratio that could be obtained. 
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Absorption spectra of PLP-based polymers were collected using a Thermo Nicolet 
Nexus 870 spectrometer (Waltham, MA, USA) as the average of 32 scans with a 
wavenumber resolution of 4 cm-1 in the 600-4000 cm-1 range. As a control, unmodified 
PLP was used to be compared to modified polymers. 
 
 
2.2.4.3 Size Exclusion Chromatography (SEC) 
 
 
The SEC measurements were performed in collaboration with Ms. Shiqi Wang at the 
Department of Chemical Engineering, Imperial College London. The experiment was 
performed according to Dabai et al. using polystyrene (PS) as a standard using a 300 
mm long, 7.5 mm i.d., PS/polydivinylbenzene-packed, Mixed D size exclusion column 
(Polymer Laboratories, UK) with 1-methyl-2-pyrrolidinone (NMP) as the mobile phase at 
flow rate of 0.5 mL/min and 80 ºC. Signal detection was measured by a Knauer diode 
array Smartline 2600 detector with UV absorbance at 270, 300, 350, and 370 nm 
(Herod et al., 2000; Dabai et al., 2014). The standard curve was constructed using PS at 
molecular weight (MW) ranging from 580 to 5x106 Da. A linear relationship between the 
log of MW and elution time was established for estimating the sample molecular weight. 
 
 
2.2.4.4 Measuring Transition pH of Polymers Through Turbidity 
 
 
Polymers were each dissolved in DI-water to make 10 mg/mL polymer stock solution. 
Phosaphase buffer (PB) at different pHs were prepared by first making 0.1 M PB with 
corresponding amount of phosphoric acid, sodium phosphate monobasic and sodium 
phosphate dibasic. The pHs of the stock solutions were measured by a pH meter (n=3). 
The polymer solutions were added to PB buffer at various pH in a 1:10 dilution to make 
1 mg/mL final concentration in clear Eppendorf semi-micro Vis cuvettes (Eppendorf, 
UK). The UV spectra of the solutions were measured at 460 nm with a BMG Labtech 
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2.2.4.5 Circular Dichroism (CD) of PLP-based polymers 
 
 
Circular dichroism is the spectrum generated by recording the absorbance of polarised 
light at various wavelength of a chiral molecule. The method is commonly used to 
characterise chiral molecules and secondary structure of chiral macromolecules. In the 
case of polypeptides and proteins, the near UV region of CD spectra in proteins often 
arise from the aromatic amino acids. Each aromatic amino acid has a unique wavelength 
profile and spectrum arises from the vibronic transitions of different excitation level 
(Langeveld-Voss et al., 1996; Greenfield, 2006). The shape and magnitude of the near 
UV spectrum heavily depends on the type of aromatic amino acid present, their mobility, 
their environment (H-bond, polar group and polarisability) and their spatial disposition in 
the protein. Even though the understanding for the near UV CD spectra is currently not 
advanced enough to provide concrete structural information, it is still a useful tool to unveil 
the changes of proteins with exposure to different environments or site directed 
mutagenesis (Kelly, Jess and Price, 2005; Miyahara, Nakatsuji and Sugiyama, 2013). In 
the case of PLP and PLP-based polymers, data from the near UV region could unveil 
some important changes in different pH environments relating to the aromatic groups of 
the polymers (Freskgaard et al., 1994). 
 
Stock solution of the polymers were prepared by dissolving lyophilised polymers in their 
sodium form in DI water at 1 mg/mL. PB at different pHs were prepared by first making 
stock solution of 0.1 M PB with corresponding amount of phosphoric acid, sodium 
phosphate monobasic, and sodium phosphate dibasic. The pHs of the stock solutions 
were measured by a pH meter (n=3) before diluted with DI water into 10 mM PB solution. 
Stock polymer solution were added to 10 mM PB at the corresponding pH for CD 
measurements with a final polymer concentration of 0.1 mg/mL. Spectra were recorded 
at 25ºC on an Aviv model 410 circular dichroism spectrophotometer (Aviv Instruments, 
Lakewood, NJ, USA). Far UV-spectra were scanned from 185 nm to 260 nm while near 
UV-spectra were scanned from 260 nm to 320 nm. Data was collected for every 1-nm 
interval and averaged for 5 seconds. Each of the final spectra was the result of averaging  
three scans. All spectra were baseline corrected and smoothed with Aviv 540 software  
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(Aviv Instruments, Lakewood, NJ, USA). 10 mM PB of the tested pH were measured and 
used as blank for baseline correction. Mean Residual Ellipticities (MRS) were calculated 
with Function 2-1. 
 
 
[𝜃]𝑀𝑅𝑊,𝜆  = 𝑁 × 𝑀𝑅𝑊 × 𝜃𝜆/10 × 𝑐 × 𝑑 Function 2-1 
 
 
The  is the ellipticity measured in millidegrees at a given wavelength, d is the length of 
the cell in centimeters, c is the polymer concentration in grams per liter. The Mean 
Residue Weight (MRW) is the polymer subunit molecular weight. N is the number of 
peptide bonds in the PLP or PLP-based polymer per subunit. Grafting percentages were 




2.2.4.6 Small Angle Neutron Scattering (SANS) 
 
 
SANS experiments were performed at ISIS, Science & Technology Facilities Council 
(STFC), Didcot, UK under the supervision of Dr. Ian Tucker from Unilever and Dr. Robert 
Dalgliesh from the STFC. The scattering studies were carried out using the Larmor 
beamline using the white beam time of flight method. The geometry and neutronics were 
set up so as to collect data from 0.005 to 0.5 reciprocal angstroms in Q. Samples were 
prepared in D2O and using appropriate phosphoric acid-d3, potassium dideuterium 
phosphate, and potassium deuterium phosphate salts so as to maintain the pH at either 
4.1, 6.1 or 7.4. Samples were placed into clean cylindrical 2 mm quartz 
spectrophotometer cells and data were collected for a period of 60 minutes, followed by 
10 minutes for the sample transmission. Time of flight data were reduced, regrouped 
into 1-D radial averaged data using the Mantid data reduction suite. The scattering 
length density (SLD) was calculated as discussed later in this section and was fed into 
the models. SLD calculator Web (https://sld-calculator.appspot.com/) was used to 
determine the SLD of the 0.1 M deuterated PB used in the experiment. A 550:1 of D2O 
and Na2DPO4 was used as input for Compound Formula from the calculated molar ratio. 
Density of D2O of 1.1 g/mL was used in place of 0.1 M deuterated PB as the density of 
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0.1 M PB is 0.2% greater than H2O and the difference can be considered trivial in this 
experiment. 
 
Data were processed using Igor 7 (Wavemetrics inc., OR, USA) with the NIST Center for 
Neutron Research (NCNR) Analysis Macro extension (Kline, 2006). Primary analyses 
on the slope of the Intermediate region (0.01 Å-1 < q < 0.1 Å-1), which measures the size 
and compactness of the objects at a scale of approximately 100 to 1,000 Å, was 
performed to determine the microscopic shape of the individual objects in the samples 
using the slope of the SANS spectra. After selecting the most probable shapes, the 
corresponding models from an existing library in the Igor software (Wavemetrics inc., 
OR, USA) were selected. The fit function of the software then automatically projects a 
SANS spectrum and compares it to the experimental spectrum. Different models will 
provide prediction on different dimensional characters of an object. For example, a 
model for cylinders would predict the length and the radius while a model for spheres 
would provide only the radius. Depending on the number of outputs, this would 
determine the degree of freedom the model would have to generate a best-fitting model 
to describe the sample. How well the model fit would be described as reduced Chi-
square value which would depend on the degree of freedom of the model and how the 
projected spectrum and experimental spectrum deviate. Reduced Chi-square value is 
commonly used commonly to measure the goodness of fit and is defined as chi-square 
per degree of freedom (Andrae, Schulze-Hartung and Melchior, 2010). Models selected 
as the best fit reported in this study had a reduced Chi-square value closest to 1. 
 
 
2.2.5 Biological Assays 
2.2.5.1 Cell Culture 
 
 
All tissue culture experiments were conducted in sterile laminar flow cabinets (Microflow 
Class 2), using sterile disposable plasticware, to minimise contamination. Material or 
chemical introduced to cell culture vessels was sterilised by autoclave (121 ˚C for 20 
minutes) or filtered through 0.22 µm-filters (Millex-Fisher Scientific, Paisely, UK). 
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HeLa adherent epithelial cells (human cervical cancer cells) were grown in DMEM media 
supplemented with 10% (v/v) fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/mL 
penicillin/streptomycin (Pen-Strep) unless specified otherwise. HeLa cells were 
trypsinised using trypsin-EDTA and maintained in a humidified incubator with 5% CO2 at 
37 ºC. 
 
Cell concentration was determined by manual counting with a haemocytometer (Sigma, 
UK). The cell suspension was stained with trypan blue, to discriminates between live and 
dead cells. Cell suspensions (10 µL) were introduced to the haemocytometer and covered 
with a glass slip and counted under an Olympus CK2 microscope. The four corner 
squares of cells on the heamocytometer were averaged and converted to a cell count by 
multiplying the dilution factor times and the area of a standard haemocytometer square. 
 
 
2.2.5.2 Intracellular Delivery of Membrane Impermeable Calcein 
2.2.5.2.1 Flow Cytometry for Fluorescence Measurement 
 
 
Calcein (a membrane impermeable fluorophore) was used as a tracer molecule to monitor 
the effect of polymer intracellular delivery efficiency. Disodium calcein salt was dissolved 
in phosphate buffer saline (PBS) at pH 7.4 to make 200 mM stock solution. HeLa cells 
were seeded in 24-well plates at 5x104 cells/mL in 0.5 mL supplemented DMEM to full 
confluence in 24 hours followed by incubation with 0.22 µm filter-sterilised 
supplemented media and 2 mM calcein in the presence or absence of polymers. Cells 
were washed twice with PBS, trypsinised and resuspended in phenol red-free DMEM 
supplemented with FBS spun down at 0.2 g for 5 minutes. The supernatant was 
removed and the cell pellets were resuspended in phenol red- and FBS-free DMEM and 
transferred into a Titertube 1 mL micro test tube (Bio-Rad, UK). Cells were analysed by 
Cytek DxP8 cell sorter (Cytek Bioscience, USA) with 10,000 event count measuring side 
scattering and fluorescent intensity at various emission wavelengths. The results were 
processed by FlowJo software (Cytek Bioscience, USA) by quantifying fluorescent 
intensity of the gated cells. All experiments were conducted in triplicates. 
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2.2.5.3 Structure Transformation of PLP Polymers in the Presence of Lipid 
Vesicles 
2.2.5.3.1 Preparation of DOPC Giant Unilamellar Vesicles (GUV) 
 
 
GUV used in this study was synthesised by Mr. Mattia Morandi of Institut Charles Sadron, 
Strasbourg, France. GUVs were prepared using a variation of the gel-assisted formation 
method introduced by Weinberger (Weinberger et al., 2013). Simply a polyvinyl alcohol 
(PVA) gel formed with a 5% volume fraction of PVA in PBS at pH 7.4 was deposited on 
a borosilicate glass and placed at 80°C for 2 hours to form a homogenous gel substrate. 
10 L of 1,2-Di(cis-9-octadecenoyl)-sn-glycero-3-phosphocholine (DOPC) in chloroform 
(2 mg/mL) were deposited on the gel substrate and kept in vacuum for 30 min to ensure 
complete solvent evaporation. The resulting lipid film was hydrated with a polymer 
solution in 10 mM PB for at least 1 hour to the appropriate concentration. The liposome 
suspension solutions were then collected by pipettes for experiment. 
 
 
2.2.5.3.2 CD Measurement of polymer in the presence of GUV 
 
GUV solutions prepared as mentioned in the previous section were used for the CD 
experiment. Spectra were recorded at 25 ºC on an Aviv model 410 circular dichroism 
spectrophotometer (Aviv Instruments, Lakewood, NJ, USA). Far UV-spectra were 
scanned from 185 nm to 260 nm. Data was collected and treated as mentioned in the 
previous CD section. GUV in 10 mM PB was used as blank for baseline correction. 
 
PLP or PP-75 aqueous solution was diluted in 10 mM PB at different pHs to make 0.1 
mg/mL in 10 mM solution at various pHs. Solutions with 0.2 mg/mL GUV in the presence 
of 0.1 mg/mL PLP or PP-75 in 10 mM PB at different pHs were also measured by CD. All 
spectra were baseline corrected and smoothed with Aviv 540 software (Aviv Instruments, 
Lakewood, NJ, USA). 
2.2.6 Statistical Analyses 
 
All data are reported as the mean ± standard deviation from at least three independent 
measurements. The statistical significance in mean values between two groups was 
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analysed using a one-way ANOVA followed by a Tukey’s test for multiple comparisons. 
The tests were analysed using GraphPad Prism (GraphPad Software, US). A p-value of 
<0.05 was taken as statistically significant and noted as * (p< 0.05), ** (p< 0.005); and 




2.3 Results and Discussion 
2.3.1 PLP synthesis and characterisation 
 
 
After synthesis and purification, the polymer was a white solid in both its sodium and 
acidic forms. Structural characterisation was performed via 1H-NMR, FTIR and Gel 
Permeation Chromatography (GPC). The acidic form of PLP in DMSO-d6 was used for 
NMR to confirm the chemical structure. The 1H-NMR spectrum and the chemical 
structure of PLP are depicted in Figure 2-4 with the appropriate proton assignment as the 
following δ 1.28-1.62 (g, -CH2-), 3.26 (f, -CH2-), 4.38 (h, -CH-), 7.5 (c, bezene-H), 7.9 – 
8.02 (b, d, H-benzene-H), 8.32 (a, benzene-H), 8.56 -8.76 (e, i, -NH-). The 1H-NMR 
spectrum agreed with the chemical shifts reported (Eccleston et al., 2000; Chen et al., 
2009). Of note, the peak at 12.3 is assigned to the proton on the COOH group as it has 
a high chemical shift typical the functional group. However, the presence of this peak at 
approximately 12 ppm for PLP and its derivative will depend on the purity of the sample 
and may not be observed in all NMR spectra. 
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Figure 2-4: Chemical structure and 1H-NMR Spectrum of poly (L-lysine iso-phthalamide) in DMSO- 
D6. The protons on the chemical structure of PLP were each assigned to a legend and labelled on the 1H- 
NMR spectrum. The peak at 2.5 ppm was due to water residue and can be ignored. 
 
 
Further confirmation of the PLP chemical formulation could be observed in the FTIR 
spectrum with the appropriate chemical functional group assignment in Figure 2-5. The 
absorption peaks include N-H and O-H stretch (3300 cm-1), carboxylic acid C=O stretch 
(1710 cm-1), amide band I (1630 cm-1), amide band II (1530 cm-1), and C-O stretch (1270 
cm-1), which agreed with what was previously reported (Chen, 2007). 
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Figure 2-5: FTIR spectrum of poly (L-lysine iso-phthalamide). Peaks labelled were assigned to the 
appropriate functional groups of PLP. 
 
 
SEC result of PLP obtained with the method used in this study method suggested a Mn 
of 472.39 kDa and Mw of 882.24 kDa (Figure 2-6). The result was different from the Mw 
of 23820 Da and Mw of 5894 Da previously reported by Chen and Khormaee using gel 
permeability chromatography (GPC) and matrix-assisted laser desorption/ionization time-
of-flight mass spectroscopy (MALDI-TOF) respectively (Chen, 2007; Khormaee, 2009). 
The molecular weight obtained was different from the previous results as the polymers 
in this study were dissolved in an organic solvent, N-Methyl-2-pyrrolidone (NMP), rather 
than an aqueous solution like the two previously reported methods. Additionally, the 
standard polymer, PS, used in this experiment is an extremely flexible polymer without 
polar amide groups compared to PLP that contains amphiphilic functional groups and 
could adopt an organised structure. Therefore, the PLP molecular weight determined by 
the PS standard would not be an accurate representation of the true molecular weight. 
This GPC method could however, be a useful alternative to compare the molecular 
weight of PLP and PLP- based polymer. 

























Figure 2-6: Size exclusive chromatography spectrum of poly (L-lysine iso-phthalamide). Molecular 
weight and polydispersity of PLP were determined by comparing to a standard curve constructed by PS 
and results are presented in the table below the spectrum. 
 
 
2.3.2 Amino acid-grafted PLP synthesis and characterization 
 
 
Phenylalanine (Phe) grafted PLP (PP) is the most effective form of delivery polymer of 
the modified PLP. PP-50 and PP-75 were synthesised using the same DCC/DMAP 
protocol developed by Chen et al. to yield white solids. 1H-NMR showed that the PP 
polymer had comparable chemical composition compared to that previously reported 
(Figure 2-7) (Chen, 2007). The peak at 7.3 ppm corresponds to the five hydrogens on 
the phenyl group of Phe and was used to calculate the grafting percentage. The grafting 
percentage calculated by 1H-NMR was 46.0 % and 60.8% for PP-50 and PP- 75 
respectively. The results were comparable to what was previously reported (Chen, 
2007). 
 57  
 
 
Figure 2-7: Chemical structure and 1H-NMR Spectra of PLP, PP-50, and PP-75. The unique proton on 
the backbone benzene was denoted as a and assigned to the according peak on the NMR spectra. Five 
protons on the phenyl group were denoted as b and assigned to the peak on the NMR spectra of PP-50 
and PP-75. DMSO and water peaks at 2.5 and 3.5 ppm were removed for better visualisation of the spectra. 
 
 
In order to better understand how amino acid modifications affected PLP and how efficient 
were the reactions, the simplest form of amino acid, glycine (Gly), was used for 
modification of PLP. After reaction and purification, a white PG-50 solid was yielded. The 
polymer was characterised by 1H-NMR with a grafting percentage of 49.0% (Figure 2-8). 
The overall reaction efficiency was 98.0% for PLP glycine grafting compare to 92.0 % of 
PP-50 and 81.1 % for PP-75. This could be due to the fact that there was no steric 
hindrance effect for glycine methyl ester compared to L-phenylalanine ethyl ester that 
contains a benzene ring on the side chain. Therefore, the amine group on the glycine has 
a higher chance to react with the free carboxylate group on the PLP side chains. The 
reaction efficiency could also be affected by the solubility of L-phenylalanine methyl ester 
in DMSO/DMF. 
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Figure 2-8: Chemical structure and 1H-NMR Spectra of PG-50 and PLP. The unique proton on the 
backbone benzene was denoted as a and assigned to the according peak on the NMR spectra. The 
unique proton on the amine group of the grafted glycine was denoted as b and assigned to the peak on 
the NMR spectrum of PG-50. DMSO and water peaks at 2.5 and 3.5 ppm were removed for better 
visualisation of the spectra. 
 
 
The chemical structures of the polymers were further confirmed through FTIR and the PP 
polymers’ spectra agreed with what were previous reported by Chen et al. (Chen et al., 
2009). The transition pHs of PLP, PG-50 and PP-50 were shown in Figure 2-9, where 
PP-50 had the highest transition pH at pH 4.9. Surprisingly, glycine modification slightly 
increased the transition pH by approximately 0.6 while transition pH of PLP and PP-50 
were determined to be 3.67 and 4.90. The transition pH of both PLP and PP-50 were 
lower than what was previously reported 4.7 and 5.5 at 1 mg/mL (Chen, 2007). The 
main reason for the difference could be due to the buffer system that was used in this 
study. The higher transition pH values were determined using a phosphate citrate system 
while phosphate buffer was used in this study. 
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Figure 2-9: Variation of the turbidity of PLP, PG-50, and PP50 in different pH conditions. The turbidity 
of polymers in phosphate buffer at pH between 2.5 and 7.8 were measured at λ = 460 nm. 
 
 
The buffer range for phosphate buffer is between pH 5.8 and 8.0 while citrate buffer’s 
between pH 3.0 and 6.2. In the experiments previously conducted used a mix of 
phosphate and citrate buffer was used to determine the transition pH (Chen, 2007). In 
this study, phosphate buffer was used and that could cause the difference in transition 
pH. Citrate could not be used in CD experiments because it absorbs strongly in the far 
UV region that could interfere with the spectrum of PLP polymers. For consistency and 
because PB has the capacity to make the desired pH, it was used throughout the 
experiment. The pH of each solution was measured by a pH meter (n=3) and 
determined to be the desired pH in agreement with what was listed on the Sigma 
website. No titration experiments were involved, therefore, buffering capacity would not 
have a major impact on the result. 
 
As Phe and Tyr were both used to modify PLP, to completely test the hypothesis that the 
aromatic side chain was a main factor to increase membrane disruptive activity, L- 
tryptophan (Trp) was used to modify PLP polymer to yield a water insoluble yellow solid 
PW-50. 1H-NMR was used to characterise the polymer and the six hydrogens on the 
aromatic group of Trp were assigned to the peaks between 6.8 and 7.3 ppm as shown on 
Figure 2-10. The assignment was based on comparing the spectrum of PW-50 and PLP 
side by side. There was methanol residue in the PW-50 sample which resulted in 
additional peaks between 1.0 to 1.4 ppm and a single peak at 4.3 ppm. The ethanol 
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residue was from the hydroxylation of ethyl ester PW-50. The grafting percentage of PW- 
50 was determined to be 30.8 % by 1H-NMR (Figure 2-10). The grafting efficiency was 
rather low (61.6 %) compare to other modifications such as Phe (92.0%) and Gly 
(98.0%). What might had affected the reaction efficiency could be the lower solubility of 
Trp in DMSO/DMF and the solubility of PW-50 in polar solvents which may cause the 
polymer to crash out before reaching higher grafting percentage. Even at this lower 
grafting percentage PW-50 was insoluble in water and PB and exhibited a surfactant 
effect. Various methods such as sonication or increasing temperature to 60 ºC did not 




Figure 2-10: Chemical structure and 1H-NMR Spectra of PW-50 and PLP. The unique proton on the 
backbone benzene was denoted as a and assigned to the according peak on the NMR spectra. The five 
protons on the aromatic group excluding the one on the secondary amine of the grafted tryptophan were 
denoted as b and assigned to the peaks accordingly on the NMR spectrum of PW-50. DMSO peaks at 2.5 
ppm were removed for better visualisation of the spectra. 
 
 
As PW-50 was determined to be insoluble in water, replacement of half of the Trp with 
Phe in the reaction on a molar basis was an attempt to create a soluble hybrid polymer. 
A cream colored solid PPW-50 was obtained after purification and lyophilisation. The 
polymers were characterised by 1H-NMR and calculated to have a total grafting 
percentage of 37.6 % for PPW-50 (Figure 2-11). Phe and Trp individual grafting 
percentage were 21.6 % and 15.8 % respectively. In other words, the reaction efficiency 
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for Phe and Trp in the reaction were 87.2 % and 47.2 %. The result was interesting as the 
hybrid grafting reaction efficiency of Phe and Typ grafting were both lower compared to 
using a single amino acid. Even comparing the two amino acids in the same reaction, 
Phe had a much higher efficiency. This could be explained by the different in solubility of 
Phe and Trp in the reaction condition as mentioned before. Additionally, the nitrogen on 
the aromatic sidechain of Trp might have hindered its efficiency on forming reactive 
complex with the DCC catalyst, which in turn, decreased the overall reaction efficiency. 
The activity of PPW-50 will be discussed in a later section. 
 
 
Figure 2-11: Chemical structure and 1H-NMR Spectra of PPW-50. The 1H-NMR spectra of PP-50 and 
PLP were included as references. The unique proton on the backbone benzene was denoted as a. The five 
protons on the aromatic group excluding the one on the secondary amine of the grafted tryptophan were 
denoted as b and assigned to the peaks accordingly on the NMR spectrum of PPW-50. The five protons 
on the phenyl group of the grafted phenylalanine were denoted as c and assigned to the peak at 7.2 ppm. 
DMSO peaks at 2.5 ppm were removed for better visualisation of the spectra. 
 
 
2.3.3 Polymer Secondary Structure and Conformation Characterisation by CD 
 
 
Each polymer was dissolved in 10 mM PB at various pHs and characterised by CD 
spectroscopy. PLP and PG-50 had very similar CD spectra at pH 7.4 while PP-50 had a 
distinct spectrum with a stronger absorption of both left- and right-circularly polarised light 
relatively to the two other polymers (Figure 2-12A). As shown in Figure 2-12B, PLP at 
physiological pH had negative CD at 215 nm. Increase in positive CD absorption was 
 62  
observed as the pH decreased until pH 4.0 which was close to the transition pH 3.6 of 
PLP determined in this study. Further decrease in pH did not contribute to enhanced 
polarised light absorption. Instead, a decrease in CD was observed at pH 3.0. This 
observation could be due to the precipitation of PLP polymer that decreased the overall 
concentration of optically active groups in the solution. The spectra at pH 3.0 was still 
similar to the spectrum at pH 6.1 but with decreased strength. The increase in CD as the 
pH decreased to its transition pH is an evidence that that the overall polymer was forming 
into a more ordered structure. This phenomenon could be further verified by SANS 
discussed in the following section. 
 
 
Figure 2-12: Circular Dichroism spectra of A) an overlay of PLP, PG-50, and PP-50 at pH 7.4. B) CD 
spectra of PLP C) PG-50, and D) PP-50at various pHs. Polymers were analysed at 0.1 mg/mL in 
phosphate buffer at the specified pH between 185 and 260 nm. 
 
 
PG-50 was characterised by CD at four different pHs in 10 mM PB. The CD spectra of 
PG-50 was comparable to the PLP while PG-50 did not have a significant change in the 
CD at 215 nm as pH decreased (Figure 2-12C). This could be explained by the glycine 
modification on the pendant group of the PLP backbone. As glycine is not hydrophobic 
nor does it contain an aromatic group, therefore, it would disturb the packing of 
hydrophobic groups in PLP as pH decreases. Making it more difficult for PG-50 to 
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consolidate into a more compact macrostructure that PLP could potentially form. 
 
PP-50 was characterised by CD spectroscopy in the same conditions as PLP and PG- 
50. The CD spectra of PP-50, unlike PG-50, had very different spectra compared to PLP. 
The broad positive peak between 225 and 255 nm could not be observed in PP-50’s 
spectra. Instead having a local minimum at 215 nm, there were two maxima at 198 and 
218 nm (Figure 2-12D). Similar to PLP, as the pH approached the transition pH, the CD 
became most prominent. In the case of PP-50, strongest signals could be observed at pH 
6.1 and 5.0. Incidentally the two pHs were very close to the transition pH of PP-50 that 
was discussed in the previous section. The same observation was also observed in the 
case of PLP. The CD spectra of the polymers, however, suggested that the structure of 
the polymer might not shifted as dramatically as observed in typical fusogenic proteins. 
Never the less, the aggregation or formation of macrostructure might have contributed to 
the membrane disruptive activity of PLP-based polymers upon the change in response to 
environmental pH. Furthermore, the structural information was obtained in the absence 
of lipid membranes such as liposome or giant unilamellar vesicles (GUV). A more 
accurate structural information on the membrane-disruptive state could only be revealed 
with a more sophisticated study. 
 
The near UV CD spectra of the three polymers at different pHs were also recorded 
between 260 and 320 nm in similar experimental conditions. For polypeptides, the near 
UV region reflects the environment where aromatic side chains and often change when 
the polypeptide changed conformation or was denatured (Freskgaard et al., 1994; Kelly, 
Jess and Price, 2005). As shown in Figure 2-13A, the near UV spectrum of PLP 
changes as pH decreases. The change reflects that the aromatic benzene groups within 
the polymer experience different environment at different pH which may be result of 
changing intra- polymer conformation or inter-polymer interaction. A similar trend was 
observed in the near UV spectra of PG-50 and PP-50 shown in Figure 2-13B and Figure 
2-13C respectively. Interestingly, the near UV spectrum of PP-50 at pH 7.4 was similar 
to the near UV spectrum of PLP at pH 7.4 while the spectrum of PG-50 at pH 7.4 was 
slightly different. As the pH decreases, the near UV spectrum of PG-50 seems to have 
less changes compared to the spectra of PLP and PP-50. This observation could imply 
that the packing of aromatic groups in PG-50 is slightly different from PLP. 
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Figure 2-13: Circular Dichroism near UV spectra of A) PLP B) PG-50, and C) PP-50 at various pHs. 




2.3.4 Small Angle Neutron Scattering 
 
 
Neutron scattering has gained popularity as a method to characterise molecular 
structure especially for macromolecules in solution. The high resolution and non-
destructive nature of the method enables the detection of even small changes in 
molecular structure while retaining the sample (Penfold and Thomas, 2014). In this 
study, SANS was used to characterise PLP and PP-50 polymer structures in deuterated 
10 mM PB solution at different pHs. As shown in Figure 2-14, PLP was determined to 
have adopted a stiff rod structure with length of 200 Å and cylinder diameter at pH 7.4, 
6.1 and 4.1. The diameter of the PLP increased as the pH decreased. 




Figure 2-14: SANS spectra of PLP at pH 7.4, 6.1 and 4.1 in deuterated phosphate buffer solution. 
Deuterated phosphate buffer at selected pH was used as background. Spectra were fitted with the best 
matching models to determine the shape and dimensions of the polymer in solution. The simulated model 
and dimensions are presented in the Table 2-1. 
 
 
pH 4.1 6.1 7.4 
Form Cylinder Cylinder Cylinder 
Length (Å) 200 200 200 
Diameter (Å) 21 16 14 
Volume Fraction 0.0009 0.0015 0.002 
SLD (10-6) 1 1 1 
 
Table 2-1: The list of dimensions and projected structures of PLP at three pHs. The dimensions were 
derived from models that were simulated to best fit the SANS spectra shown in Figure 2-14. 
 
 
Different from the previous hypothesis that PLP changes from an extended structure to a 
more compact globular structure upon lower pH, SANS data suggest that PLP is a rod 
structure between pH 7.4 and 4.1. From the increase in diameter and aggregation pattern 
of PLP, it is likely that the polymer is a thinner rod bundled into a larger structure. It is 
likely that the protonation affected the diameter of individual coils of PLP as well as the 
ability of PLP to aggregate into multi-coil bundles. The attenuated ionic repulsion intra- 
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molecularly induced a more compact coil of PLP, thus the slight decrease in diameter. 
Inter-molecularly, hydrophobic interaction was relatively strengthened and more PLP 
coils aggregated in PB buffer. As seen in Table 2-2, it is hypothesised that the diameter 
of individual PLP bundles would decrease as pH decreases while the number of PLP in 
each bundle increases. The projected diameter was calculated based on the perfect 
stacking of different number of identical cylinders (Figure 2-15). As shown in Table 2-2, 
the projected diameter agreed with the SANS data with only a small amount of difference. 
At pH 4.1, however, the projected diameter was 25.7 % larger than the data from SANS. 
This could be due to either underestimation of how much individual PLP diameter 
decreased or the false assumption of the individual PLP packing pattern. The 
hypothesis of PLP packing as a functioning multi-bundle rod was inspired by helical 
peptides with membrane disrupting properties, more specifically, celling penetrating 
peptides (CPP). For example, HA2 protein’s fusion peptide subunit, X31, is most 
effective in membrane penetration when forming a triple helix structure. Another cell 
penetrating peptide, sweet arrow peptide (SAP), is an amphiphilic peptide with five 
helixes. According to a review, CPPs usually form a helical structure with hydrophobic 
and hydrophilic groups on two opposing sides (Lau et al., 2004). This observation for 
CPPs that have similar membrane disruptive and amphiphilic characteristics forms the 
basis for the hypothesis that multiple helixes bundle into a rod with the hydrophilic side 
on the exterior. However, SANS does not have the resolution to confirm this theory and 
additional characterisation techniques such as X-ray crystallography would be required. 
 
Figure 2-15: Proposed structure of PLP in solution at pH 7.4, pH 5.1, and pH 4.1. Each rod represents 
a PLP polymer chain and each grey sphere represent a negative charge. The bundle of rods depicts the 
hypothesised macrostructure of PLP in solution. 
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 pH 7.4 pH 6.1 pH 4.1 
Hypothesised Individual 
PLP Diameter (Å) 
6.8 6.4 6.0 
Number of PLP Coils 3 4 5 
Projected Diameter (Å) 14.65 15.45 26.4 
Diameter Calculated by 
SANS (Å) 
14 16 21 
% Difference 4.64 % 3.44 % 25.71 % 
Table 2-2: The list of proposed dimensions of PLP macrostructure at three pHs compared to SANS 
predicted dimensions. The dimensions were calculated by adding hypothesised individual PLP diameters 
which was derived from approximately the dimension of benzene ring. 
 
 
PP-50 was also characterised by SANS at pH 7.4, 6.1, and 4.1. As shown in Figure 2-16, 
PP-50 resembles a barbell at pH 7.4 in PB buffer with length of 282 Å, diameter of 16.8 
Å and an end cap diameter of 38.9 Å. The transition from a rod-like barbell object to a 
lamellar surface structure were derived from the best fitting model to the corresponding 
PP-50 SANS spectra and could be observed from the three PP-50 spectrum below. 
 
 
Figure 2-16: SANS spectra of PP-50 at pH 7.4, 6.1 and 4.1 in deuterated phosphate buffer solution. 
Deuterated phosphate buffer at selected pH was used as background. Spectra were fitted with the best 
matching models to determine the shape and dimensions of the polymer in solution. 
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Derived from models, PP-50 forms a fluid lamellar structure at pH 6.1, indicating that the 
polymer could aggregate and form organized macrostructure. At pH 4.1, PP-50 was 
observed to form a lamellar structure with 12 Å thickness. This observed self-assembly 
formation of lamellar structures could be of crucial importance to the enhanced 
membrane disruptive effectiveness of PP-50 compared to PLP. It was proven that 
forming high concentration of localized aggregation could significantly alter the 
membrane disruptive activity as shown in fusogenic X31 peptides. For X31 fusogenic 
peptide, the affinity towards lipid bilayer was not the most important factor for membrane 
disruptive activity but a “corporate effect” where coiled coil trimer was formed and is far 
more effective than the monomer. For PP-50, increase in amphiphilicity did decrease the 
membrane lysis tension [increase membrane vulnerability], but forming a localized 
structure or defect was a more effective mechanism to cause membrane lysis. The 
hydrophobic modification could indeed increase the interaction between the polymer and 
lipid bi-layer, however, the polymer intermolecular attraction contributed to the significant 
increase in the intracellular delivery efficiency. 
 
 
2.3.5 Biological Activity of PLP-based polymers 
2.3.5.1 Membrane activities of polymers determined by CD 
 
 
Initial studies using the polymer with giant unilamellar vesicles (GUV) were conducted 
using PLP and PP-75 polymers. As shown in Figure 2-17A, the CD spectra of PLP with 
GUV at pH 7.4 is similar to PLP alone with a local maximum at 245 nm and minimum at 
approximately 215 nm. The circular light absorption was, however, less intense in the 
presence of GUV. This result suggested that PLP formed a less ordered structure in the 
presence of lipids indicating polymer-lipid interaction. The effect of pH responsiveness in 
the presence of lipid was further tested on PP-75 and studied by CD. 

























Figure 2-17: Circular dichroism spectra of A) PLP at 7.4 B) PP-75 at pH 7.4, and C) PP-75 at pH 5.1 
in the absence or presence of giant unilamellar vesicle (GUV). Polymers were analysed in phosphate 




As shown in Figure 2-17B, GUV did not affect the overall CD spectra of PP-75 compared 
to PLP. The far UV region of PP-75 in the presence of GUV was similar to PP-75 alone 
at pH 7.4 with a comparable maximum value at 198 nm. The reason of this result may be 
that at physiological pH, PP-75 forms an ordered structure that does not interact with lipid. 
However, as pH was dropped to 5.1, the absorbance of polarised light of PP-75 in the 
presence of GUV became less prominent at 198 nm (Figure 2-17C). This observation 
could be due to the enhanced membrane interaction of PP-75 at pH 5.1 where the 
polymer-membrane interaction became more prominent as the negative charge on PP- 
75 reduce. This interaction, in turn, affected the packing of PP-75 and made the optically 
active amide groups oriented in a less orderly fashion. 
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2.3.5.2 Intracellular Delivery of Membrane Impermeable Fluorophore 
 
 
The intracellular delivery efficiency was measured by enhanced uptake of membrane 
impermeable fluorescent calcein dye in the presence of polymer. Flow cytometry was 
used to quantify the increase in fluorescent signal in HeLa cells. As shown in Figure 2- 
18, PLP increases calcein uptake slightly compared to control while PP-50 increases 
calcein uptake significantly. The results in HeLa cells were comparable to what was 
previous reported (Chen et al., 2009). Interestingly, the hybrid polymer PPW-50 was as 
effective as PP-50 in enhancing intracellular delivery of calcein at 1 mg/mL and 
incubated for 24 hours in HeLa cells despite having a lower grafting percentage at 
37.4% compared to 46.0% in PP-50 (Figure 2-18). It was previously reported by Chen et 
al., that the increase in grafting percentage of Phe positively corresponded to higher 
intracellular delivery efficiency in modified PLP. Therefore, the fact that PPW-50 at lower 
grafting percentage and a less hydrophobic amino acid modifier could achieve high 
calcein intracellular delivery efficiency further confirmed that aromatic side chains of the 





Figure 2-18: Intracelluar calcein concentration of HeLa cells determined by flow cytometry. HeLa 
cells were incubated with 2mM of calcein in the presence or absence of 1 mg/mL of polymer for 24 hours. 
Cells without calcein incubation were used as control. The fluorescent signal was normalised to calcein 
only without polymer (n=3). ** (p = 0.0048); **** (p < 0.0001). 




PLP was confirmed by various characterisation methods to be similar to that previously 
reported (Chen, 2007; Khormaee, 2009). CD and SANS were new methods applied for the 
first time to characterise PLP. It was revealed that PLP forms an optically active helical 
secondary structure that is 200 Å by length. As pH decreases from physiological norm, 
the length of PLP remains the same while the macrostructure of the polymer changes. 
Based on the SANS data, a larger bundle rod structure as pH decrease was proposed. 
The proposed structure shown in Figure 2-15 did not deviate to much from the data 
collected. Therefore, it is likely that the previous hypothesis that PLP is a flexible polymer 
chain at pH 7.4 and condense into a globular structure at lower pH may not be accurate. 
 
PG-50 studies provided evidence that steric hindrance of the amino acid side chain 
somewhat affects the grafting efficiency. Although Gly grafting did not significantly affect 
the polymer secondary structure, it does increase the transition pH slightly. As shown by 
SANS and CD data, PP-50 had a significant different secondary structure compared to 
PLP and it also forms a lamellar macrostructure. The formation of a larger lamellar 
macrostructure could potentially be an important factor for PP polymers to be a more 
effective membrane disruptive agent at its transition pH compared to PLP. 
 
Hybrid PPW-50 polymer was the first time two amino acids were used simultaneously to 
modify PLP polymer. The grafting percentages of Phe and Trp were similar to if Phe 
and Trp were used individually. Despite having a lower overall grafting percentage 
PPW-50 had comparable intracellular delivery activity as PP-50 in HeLa cells. The 
result suggested that an aromatic amino acid has large impact on the effectiveness of 
modified PLP as an intracellular delivery agent. 
 
This study did reveal new information on the structure of PLP and how modification could 
affect the resulting polymer. However, more in-depth studies are still warranted to reveal 
the exact structure of PLP and the mechanism of how PLP disrupts lipid membranes. 
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Chapter 3 THE EFFECTS OF CHIRALITY ON THE STRUCTURE 




3.1.1 Chirality and Enantiomers 
 
 
Nature consists of complex and sophisticated macromolecular structures for tasks such 
as information storage, support of tissue and localised chemical catalysis. Despite the 
large amount of resources and researchers devoted to achieving the same goal using 
synthetic systems, nucleic acid and proteins still outperform man-made materials. Nature 
utilises the self-assembly of both low- and high-molecular weight compounds as the 
building block for various biological architectures. The most common structural 
components relied on are the -helix and -sheets of peptides. These secondary 
structures along with steric, hydrophobic, electrostatic, and hydrogen bonding 
interactions give rise to the tertiary structure of proteins that provide the foundation of life. 
The smallest component, amino acids, contain different information through the form of 
chirality. In fact, the biological system relies heavily on chiral molecules such as L-amino 
acids and D-sugars (Hein and Blackmond, 2012). 
 
A chiral molecule is a molecule that is non-superimposable on its mirror image. Chiral 
molecules consist of at least one chiral centre that is commonly induced by an 
asymmetrical carbon. The mirror image or images of a chiral molecule are called 
enantiomers. Enantiomers have the same chemical formula and the same functional 
groups but they all have a unique absolute configuration. The configuration of a chiral 
molecule could be described differently based on the entity’s geometry or its ability to 
rotate plane-polarised light, which is a common technique to study chirality (Kelly and 
Price, 2000). Take the most common amino acid in the biological system, -amino acid, 
as an example. The -carbon of amino acids is the chiral centre except for glycine. The 
absolute configuration of amino acid could be defined by the Cahn-Ingold-Prelog 
system where the four groups attached to the -carbon is described either clockwise (R) 
or counterclockwise (S) (Wang et al., 2017). Amino acids could also be described by  
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relative configuration derived from Fischer’s research in glyceraldehyde. The amino acid 
can be assigned the dextrorotatory (D)- or levorotatory (L)- configuration depending on 
how the chiral centre is arranged relative to chiral glyceraldehydes. Coincidentally, the 
assignment, D- and L-amino acids also rotated the polarised light clockwise and 
counterclockwise, respectively. Amino acids in the mammalian cells are almost 
exclusively the L enantiomers (Hein and Blackmond, 2012; Wang et al., 2017). 
 
The importance of using enantiomers to study macrostructures is that different 
enantiomers could result in different structure or activity. For example, only one 
enantiomer of a drug may be active because the cell receptors recognise distinct structure 
even when the molecules contain the same chemical composition (Nguyen, He and 
Pham-Huy, 2006). Using different enantiomers as starting material could provide 
additional insight in how synthetic polymers such as PLP and PP-50 form 
macrostructures and how that affect their interaction with the biological system. In this 
study L- and D-lysine were used to synthesise PLP while L- and D-phenylalanine were 
used to modify PLPs. The resulting polymers were characterised and studied in vitro to 
provide further insight for how PLP and PP-50 function. 
 
 




Chemicals were purchased from Sigma Aldrich and biological reagents for cell culture 
were purchased from Thermo Fisher/Invitrogen if not otherwise specified. 
 
 
3.2.2 Synthesis and Characterisation of PLP Enantiomers 
 
 
Poly (lysine iso-phthalamide) (PLP) was synthesised as described in CHAPTER 2, 
section 2.2.2 Synthesis of Poly (L-Lysine Iso-phthalamide), except L-lysine was replaced 
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with D-lysine or equal amounts of L-lysine and D-lysine for poly (D-lysine iso-phthalamide) 
PLP-D and poly (L- and D-lysine iso-phthalamide) (PLP-L-D) respectively. Polymers were 
de-protected and purified as described in the previously and the characterisation methods 
are described below. 
 
 
3.2.3 Synthesis and Characterisation of 50% Phenylalanine Modified Poly (Lysine Iso- 
phthalamide) Enantiomers 
 
PLP-L and PLP-D were each used as the backbone to synthesise PP-50 polymers. The 
reaction was carried out as described in CHAPTER 2, section 2.2.3 Amino Acid Modified 
Poly (L-Lysine Iso-phthalamide) except the amount of PLP used was reduced to 1 g per 
reaction with all other chemicals and solvents reduced accordingly. Two enantiomers of 
Phenylalanine (Phe) were used separately in combination with PLP-L and PLP-D to yield 
four types of PP-50. The PP-50 were assigned as PP-50-L-L, PP-50-L-D, PP-50-D-L and 
PP-50-D-D where the first letter after PP-50 is the configuration of Phe and the second 
being the configuration of PLP backbone. Polymers were purified and treated as 
described in the previous chapter. 
 
 




Polymers in acidic form were dissolved in DMSO-d6 and characterised by Bucker 
Advance 500 MHz NMR spectroscopy (Bruker Biospin GmbH, Germany). The 1H-NMR 
spectra were processed through peak picking and integration with MNova software 
(Mestrelab Research, Spain). 
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3.2.4.2 Fourier Transform Infrared Spectroscopy (FTIR) 
 
 
Absorption spectra of PLP polymers were collected using a Thermo Nicolet Nexus 870 
spectrometer (Waltham, MA, USA) as the average of 32 scans with a wavenumber 
resolution of 4 cm-1 in the 600-4000 cm-1 range. As a control, unmodified PLPs were used 
to be compared to modified polymers. 
 
 
3.2.4.3 Size exclusive chromatography (SEC) 
 
 
The SEC experiment was performed according to Dabai et al. using polystyrene (PS) as 
a standard using a 300 mm long, 7.5 mm i.d., PS/polydivinylbenzene-packed, Mixed D 
size exclusion column (Polymer Laboratories, UK) with 1-mehtyl-2-pyrrolidinone (NMP) 
as the mobile phase at flow rate of 0.5 mL/min and 80 ºC. Signal detection was measured 
by a Knauer diode array Smartline 2600 detector with UV absorbance at 270, 300, 350, 
and 370 nm (Herod et al., 2000; Dabai et al., 2014). The standard curve was 
constructed using PS at molecular weight (MW) ranging from 580 to 5x106 Da. A linear 
relationship between the log of MW and elution time was established. 
 
 
3.2.4.4 Measuring Transition pH of Polymers Through Turbidity 
 
 
Polymers were each dissolved in DI water to make 10 mg/mL polymer stock solution. PB 
at different pHs were prepared by first making 0.1 M PB with corresponding amount of 
phosphoric acid, sodium phosphate monobasic and sodium phosphate dibasic. The pHs 
of the stock solutions were measured by a pH meter (n=3). The polymer solutions were 
added to PB buffer at various pH in a 1:10 dilution to make 1 mg/mL final concentration 
in clear Eppendorf semi-micro Vis cuvette (Eppendorf, UK). The UV spectra of the 
solutions were measured at 460 nm with a BMG Labtech SPECTROStar Nano (BMG, 
Allmendgruen, Germany). 
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3.2.4.5 Circular Dichroism Spectroscopy 
 
 
Circular dichroism (CD) is a powerful spectroscopic technique utilising left- and right- 
handed polarised light to determine asymmetrical structures in molecules. It was 
commonly used to determine the secondary structure of macromolecules such as 
proteins and the helical sense of synthetic polymers (Freskgaard et al., 1994; Miyahara, 
Nakatsuji and Sugiyama, 2013; Zhang and Deng, 2016). 
 
Stock solutions of polymers were prepared by dissolving lyophilised polymers in their 
sodium form in DI water at 1 mg/mL. PB at different pHs were prepared by first making 
stock solution of 0.1 M PB with corresponding amount of phosphoric acid, sodium 
phosphate monobasic and sodium phosphate dibasic. The pHs of the stock solutions 
were measured by a pH meter (n=3) before diluted with DI water into 10 mM PB solution. 
Stock polymer solution were added to 10 mM PB at the corresponding pH for CD 
measurements with a final polymer concentration of 0.1 mg/mL. Spectra were recorded 
at 25ºC on an Aviv model 410 circular dichroism spectrophotometer (Aviv Instruments, 
Lakewood, NJ, USA). Far UV-spectra were scanned from 185 nm to 260 nm while near 
UV-spectra were scanned from 260 nm to 320 nm. Data was collected for every 1-nm 
interval and averaged for 5 seconds. Each of the final spectra was the result of averaging 
three scans. All spectra were baseline corrected and smoothed with Aviv 540 software 
(Aviv Instruments, Lakewood, NJ, USA). 10 mM PB of the tested pH were measured and 
used as blank for baseline correction. Mean Residual Ellipticities (MRS) were calculated 
with the following formula. 
 
[𝜃]𝑀𝑅𝑊,𝜆  = 𝑁 × 𝑀𝑅𝑊 × 𝜃𝜆/10 × 𝑐 × 𝑑 Function 3-1 
 
The  is the ellipticity measured in millidegrees at a given wavelength, d is the length of 
the cell in centimeters, c is the polymer concentration in grams per liter. The Mean 
Residue Weight (MRW) is the polymer subunit molecular weight. N is the number of 
peptide bonds in the PLP or PLP-based polymer per subunit. Grafting percentages were 
taken into account for modified PLP polymers (Kelly, Jess and Price, 2005). Protein A, a 
protein with three alpha-helix residues commonly used to purify or detect 
immunoglobulins, was used at 0.1 mg/mL as a model to compare to PP-50 enantiomers 
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(Kessler, 1975). The average molecular weight of amino acid was used for MWR while 
N=1 were used as parameters to calculate the MRS for protein A. The calculated MRW 
spectrum of protein A was inversed while comparing to PP-50-L-L and PP-50-D-L. 
 
 
3.2.4.6 Small Angle Neutron Scattering (SANS) 
 
 
SANS experiments were conducted in the same condition as described in CHAPTER 2, 
section 2.4.6 Small Angle Neutron Scattering (SANS). Enantiomers of PLP and PP-50 
were each conducted in the conditions same as PLP and PP-50. 
 
 
3.2.4.7 Cell Culture 
 
 
HeLa cells were handled, passaged and maintained as described in CHAPTER 2, using 
the same cell line, reagents, and conditions. 
 
 
3.2.4.8 Biological Activities of Polymers 
3.2.4.8.1 Flow Cytometry for Fluorescence Measurement 
 
 
Calcein (a membrane impermeable fluorophore) was used as a tracer molecule to monitor 
the effect of polymer intracellular delivery efficiency. Disodium calcein salt was dissolved 
in PBS to make 200 mM stock solution. HeLa cells were seeded in 24-well plates at 5x104 
cells/mL in 0.5 mL supplemented DMEM to full confluence in 24 hours followed by 
incubation with 0.22 µm filter-sterilised supplemented media and 2 mM calcein in the 
presence or absence of polymers. Cells were washed twice with PBS, trypsinised and 
resuspended in phenol red-free DMEM supplemented with FBS spun down at 0.2 g for 5 
minutes. The supernatant was removed and the cell pallets were resuspended in phenol 
red- and FBS-free DMEM and transferred into a Titertube 1 mL micro test tube (Bio-Rad, 
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UK). Cells were analysed by Cytek DxP8 cell sorter (Cytek Bioscience, USA) with 10,000 
event count measuring side scattering and fluorescent intensity at various emission 
wavelengths. The results were processed by FlowJo software (Cytek Bioscience, USA) 




3.2.4.8.2 Confocal Microscopy 
 
 
HeLa cells were incubated in supplemented DMEM for 48 hours before the experiment in 
a 4-well 1.8 cm2 chambered cover glass system (Nunc, UK) at 5x104 cells/well and 500 
L/well. Cells were first washed twice with PBS and incubated with phenol red- and FBS- 
free DMEM in the presence or absence of 2 mM calcein for 24 hours with or without 
polymers. Cells were then washed twice with PBS and incubated with 5 g/mL Hoecht 
33342 and 5 g/mL PI in phenol red- and FBS-free DMEM for 20 minutes. Subsequently, 
cells were washed again twice with PBS before phenol red-free DMEM was added to 
each well and imaged under confocal microscopy. 
 
 
3.2.4.9 Measuring Cytotoxicity of Polymers 
 
 
Cytotoxicity of polymer in HeLa cells was determined by commercially available MTS 
assays. The assay is a standard colorimetric method for determining the number of viable 
cells under proliferation. The active chemicals are a novel tetrazolium compound [3-(4,5- 
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium; 
MTS] and an electron-coupling reagent (ohenazine ethosulfate; PES). The MTS 
tetrazolium compound is reduced by metabolically active cells to a colored formazan 
product that could be quantified at an absorbance of 490 nm by a spectrophotometer. 
The absorbance of the formazan product and viable cells within the range of the cell 
concentrations was a linear relationship. Therefore, the reduction of cellular metabolic 
activity of HeLa cells, followed by polymer or chemical exposures, was determined by
MTS assay. The assay was performed according to the manufacturer’s protocol. 
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Experiments were performed in six repeats. The spectra were recorded using a BMG 
Labtech SPECTROStar Nano plate reader (BMG, Allmendgruen, Germany). 
 
 
3.3 Results and Discussion 
3.3.1 PLP enantiomers 
 
 
In this study, the effect of lysine enantiomers (L- or D-) has on the resulting polymer 
PLP-L, PLP-D, and PLP-L-D were studied (Figure 3-1). Polymers were synthesised and 
characterised with various methods to study how the PLP enantiomers differ and 
elucidate additional information on how the polymers interact with the biological system. 
 
 
Figure 3-1: Chemical structure of PLP-L, PLP-D, and PLP-L-D. The Chiral centers on the α-carbon of 
lysine were specified and assigned either L or D. The total of x and y subunit in PLP-L-D is equal to n. 
 
 
3.3.1.1 Synthesis of PLP enantiomers 
 
 
L-lysine, D-lysine, or an equal molar amount of L-lysine and D-lysine were used 
separately to synthesise PLP-L, PLP-D and PLP-L-D. All three PLP enantiomers, PLP-L, 
PLP-D, and PLP-L-D, were synthesised, purified, and lyophilised in the same conditions 
as described in the materials and methods section to yield white solids. There were no 
observable differences in the color, texture, or yield of the three polymers throughout the 
syntheses and purification processes. Five characterisation methods including 1H-NMR, 
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FTIR, SEC, CD, and SANS were applied to characterise the three polymers and the 
results would be reported in the sections below. In addition to the above-mentioned 
characterization methods, the three polymers were each tested in vitro with membrane 
impermeable fluorophore, calcein, for their intracellular delivery activities and 
biocompatibility with MTS metabolic assay. 
 
 
3.3.1.2 Characterisation of PLP enantiomers 
3.3.1.2.1 1H-NMR of PLPs 
 
The three PLP enantiomers, PLP-L, PLP-D, and PLP-L-D, were each characterised by 
1H-NMR and shown to have identical peaks at δ 1.28-1.50 (g, -CH2-), 3.26 (f, -CH2-), 4.38 
(h, -CH-), 7.5 (c, bezene-H), 7.9 – 8.02 (b, d, H-benzene-H), 8.32 (a, benzene-H), 8.56 - 
8.76 (e, i, -NH-) (Figure 3-2). The peaks agreed with what was previously reported by 
Ecclestion et al. and in Chapter 2 of this study. Integrated ratios of the peaks obtained 
through 1H-NMR for the three polymers were calculated to be similar which proved further 
evidence that the three polymers have similar proton distributions and environments. 
There were two observable differences in the NMR spectra of the three PLPs which are 
peaks at 3.3 ppm and 12.7 ppm. The first peak at around 3.3 ppm corresponded to water 
residue in the polymer samples or solvent that are typical in H-NMR preparations. The 
peak should not be taken into account for determining polymer chemical structures in the 
case of PLP. The second peak at 12.7 ppm was the proton on the pendant carboxylate 
group of PLP that are commonly affected by hydrogen bonding and the pH environment. 
The peaks at the chemical shifts that high are usually weak and neglected for determining 
proton molar ratio due to its high variability. 




Figure 3-2: Chemical structure of PLP and 1H-NMR Spectra of PLP-L, PLP-D, and PLP-L-D in DMSO- 
D6. The protons on the chemical structure of PLP were each assigned to a legend and labelled on the 1H- 
NMR spectrum. The DMSO peak at 2.5 ppm was removed for better visualisation. 
 
 
3.3.1.2.2 FTIR of PLP enantiomers 
 
 
FTIR was applied to characterise the three PLPs as additional evidence for their chemical 
structure. As shown in Figure 3-3, the three FTIR spectra of PLP-L, PLP-D, and PLP-L- 
D, in the respected order, all absorbed at key wavenumbers corresponding to N-H and 
O-H stretch (3300 cm-1), carboxylic acid C=O stretch (1710 cm-1), amide band I (1630 cm- 
1), amide band II (1530 cm-1), and C-O stretch (1270 cm-1). The data suggested that all 
three polymers contain the above mentioned functional groups at the respected peaks 
assigned. Both 1H-NMR and FTIR results strongly suggested that the three polymers 
have the same proton distribution and functional groups. Therefore, the three polymers 
could be concluded to have the same chemical formula. Note that NMR and FTIR both 
does not have the capability to distinguish enantiomers. To determine whether the three 
polymers are structurally different, CD and SANS were applied to elucidate further 
information about the three PLP polymers. 
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Figure 3-3: FTIR spectrum of PLP-L, PLP-D, and PLP-L-D. Peaks labelled were assigned to the 
appropriate functional groups of PLP. The spectrum of each polymer was color coded and listed below the 
horizontal axis label. 
 
 
3.3.1.2.3 Size Exclusion Chromatography of PLP enantiomers 
 
 
SEC was conducted to determine the molecular weight of all three polymers. As 
mentioned in the previous chapter, the SEC system used in this study was not the optimal 
system to characterise PLP and PLP-derived polymers. The SEC data could, however, 
be a useful reference to compare the size of the three PLP enantiomers and their poly 
dispersity. As shown in Figure 3-4, the three PLPs had very similar retention time with a 
large peak at approximately 12 minutes and a small peak at around 22 minutes. Based 
on the SEC data, PLP-L, PLP-D, and PLP-L-D had very similar size, distribution, and poly 
dispersity at 1.87, 1.85, and 1.99. respectively. This data suggested that the three PLPs 
adopt structures similar in size in the NMP solution. This data supported the theory that 
the three PLP enantiomers have similar size and macrostructures in solution. 





Figure 3-4: Size exclusive chromatography spectrum of PLP-L, PLP-D, and PLP-L-D. Molecular 
weight and polydispersity for each of the three PLPs were determined by comparing to a standard curve 
constructed by PS and results are presented in the table below the spectra. 
 
 
3.3.1.2.4 Measuring the Transition pH of PLPs by Turbidity 
 
 
One of the important characters of PLP is its pH responsiveness. As determined in the 
previous chapter, PLP has a transition pH in PB at approximately 3.7. Using the same 
experimental setup, the transition of the three PLPs were determined. As shown in Figure 
3-5, transition pHs of PLP-L, PLP-D, and PLP-L-D were determined to be 4.2, 4.0, and 
3.6 respectively (n=3). This was surprising as the three PLPs were characterised to have 
the same chemical formulation, functional group and polydispersity. Transition pH of PLP- 
L was also previously determined to be 3.7, which is 0.5 apart from what was determined 
in this study. However, PLP-L and PLP-D had very close transition pH which was 
expected. PLP-L-D on the other hand, had a much lower transition pH. As previously 
mentioned, the aggregation of PLP is caused by the decrease in inter- and intra-molecular 
ionic repulsions. PLP-L-D might have similar structure to the other two PLPs, but because 
the alternating L- and D-lysine may cause the packing of PLP-L-D to require higher 
enthalpy compared to its two other enantiomers which resulted in the lower transition pH. 
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Figure 3-5: Variation of the turbidity of PLP-L, PLP-D, and PLP-L-D in different pH conditions. The 
turbidity of polymers in phosphate buffer at pH between 2.5 and 7.8 were measured at λ = 460 nm. Each 
data point was derived from three replicates. Error bars represent standard error. 
 
 
3.3.1.2.5 Circular Dichroism 
 
 
All three PLP enantiomers were characterised by CD spectroscopy at three different pHs 
between wavelength 185 nm to 320 nm. The spectra were separated into two different 
regions, the far- and near-UV regions, based on common methods used to analyse 
protein and peptide CD spectra. The far UV region (185 to 260 nm) is usually dominated 
by amide bonds and the near UV region (260 to 320 nm) by aromatic functional groups. 
As shown in Figure 3-6A, far-UV spectra of PLP-L and PLP-D were mirror images. This 
indicated that the two chemically identical polymers both have asymmetrical centres but 
with different chiralities. The structure of PLP-L was hypothesised to be a helical coil 
supported by CD and SANS discussed in Chapter 2. For coil structures, the direction, 
either clockwise or anti-clockwise, of which the coil is formed is defined as sense 
(Yashima et al., 2009). And logically in PLP synthesis, using L-lysine would produce a 
helix of one sense while using D-lysine would produce a helix with the opposite sense 
since iso-phthalic acid linker contains no chiral centre. Therefore, the CD spectra provided 
strong evidence that PLP-D adopted a helical structure of opposite sense to PLP-L. On
the other hand, PLP-L-D which was synthesised using equal molar ratio of L-lysine and 
D-lysine as starting material, had no prominent CD spectrum in the far UV region at pH 
7.4, 6.0, and 4.0. There are two possible explanations for the lack of CD signal in the far 
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UV region for PLP-L-D. First, PLP-L-D may lack the secondary helical structure like the 
other two PLPS that is oriented to exhibit CD signal. This phenomenon could be observed 
in proteins that were denatured either by high temperature or detergent and lost their 
secondary structure (Kelly, Jess and Price, 2005; Greenfield, 2006). To parallel this lack 
of CD signal in proteins with PLP-L-D, the L- and D-lysine mixture might have induced 
the polymer to adopt a random coil formation. The second hypothesis is that the L- and 
D-lysine regions each form micro-domain of opposite sense within the polymer resulting 
in destructive interference of CD signal. This phenomenon was well documented in 
synthetic chirality- induced helical polymers such as polyacetylenes. The polymer 
backbone forms into helical domains with opposite sense in water but could be induced 
into a single sense by adding chiral solvents (Yashima and Katsuhiro, 2007). As the L- 
and D-lysines are chemically identical, there is no direct way to prove the lysine 
distribution in the PLP polymer. In other words, there is no simple method to determine 
whether L-lysine and D- lysine alternate in each subunit or form sub-regions where L-
lysine-based subunits repeat for a number of times before a D-lysine sub-region occur in 
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Figure 3-6: Far UV Circular Dichroism spectra of A) an overlay of PLP-L, PLP-D, and PLP-L-D at pH 
7.4. B) CD spectra of PLP-L C) PLP-D, and D) PLP-L-D at three different pHs. Polymers were analysed 
at 0.1 mg/mL in phosphate buffer at the specified pH between 185 and 260 nm. 
 
 
The two hypotheses could, however, be indirectly proven by analysing the structural data 
obtained by SANS in a later section. When the PLP polymer lacks secondary structure, it 
could be more flexible and take up a random coil conformation which should in theory 
have a larger volume in solution. 
 
As previously mentioned, far UV region of CD spectra could provide useful structural and 
environmental data of the aromatic groups in different conditions (Kelly and Price, 2000; 
Kelly, Jess and Price, 2005; Greenfield, 2006). As shown in Figure 3-7A, the three PLP 
enantiomers had similar CD spectra at pH 7.4 between 285 to 320 nm. This indicated that 
the aromatic ring in the three polymers have similar orientation and neighbouring 
environment even when all three polymers had very different CD spectra in the far-UV 
region (Kelly and Price, 2000; Kelly, Jess and Price, 2005). Additionally, the three 
polymers all respond to pH change similarly in the near-UV region (Figure 3-7). All three 
polymers had inversed signals when the pH was changed to 6.0 and 4.0 while the 
spectra at the lower pH were very similar. This observation is interesting as the three  
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polymers all have transition pH at approximately 4, but the spectra were inversed at 
pH 6.0. Therefore, despite having different secondary structure, the aromatic component 





Figure 3-7: Near UV Circular Dichroism spectra of A) an overlay of PLP-L, PLP-D, and PLP-L-D at 
pH 7.4. B) CD spectra of PLP-L C) PLP-D, and D) PLP-L-D at various pHs. Polymers were analysed at 
0.1 mg/mL in phosphate buffer at the specified pH between 260 and 320 nm. 
 
 
3.3.1.2.6 SANS data analyses for PLP enantiomers 
 
 
SANS data was obtained to determine the dimension of different PLP enantiomers and 
compare the structural differences at a high resolution. As shown in Figure 3-8, the three 
polymers have very similar spectrum at pH 7.4. The intermediate region indicated that 
all three polymers adopted a cylindrical shape at pH 7.4, which is similar to the helical 
structure of PLP discussed in CHAPTER 2. differences of the three spectra are mainly 
in the low-Q region (Q<0.01) where, in the case of PLPs, the ratio of length and radius 
was determined. As shown in Table 3-1, all three PLP enantiomers adopted a cylinder 
structure with approximately the same length (within 10%) compared to PLP-L at around
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200 nm. However, there were some variabilities in the low Q region, indicating that the 
radius of PLP-D and PLP-L-D rods were slightly smaller than that of PLP-L. According to 
the models, PLP-D and PLP-L-D had diameter of 8.2 Å and 8.5 Å respectively. As there 
were a lot of variability in low Q region of PLP-D and PLP-L-D, it is difficult to conclude 
whether the measurement was accurate and whether the derived radius was a true 
representation of PLP-D and PLP-L-D at pH 7.4. 
 
 
Figure 3-8: SANS spectra of PLP-L, PLP-D, and PLP-L-D at pH 7.4 in deuterated phosphate buffer 
solution. Deuterated phosphate buffer at selected pH was used as background. Spectra were fitted with 
the best matching models to determine the shape and dimensions of the polymer in solution. The simulated 
model and dimensions are presented in the Table 3-1. 
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pH PLP-L PLP-D PLP-L-D 
Form Cylinder Cylinder Cylinder 
Length (Å) 200 178 226 
Diameter (Å) 14 8.2 8.5 
Volume Fraction 0.002 0.0036 0.0014 
SLD (10-6) 1 1 1 
Table 3-1: The list of proposed dimensions of PLP enantiomers at pH 7.4 compared to SANS 
predicted dimensions. The dimensions were derived from models that were simulated to best fit the 
SANS spectra of PLP enantiomers shown in Figure 3-8. 
 
 
The three PLP enantiomers were also studied at pH 6.1 and 4.1 to compare the pH- 
induced conformational changes. As shown in Figure 3-9, pH affected the low Q region 
and the high Q region of the SANS spectrum of PLP-L. The changes translated to an 
increase in the diameter as the pH decreases. As discussed in the previous chapter, it is 
hypothesised that the individual rods bundle to form a larger rod, and as pH decrease, 
more rods form an even larger bundle. The projected dimensions of PLP-L could be found 
in Table 3-2. 




Figure 3-9: SANS spectra of PLP-L at pH 7.4, 6.1 and 4.1 in deuterated phosphate buffer solution. 
Deuterated phosphate buffer at selected pH was used as background. Spectra were fitted with the best 
matching models to determine the shape and dimensions of the polymer in solution. The simulated model 
and dimensions are presented in the Table 3-2. 
 
 
pH 4.1 6.1 7.4 
Form Cylinder Cylinder Cylinder 
Length (Å) 200 200 200 









SLD (10-6) 1 1 1 
 
Table 3-2: The list of dimensions and projected structures of PLP-L at three pHs. The dimensions 
were derived from models that were simulated to best fit the SANS spectra shown in Figure 3-9. 
 
 
As shown in Figure 3-9, similar to PLP-L, PLP-D forms a rod structure and the dimensions 
were affected by a change in pH. The observation of decrease of intensity in the high Q 
region on the right side of Figure 3-9 was similar to what was observed in the spectra of 
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PLP-L at the three pHs. The predicted dimensions of PLP-D’s structure in deuterated 
phosphate buffer can be found in Table 3-3. As shown in the table, the length and 
diameter of the PLP-D rod slightly increase as pH decreases. Interestingly, the low Q 
region of PLP-D did not change to the extent as PLP-L did and along with an increase in 
rod length, the PLP-D diameter did not increase as significantly. As described earlier, the 
dimensions of the assigned shape were derived from a model that best fit the spectra and 
may, in some cases, deviate from the true form of the polymer in solution. For PLP-D, if 
the length were fixed at 200 nm, the diameters of PLP-D at the three pHs would be 
comparable to the diameters predicted for PLP-L and would fit the bundle-aggregation 
theory. The theory was proposed in CHAPTER2 where the smaller individual PLP rods 
does not change conformation as pH changes, but aggregates into a larger bundle 




Figure 3-10: SANS spectra of PLP-D at pH 7.4, 6.1 and 4.1 in deuterated phosphate buffer solution. 
Deuterated phosphate buffer at selected pH was used as background. Spectra were fitted with the best 
matching models to determine the shape and dimensions of the polymer in solution. The simulated model 
and dimensions are presented in the Table 3-3. 
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pH 4.1 6.1 7.4 
Form Cylinder Cylinder Cylinder 
Length (Å) 219 213 178 









SLD (10-6) 1 1 1 
 
Table 3-3: The list of dimensions and projected structures of PLP-D at three pHs. The dimensions 
were derived from models that were simulated to best fit the SANS spectra shown in Figure 3-10. 
 
 
In the case of PLP-L-D, the polymer forms cylindrical polymers at all three tested pHs. At 
pH 7.4, the length was in the 200 Å range with diameter at 8.5 nm according to model 
that best fit the SANS spectrum (Table 3-4). Notable changes were observed in the high 
Q region similar to PLP-L and PLP-D as the pH decreases. Interestingly, the change in 
the low Q region was more significant than both PLP-L and PLP-D. Judging from the 
change in slope at the low Q region, notably larger structures that are potentially 
aggregates were observed (Figure 3-11). It is not surprising as PLPs were previously 
determined to precipitate at pH below the transition pH at around 4. Limited by the 
models chosen, the projected diameter may slightly deviate from the actual diameter of 
the objects. Even with a less precise diameter, a trend of increase in diameter of the 
cylinder as pH decreases could still be observed (Table 3-4). Like PLP-D, the 
observation in PLP- L-D also provide evidence to support the bundle-aggregation 
theory. 




Figure 3-11: SANS spectra of PLP-L-D at pH 7.4, 6.1 and 4.1 in deuterated phosphate buffer solution. 
Deuterated phosphate buffer at selected pH was used as background. Spectra were fitted with the best 
matching models to determine the shape and dimensions of the polymer in solution. The simulated model 
and dimensions are presented in the Table 3-3. 
 
 





Length (Å) 200 220 226 









SLD (10-6) 1 1 1 
 
Table 3-4: The list of dimensions and projected structures of PLP-L-D at three pHs. The dimensions 
were derived from models that were simulated to best fit the SANS spectra shown in Figure 3-11. 
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3.3.1.3 Biological Activities of PLP enantiomers 
 
 
The biological activities of PLP enantiomers were studied in the aspect of how efficient 
are PLPs in facilitating intracellular delivery of membrane impermeable fluorescent dye 
and how cytotoxic are the PLPs at different concentration and incubation time. 
 
 
3.3.1.3.1 Intracellular Delivery Efficiency of PLPs 
 
 
Membrane impermeable calcein was used to evaluate the intracellular delivery efficiency 
of PLPs in HeLa cells. 2 mM of calcein was co-incubated with PLP-L, PLP-D, PLP-L-D or 
equal amount of PLP-L and -D for 24 hours. As shown in Figure 3-12, all the PLPs were 
able to increase intracellular calcein concentration of HeLa cells by at least 10%. There 
was no significant difference in delivery efficiency observed between the four conditions. 
This suggested that the PLP intracellular delivery mechanism was not helical-sense 
sensitive. In other words, HeLa cells may not have discriminated between clockwise or 
counterclockwise helical PLP enantiomers that were implied through CD spectroscopy 
data. This observation could indicate two scenarios. Firstly, the interaction of the cell 
and polymer may not be receptor-mediated. The reason being cell surface receptors 
tend to have high specificity and can usually distinguish between enantiomers. The fact 
that all the PLPs had similar intracellular delivery efficiencies suggested that the role of 
discriminative receptors mediating the delivery may be minimal. Secondly, the difference 
in sense of the helix did not affect the overall interaction of the polymer and cell. It may 
be the case that when the polymers bundle into a larger cylindrical structure as 
proposed in this thesis, the helical sense would not distinctive enough to be recognised 
by the HeLa cell. This is to say that the scale of the sense may be too small for the 
HeLa cell to perceive as different. The fact that PLP-L-D and equal amount of PLP-L 
and PLP-D had comparable intracellular delivery with PLP-L and PLP-D strongly 
supports these two theories, but would require more in-depth studies to confirm each 
scenario. 
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Figure 3-12: Intracelluar calcein concentration of HeLa cells with or without PLP polymers 
determined by flow cytometry. HeLa cells were incubated with 2mM of calcein in the presence or absence 
of 1 mg/mL of polymer for 24 hours. PLP-L+PLP-D represented condition using total polymer concentration 
of 1 mg/mL using equal amounts of PLP-L and PLP-D. Cells without calcein incubation were used as 
control. The fluorescent signal was normalised to calcein only without polymer. Data were derived from 
three replicates. Error bars represent standard error. ** (p < 0.004); *** (p = 0.0002); **** (p < 0.0001). 
 
 
3.3.1.3.2 Biocompatibility of PLP 
 
 
The biocompatibility of PLPs were determined by assessing metabolic activities of HeLa 
cell after 12 and 24 hours incubation with PLPs using a commercially available MTS assay 
(Chen, 2007; Mercado, 2016). As shown in Figure 3-13A, the three PLPs were all well 
tolerated by HeLa cells even at concentration as high as 10 mg/mL. Interestingly, all 
three PLPs raised the signal at 10 mg/mL which may not necessarily reflect an increase 
in the metabolic activity of HeLa cells. As MTS assay rely on the absorbance of 
formazan as 490 nm, where aromatic groups in PLP could potentially interfere. 
Concentration-related effect was not observed in PLP-L at 12-hour incubation, however, 
PLP-D and PLP-L-D had the most effect on cell metabolic activity at 2 mg/mL and 5 
mg/mL respectively. A more significant impact on the cell metabolic activity could be 
observed after 24 hours of PLP incubation but all three polymers were still well tolerable 
at 2 mg/mL (Figure 3-13B). From the MTS assay result, PLP-L, PLP-D, and PLP-L-D 
had very similar toxicity profile in HeLa cells and seem to be well tolerated at 10 mg/mL 
and 2 mg/mL for 12- and 24-hour incubations respectively. 
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Figure 3-13: Metabolic activity of HeLa cells after incubation with PLP-L, PLP-D, or PLP-L-D at 
various concentrations for A) 12 hours and B) 24 hours. Data were normalised to cells incubated in 
the absence of polymer at the same incubation time. Data were derived from three replicates. Error 
bars represent standard error. 
 
 
3.3.2 Syntheses and Characterisation of PP-50 Enantiomers 
 
 
The parental polymer PLP was synthesised as aforementioned into three different 
enantiomers. Two forms of PLP, namely PLP-L and PLP-D, were used to synthesise 
PP-50. L-phenylalanine or D-phenylalanine were used to modify either PLP-L or PLP-
D, yielding four total combinations or PP-50. The chirality of phenylalanine was listed 
first followed by the chirality of lysine in the nomenclature of the polymer. 
 
L-phenylalanine grafted PLP-L (PP-50-L-L), which was referred to as PP-50 in 
previous chapters, was synthesised using protocols as previously described. PP-50-L-
D, PP-50- D-L, and PP-50-D-D were synthesised using the same protocol but 
substituting L- phenylalanine for D-phenylalanine or PLP-L for PLP-D (Figure 3-14). 
The syntheses were also scaled down by one fifth due to limited starting material. 
Grafting was achieved by standard DCC reaction and subsequently purified to yield 
cream color solids. No observable differences during the reaction for the four PP-50s 
occurred. The polymers were characterised using 1H-NMR and FTIR to confirm their 
chemical composition. The transition pH was determined by UV-vis spectrophotometry 
in PB at various pH and the poly-dispersity was obtained by SEC. CD and SANS 
were used to study the macro- and micro-structure of the four polymers in different 
pH conditions. Lastly, confocal microscopy, flow cytometry, and MTS assay were used 
to study the biological activities of the four PP-50 enantiomers. 
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Figure 3-14: Chemical structure of PP-50-L-L, PP-50-L-D, PP-50-D-L, and PP-50-D-D. The Chiral 
centres on the α-carbon of lysine were specified and assigned either L or D while the chirality of the 
grafted phenylalanine was also specified by either L or D. 
 
 
3.3.2.1 1H-NMR of PP-50 enantiomers 
 
 
The four PP-50s were each characterised in DMSO-d6 by 1H-NMR and shown to have 
identical peaks representing the five hydrogens on the phenyl group at 7.3 ppm 
(Figure 3-15). The peaks agreed with what was previously reported by Chen et al. and 
in Chapter 2 of this thesis. Integrated ratios of the peaks suggested that the grafting 
percentage are listed in Table 3-5 below. PP-50-L-L had the highest grafting 
percentage of the four enantiomers at 41.4% while PP-50-L-D, PP-50-D-L, and PP-50-
D-D had a grafting percentage of 30.2, 31.4, and 31.8%. As mentioned in the earlier 
section, the reactions other than PP-50-L-L were scaled down. The DCC grafting 
reaction is most efficient in anhydrous conditions and any residue of water would 
affect the reaction efficiency. In a scale down reaction, water in the environment, in 
lyophilised polymers, or dissolved in the solvent would have a greater impact due to its 
higher relative concentration. Judging from the grafting percentage, the relatively 
higher water content due to scaling down of the reaction was most likely the reason 
for PP-50-L-L to have the highest grafting percentage of all the four enantiomers. 
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Figure 3-15: Chemical structure of PP-50 and 1H-NMR Spectra of PP-50-L-L, PP-50-L-D, PP-50-D-
L, and PP-50-D-D in DMSO-D6. The protons on the chemical structure of PP-50s were each assigned 
to a legend and labelled on the 1H-NMR spectrum. The DMSO peak at 2.5 and H2O peak at 3.3 ppm 
were removed for better visualisation of the spectra. 
 
 PP-50-L-L PP-50-L-D PP-50-D-L PP-50-D-D 
Integrated 
Ratio 












Table 3-5: Phenylalanine grafting percentage of four PP-50 enantiomers. Grafting percentages 
were derived from the 1H-NMR spectra of PP-50 using the appropriate peaks and corresponding 
hydrogen molar ratios. 
 
 
3.3.2.2 FTIR of PP-50 enantiomers 
 
 
To further confirm the chemical structure of the four PP-50 enantiomers are 
consistent, they were characterised by FTIR (Figure 3-17). The spectra of the four PP-
50 enantiomers exhibited similar characteristics at 3,300 cm-1 (N-H and O-H stretch), 
2940 cm-1 (Methylene C-H stretch and aromatic C-H stretch), 1,630 cm-1 (amide band 
I), 1,530 cm-1 (amide band II), and 1,270 cm-1 (C-O stretch). The FTIR spectra from the 
four PP- 50 enantiomers agree with the 1H-NMR result and strongly suggested that 
the four polymers had identical chemical structures. 
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Figure 3-16: FTIR spectrum of PP-50-L-L, PP-50-L-D, PP-50-D-L, and PP-50-D-D. Peaks labelled 
were assigned to the appropriate functional groups of the four polymers. Key function groups were 
labeled on the spectra. 
 
 
3.3.2.3 Size Exclusion Chromatography of PP-50s 
 
 
As shown in Figure 3-17, all four PP-50s had very similar elution time at approximately 
14 minutes and 22 minutes. As described in CHAPTER 2, the SEC system used for 
this study was not optimal for PLP-based polymer which resulted in a different 
molecular weight from the previously reported for PP-50 (Chen, 2007). The poly 
dispersity index observed indicated that PP-50-D-D had the highest variability at 2.65, 
PP-50-L-L was the second more poly dispersed at 2.21. PP-50-L-D and PP-50-D-L 
had the lowest poly dispersity of the four polymers at 2.06 and 2.09 respectively. The 
poly dispersity determined by SEC was higher than the PDI of PLP-L and PLP-D at 
approximately 1.87. This is expected as the grafting process was performed in a non-
controlled fashion and longer polymer chains would receive more Phe grafting making 
the Mw of the chain even higher (Chen, 2007). 
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Figure 3-17: Size exclusive chromatography spectrum of PP-50-L-L, PP-50-L-D, PP-50-D-L, and 
PP- 50-D-D. Molecular weight and polydispersity for each of the four PP-50s were determined by 




3.3.2.4 Transition pH of PP-50s 
 
 
The transition pH of PP-50s were determined by UV-vis in 0.1 M PB in a wide range of 
pHs. Each polymer was tested three times at a given pH to determine the point where 
1 mg/mL PP-50 precipitates. As shown in Figure 3-18, PP-50-D-L had the lowest 
transition pH at 4.8 followed by PP-50-L-L at 4.9, PP-50-D-D at 5.0 and PP-50-L-D at 
5.3. This observation was surprising as PP-50-L-L should have the highest grafting 
percentage and in turn should have the highest transition pH. All three other PP-50s 
had similar grafting percentage but varied poly dispersity index. Therefore, from this 
experiment no pattern could be drawn for which characteristic impacted the transition 
pH of PP-50s. However, the experiment agreed with previous observation that by 
grafting hydrophobic amino acid to PLP, the transition pH of the resulting polymer 
could be raised (Chen, 2007). 
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Figure 3-18: Variation of the turbidity of PP-50-L-L, PP-50-L-D, PP-50-D-L, and PP-50-D-D in 
different pH conditions. The turbidity of polymers in phosphate buffer at pH between 2.5 and 7.8 were 




3.3.2.5 CD Spectra of PP-50s 
 
 
Previously in this chapter, CD was used as a tool to observe the secondary structure 
and determine the sense of PLP enantiomers. It was demonstrated that PLP-L and 
PLP-D adopted a similar rod-like structure while having the opposite sense. In this 
section, the far UV CD spectra of four PP-50s will be examined and discussed to 
understand the effect of polymer components’ chirality had on the overall structure. 
 
Shown in Figure 3-19A is the far UV spectrum of PP-50-L-L, a PLP-L grafted with L-
Phe, compared to the inverse spectra of Protein A. Protein A is a well-defined triple-
helix polypeptide commonly used in the purification of antibodies and the CD spectrum 
of the protein is well defined with 80% of the structure to be in the form of -helix 
(Redmann and Rhodes, 1979; Graille et al., 2000; Yashima et al., 2009). Due Protein 
A’s affinity towards immunoglobulins, it is commonly used in commercial settings to 
isolate and purify immunoglobulins. The spectrum of Protein A in this figure was 
inversed for the ease of comparison to PP-50-L-L. As seen in the figure, Protein A had 
two peaks at 222 and 209 nm and a strong inverse peak at 195 nm, which is typical for 
-helix structure of proteins. In the same figure, PP-50-L-L had two peaks at 215 and 
198 nm while having a strong inverse peak at 185 nm at pH 7.4. The spectrum pattern 
was somewhat similar to that of protein A but with the peaks shifted slightly further 
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down the far UV region and more intense. Note that the CD spectra were all corrected 
to a per unit basis and signal strengths were usually compared among polypeptides. 
Although PP-50- L-L cannot be directly compared to Protein A despite both being 
polyamines, it is a good referent to support that PP-50 adopts a consistent secondary 
structure to generate a strong CD spectrum. As shown in the Fig 3-19A, the CD signal 
at 215 and 198 nm of PP- 50-L-L did not change dramatically which was expected 





Figure 3-19: Far UV Circular Dichroism spectra of A) PP-50-L-L B) PP-50-L-D C) PP-50-D-L, and 
D) PP-50-D-D at three selected pHs. Protein A, a triple helix protein, was included as a reference 
either in its original spectrum or inversed at pH 7.4. Polymers were analysed at 0.1 mg/mL in phosphate 
buffer at the specified pH while protein A was analysed at 0.05 mg/mL at pH 7.4 in phosphate buffer 
between 185 and 260 nm. 
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PP-50-L-D, which is L-Phe grafted on PLP-D, similarly to PP-50-L-L had an inversed 
spectrum compared to its backbone. This phenomenon was observed in the previous 
chapter. Here with four variables of PP-50s, how the CD spectrum of PLP-based 
polymers are affected by grafting could be further studied. On Figure 3-19A and Figure 
3-19C are PP-50s with PLP-L backbone while Figure 3-19B and Figure 3-19C are the 
ones with PLP-D backbone. Regardless of whether L- or D-Phe was grafted onto the 
backbone, the resulting PP-50 polymer had an inverse CD spectrum compare to its 
backbone. However, there were obvious differences in CD spectrum when comparing 
polymers having the same chirality for the lysine in the backbone and grafted 
phenylalanine. It could be observed from Figure 3-19 that PP-50-L-L and PP-50-D-D had 
CD spectra representing mirror images of each other while PP-50-L-D and PP-50-D-L are 
mirror images. The main difference of the two pairs could be seen from the peak at 198 
nm where when the chirality of Phe align with Lys in the backbone had approximately 
two-fold increase in magnitude. This result implied that the two pair of polymers have 
slightly different packing patterns despite having similar chemical structure, transition pH, 
molecular weight, and poly dispersity. How this difference would affect the polymer 
microstructure and biological activity would be discussed in later sections. 
 
 
3.3.2.6 SANS Spectra of PP-50s 
 
 
The PP-50 enantiomers were characterised with SANS to understand how chirality of the 
grafted Phe and the Lys in the polymer backbone would affect the formation of secondary 
structure in solution. The four polymers were each studied in conditions described in 
CHAPTER 2 with 0.1 mM deuterated PB aqueous solutions at pH 4.1, 6.1 and 7.4. 
 
As shown in Figure 3-20, the four PP-50 enantiomers each exhibited different spectrum 
at pH 7.4. As discussed in CHAPTER 2, PP-50-L-L adopted a barbell form in which two 
spheres cap a single long rod. PP-50-D-L at pH 7.4 had a SANS spectrum similar to PP- 
50-L-L, however, the best fit model suggested that the spectrum was consisted of long 
rods and lamellar structure. Interestingly, PP-50-L-D was determined to form a parallel 
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pipe structure in solution at pH 7.4 where rods were organised into a surface. This is very 
likely the precursor of a lamellar structure that PP-50 are capable of forming. In the case 
of PP-50-D-D, it was difficult to fit into a model and the closest shape determined was a 
cylindrical structure. The dimensions determined for the cylinder was, however, smaller 
compared to what was previously observed in PLPs and PP-50s. Each PP-50 
enantiomers will be further discussed throughout this section. 
Figure 3-20: SANS spectra of four PP-50 enantiomers in deuterated phosphate buffer solution at 
pH 7.4. The four spectra were placed in the same graph to demonstrate the structural differences and 
similarities between the PP-50s. 
 
 
As the SANS spectra of PP-50-L-L was discussed in CHAPTER 2, the spectra would 
not be repeated here in this chapter.  The forms and dimension of PP-50-L-L could be 
found in the table below. As previously discussed, the polymer forms a barbell structure 
and transitioned into lamellar structure as pH decreased. 
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Length (Å) - 240 282 
Diameter (Å) - 28 16.8 
End Cap Diameter - - 38.9 
Thickness (Å) 12 - - 
 
Table 3-6: The list of dimensions and projected structures of PP-50L-L at three pHs. The dimensions 




As shown in Figure 3-21, PP-50-L-D’s SANS spectrum shifts in the low Q region as pH 
decreases which was unsurprising give PP-50-L-D was determined to be pH responsive 
in the previous section. However, PP-50-L-D, unlike PP-50-L-L, formed a parallel pipe 
structure at pH 7.4. The length of the structure was predicted to be 107 Å with width of 31 
Å and height of 61.5 Å (Table 3-7). The length of the parallel pipes was shorter than what 
was determined for PLP-D and PP-50-L-L by a factor of 2 which was unexpected as PLP- 
D was the parental polymer and the total length of the modified polymer was unlikely to 
change. 




Figure 3-21: SANS spectra of PP-50-L-D at pH 7.4, 6.1 and 4.1 in deuterated phosphate buffer 
solution. Deuterated phosphate buffer at selected pH was used as background. Spectra were fitted with 
the best matching models to determine the shape and dimensions of the polymer in solution. The simulated 
model and dimensions are presented in the Table 3-7. 
 
 
pH 4.1 6.1 7.4 
Form Lamellar/Ellipsoid Ellipsoid 
Parallel 
piped 
Length (Å) - - 107 
Width (Å) - - 31.8 
Height (Å) - - 61.5 
Thickness (Å) 10 - - 
 
Table 3-7: The list of dimensions and projected structures of PP-50-L-D at three pHs. The dimensions 
were derived from models that were simulated to best fit the SANS spectra shown in Figure 3-21. 
 
 
As the pH decreases, PP-50-L-D transform into ellipsoid and ultimately a mixture of 
ellipsoid and lamellar structure with thickness of 10 Å at below the polymer’s transition 
pH. The phenomenon is very similar to the transition of PP-50-L-L in different pH 
environments previously discussed. 
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For PP-50-D-L, the SANS spectra at the three pHs did not change as significantly as 
the two PP-50s discussed above (Figure 3-22). The structure of PP-50-D-L at pH 7.4 
was projected to be a mixture of long rods and lamellar structure. Unfortunately, no 
reasonable result for the dimensions could be obtained from the model. As shown in 
Table 3-8, PP-50-D-L fully formed into lamellar structure as the pH decreased. 
 
 
Figure 3-22: SANS spectra of PP-50-D-L at pH 7.4, 6.1 and 4.1 in deuterated phosphate buffer 
solution. Deuterated phosphate buffer at selected pH was used as background. Spectra were fitted with 
the best matching models to determine the shape and dimensions of the polymer in solution. The simulated 
models are presented in the Table 3-8. No reasonable dimension could be obtained from the model. 
 
 
pH 4.1 6.1 7.4 
Form Lamellar Lamellar 
Lamellar/Long 
rods 
Length (Å) - - - 
Diameter (Å) - - - 
Thickness (Å) - - - 
 
Table 3-8: The list of dimensions and projected structures of PP-50-D-L at three pHs. The forms were 
derived from models that were simulated to best fit the SANS spectra shown in Figure 3-22. 
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Lastly, PP-50-D-D was discussed in the beginning of this section to adopt a cylinder form 
at pH 7.4. The length assigned for the cylinder was 85 Å with a diameter of 8.6 Å which 
was shorter than what was observed for PLP-D and PP-50-L-L (Table 3-9). This 
discrepancy could be due to the fact that PP-50-D-D be a mixture of cylinder and other 
objects that is beyond what the single form factor model that is currently provided in the 
Igor software could fit to provide a accurate dimension measure (Figure 3-23). 
Therefore, other models may be more suitable for modelling PP-50-D-D. As shown in 
Figure 3-23, PP-50-D-D SANS spectra changed very significantly at pH lower than 7.4 
compared to the other three PP-50s. Models suggested that PP-50-D-D formed lamellar 
structure as pH decreased like the three other PP-50 enantiomers. 
 
 
Figure 3-23: SANS spectra of PP-50-D-D at pH 7.4, 6.1 and 4.1 in deuterated phosphate buffer 
solution. Deuterated phosphate buffer at selected pH was used as background. Spectra were fitted with 
the best matching models to determine the shape and dimensions of the polymer in solution. The simulated 
model and dimensions are presented in the Table 3-9. 
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pH 4.1 6.1 7.4 
Form Lamellar Lamellar Rod 
Length (Å) - - 85 
Diameter (Å) - - 8.6 
Thickness (Å) - - - 
Table 3-9: The list of dimensions and projected structures of PP-50-D-D at three pHs. The dimensions 
were derived from models that were simulated to best fit the SANS spectra shown in Figure 3-23. 
 
 
Despite having somewhat different forms at pH 7.4, the four PP-50s all tend to form 
lamellar structure as the pH decreased. This result, along with the previously obtained 
turbidity result, strongly support that the four polymers are all pH responsive. It also 
indicated that the three other PP-50s may have similar intracellular delivery properties 
comparable to PP-50-L-L as forming lamellar structure was hypothesised as a key trait 
of efficient delivery. In vitro experimentation with the four polymers in HeLa cells in the 
following section will provide evidence to support the hypothesis. 
 
3.3.2.7 Biological Activity of PP-50 enantiomers 




The intracellular delivery efficiency of PP-50s were determined by co-incubating the 
polymer with a membrane impermeable fluorescent calcein. Confocal microscopy was 
used to determine the calcein dye distribution in HeLa cells and flow cytometry was used 
to quantify the amount of intracellular calein. As shown in Figure 3-24A, the blue 
fluorescent Hoechst 33342 dye was used to stain the nucleus of HeLa cells while calcein 
dye was green and encapsulated most likely in endosomes. When PP-50 polymer was 
co-incubated with membrane impermeable calcein, increased amount of intracellular 
calcein of HeLa cells could be seen. Additionally, calcein was distributed throughout HeLa 
cells while most intense signals were still concentrated in confined particles. This could 
agree with previous thought that PLP-based polymers facilitate the delivery of membrane 
impermeable particles through endocytosis (Eccleston et al., 2000; Mercado et al., 
2016). 
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Figure 3-24: Confocal microscopy image and flow cytometry analyses of HeLa cells incubated in 
the presence and absence of PP-50 (1 mg/mL) for 24 hours. A) Confocal microscopy image of cells 
incubated without polymer. B) Confocal microscopy image of cells incubated with PP-50 polymers. Cells 
were incubated with 2 mM calcein (green fluorescence) in the presence or absence of polymer and 
subsequently stained with 5 μg/ml Hoechst 33342 (blue fluorescence). C) Flow cytometry analyses of 
calcein uptake in HeLa cells in the presence or absence of PP-50 polymer after 24-hour incubation. 
Fluorescence was obtained using a FACScan flow cytometer. Data were derived from three replicates. 
Error bars represent standard error. 
 
 
Flow cytometry data in Figure 3-24C showed that the four PP-50s used to facilitate calcein 
intracellular delivery were effective. All four polymers were able to increase the 
intracellular calcein concentration by two-fold compare to calcein alone in HeLa cells after 
24-hour co-incubation. As shown in the figure, PP-50-L-L and PP-50-L-D were able to 
increase the intracellular calcein level by the most. This is expected for PP-50-L-L as it 
had the highest grafting percentage compared to the three other PP-50s. The PP-50-L-D 
result on the other hand was surprising as it had approximately 30% grafting of D-
Phe.. Despite the variation, the experiment provided evidence that all four PP-50 
polymers were effective in facilitating intracellular delivery of calcein. Additionally, the data 
further support the possibility that forming lamellar structure is an important factor for the 
intracellular delivery by the PP-50 polymers. 
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3.3.2.7.2 Cytotoxicity of PP-50 enantiomers 
 
 
Commercially available MTS assay which determines the metabolic activity of cells was 
used to test the cytotoxicity of PP-50 polymers at 24- or 48-hour incubation time with 2 or 
5 mg/mL of polymer concentration in HeLa cells. 2 and 5 mg/mL were selected as the 
concentrations for the toxicity experiments as they are higher than the 1 mg/mL 
concentration previously used in PLP and PP-50 intracellular delivery experiments. As 
shown in Fig 3-25A, all four PP-50 except PP-50-L-D at 2 mg/mL was well tolerated after 
24-hour of incubation in HeLa cells. PP-50-L-D was still tolerable as the cells maintained 
79.89% metabolic activity compared to cells without polymers after 24 hours. However, 
at 5 mg/mL all four PP-50s showed dose-dependent toxicity after 24-hour incubation. Of 
the four PP-50s, PP-50-L-D still had the highest effect on HeLa cell metabolic activity 




Figure 3-25: Metabolic activity of HeLa cells after incubation with PP-50-L-L, PP-50-L-D, PP-50-D-L, 
and PP-50-D-D at 2 mg/mL or 5 mg/mL for A) 24 hours and B) 48 hours. Data were normalised to cells 
incubated in the absence of polymer at the same incubation time. Data were derived from three replicates. 
Error bars represent standard error. 
 
 
The polymers showed enhanced toxicity at 2 mg/mL when incubated with HeLa cells for 
48 hours (Fig 3-25B). PP-50-L-L, PP-50-D-L, and PP-50-D-D were still tolerated by HeLa 
cells as the metabolic activity was still maintained above 70% compared to the control 
group. PP-50-L-D, interestingly, was still the most cytotixic polymer of the four PP-50s, 
reducing the metabolic activity of HeLa cells to 51.68% after 48-hour incubation at 2  
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mg/mL. When polymer concentration was increased to 5 mg/mL, all four PP-50s induced 
high toxicity (< 20% relative metabolic activity) in HeLa cells after 48-hour of incubation. 
To conclude, the four PP-50s had very similar effect on cells metabolic activity in 
experimented conditions and the chirality of the amino acid in the polymer backbone and 
grafted amino acid did not induce a significant difference. Additionally, all four PP-50s 
were well tolerated by HeLa cells after 24-hour of incubation. The tested concentrations 
were higher than the usual intracellular delivery experimental condition of below 1 mg/mL 
and within 24-hour incubation. Therefore, all four PP-50s could be safely applied to 
HeLa cells as intracellular delivery agents. To further study the impact of chirality of 
amino acids on the cytotoxicity of PP-50s additional commercially cytotoxicity tests such 
as Annexin V-FITC apoptosis assay or lactate dehydrogenase (LDH) membrane 






In this chapter, three PLP and four PP-50 enantiomers were synthesised and 
characterised using lysine and phenylalanine isomers. The different enantiomers were 
used to explore the different characteristics to provide a better understanding of the 
polymer behavior, intracellular delivery mechanism, and cytotoxicity. 
 
The chemical structure of PLP enantiomers were characterised by 1H-NMR and FTIR and 
confirm to be chemically identical enantiomers. CD spectra showed that PLP-D adopted 
similar helical secondary structures to that of PLP-L described in the previous chapter but 
with the opposite sense. It was also confirmed by CD that PLP-L-D overall did not exhibit 
optical activity, but the optical inactivity was possibly caused by the destructive signal 
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addition of co-existing clockwise and counterclockwise helical domains. In addition to the 
CD data, SANS data confirmed that all three PLP enantiomers adopted a rod-like 
structure. The diameter of the three PLP enantiomers increased as pH decreased, which 
suggested that the three polymers respond to pH similarly to PLP and support the 
previously proposed theory that individual polymers bundle into larger rods at low pH. In 
terms of intracellular delivery efficiency and cytotoxicity, the three polymers have very 
similar profiles. These results indicated that the mammalian cell does not discriminate 
against the three PLP enantiomers and all three polymers were well tolerated. 
 
In this study, PLP enantiomers was successfully modified by phenylalanine of different 
chirality, more specifically L- or D-, to yield four PP-50 enantiomers. The four PP-50 
enantiomers were determined by 1H-NMR and FTIR to be chemically similar but the 
enantiomer other than PP-50-L-L all had approximately 10% lower grafting percentages. 
The four polymers were subsequently determined to be pH responsive and had distinctive 
CD spectra in different pH environments. Although the four PP-50 enantiomers had 
slightly different SANS spectra, all the polymers were able to form lamellar structures 
below pH 6.1. Unsurprisingly, the four polymers had very similar intracellular delivery 
efficiency of membrane impermeable calcein in HeLa cells. The result provided additional 
evidence that the ability of polymers to form lamellar structures would determine the ability 
to deliver payload intracellularly. 
 
In conclusion, using amino acids of different chirality to synthesise pH-responsive 
polymers did not affect the overall structure and characteristic. The chirality of the material 
also did not contribute to any observable impact to the polymer interaction with HeLa cells 





Chapter 4 THE SYNTHESIS AND CHARACTERISATION OF 





Biomaterials are defined by the Williams Dictionary of Biomaterials as the materials 
intended to interface with the biological systems, to evaluate, to treat, augment or replace 
any tissue organ or function of the body in 1999 (Williams, 1999). As the field of material 
science and healthcare advanced, the definition no longer could define and precisely 
describe all the material substances in contact with the biological system. In the materials 
front, as materials evolve and become ever more complex, the classical view of the three 
major forms, namely metallic, ceramic, and polymeric has become less applicable. On 
the healthcare front, materials were traditionally used as implants or grafts, but other 
applications such as nanoparticles for drug delivery or polymer scaffold for regenerative 
medicine had been redefining the field in the past two decades. Therefore, a more precise 
definition of biomaterials was revised by Williams as: “A biomaterial is a substance that 
has been engineered to take a form which, alone or as part of a complex system, is used 
to direct, by control of interactions with components of living systems, the course of any 
therapeutic or diagnostic procedure, in human or veterinary medicine.” (Williams, 2014). 
And as all materials engineered to be used to interact with the biological system, the 
compatibility, especially reducing adverse effect the material may generate, is crucial for 
the usefulness of the material. 
 
 
4.1.2 Long-term cytotoxic effect of artificial polymers 
 
 
The short-term toxicity effect of artificial polymers for intracellular delivery was well 
documented. For example, cationic gene delivery polymers were well known to be 
cytotoxic to mammalian cells (Lv et al., 2006). Polyethylenimine (PEI), one of the most 
successful polymers of this class would reduce 293T cell viability by 40% with 4-hour 
incubation in transfection experiments(Yue et al., 2011; Benjaminsen et al., 2013). The 




adversely affect the remaining cells. Therefore, the importance of creating an effective 
delivery system that does not exhibit acute cytotoxicity or deemed biocompatible is 
warranted. 
 
In the case of long-term toxicity, there is limited literature characterising the adverse 
effect in vitro which may well be due to the cost and technical difficulties associated with 
these studies. Other indirect effects of artificial polymers or nanoparticles that may be 
generated such as genetic mutation or cell receptor expression, were also not well 
understood. In some cases, biomaterials may induce undesirable adverse effects, for 
example hydroxyapatite (HAP) induces inflammatory reaction in the central nervous 
system that could trigger more serious downstream events that are still under 
investigation (Leite, Pereira and Granjeiro, 2015). Metabolites or breakdown products of 
polymers could also be a concern that may alter mammalian cell behaviour when 
materials are incubated for a prolonged period. In this study and previous publications, 
the short-term cytotoxicity of PLP and PLP-based polymers were well characterised and 
determined to be well tolerated by a number of immortalised cell lines. It is, however, 
concerning that the breakdown product of PLP contains water insoluble iso-phthalic 
acid. Therefore, before these potential effects could be determined, designing a polymer 




4.1.3 Alternative polyamide polymers as intracellular delivery carrier 
 
 
Eccleston et la. previously conducted a study examining the effect of different di-acids 
to select the optimal di-amide polymer for intracellular delivery. PLP was selected due to 
its high transition pH compared to other polymers. PLP also had the greatest membrane 
disruptive activity determined by lysis of sheep erythrocytes (Eccleston, Slater and 
Tighe, 1999; Eccleston et al., 2005). This was, however, before the discovery that 
modification using hydrophobic amino acids could raise the transition pH and increase 
the intracellular delivery efficiency. As shown in CHAPTER 2, the L-phenylalanine (Phe) 
modification could increase the intracellular delivery efficiency of membrane 




Therefore, the topic of choosing the optimal di-acid for drug delivery polymer should be 
re-examined. In this study, the main focus would be on whether a naturally occurring di-
acid, fumaric acid, could be used as the building block for an anionic pH responsive 
polymer like PLP. Additionally, the resulting polymer would be modified with Phe to 








Chemicals were purchased from Sigma Aldrich and biological reagents for cell culture 
were purchased from Thermo Fisher/Invitrogen if not otherwise specified. Please refer 
to Chapter 2 section 2.2.1 for detail of the chemicals and reagents. 
 
 
4.2.2 Synthesis of Poly (L-Lysine Fumaride) 
 
The polymer poly (L-lysine fumaride) (PLF) was synthesised by a modified method by 
Eccleston et al. and Chen et al. (Chen and Natansohn, 1999; Eccleston, Slater and 
Tighe, 1999; Eccleston et al., 2000). A schematic of the synthesis procedure and the 
chemical structure of PLF is provided in Figure 4-1. In a typical reaction, L-lysine methyl 
ester·2HCl (0.02 mol) and an acid acceptor, potassium carbonate (K2CO3 0.08 mol), 
were dissolved in deionised water (40 mL). The aqueous solution was placed in an ice 
bath and stirred with a Teflon-coated magnetic stir bar. A pre-cooled dry chloroform (3 
mL) solution containing fumaryl chloride (0.02 mol) was added rapidly to the water 
solution. The reaction was allowed to proceed for 30 minutes, during which poly (L-
lysine methyl ester fumaride) precipitated out of the solution. The polymer was 
transferred to a beaker containing deionised water (DI water) soaked for 3 hours. The 
raw material was dried overnight in a vacuum oven at 55 ºC. Dried poly (L-lysine methyl 
ester fumaride) was broken down and dissolved in DMSO. Same volume of 5 wt% 
NaOH solution in ethanol (2.5 molar equivalents to each poly (L-lysine methyl ester 




The hydrolysed polymer precipitated out in 2-3 minutes and was collected by vacuum 




Figure 4-1: Reaction scheme for the synthesis poly (L-lysine fumaride). The synthesis is a 
polycondensation of L-lysine methyl ester and fumaryl chloride in Chloroform/Water solution. The resulting 
polymer was de-protected by NaOH solution in ethanol (EtOH). 
 
 
The crude polymer solution was dialysed in Visking tubing membrane (MW cut-off 12-14 
kDa) against deionised water for 1 week to remove inorganic salts, residual organic 
solvents, and low molecular weight oligomers. Solid impurities were removed by vacuum 
filtration. The pH of the solution was adjusted to 7.4 using 1M NaOH and lyophilised to 
yield the sodium form of poly (L-lysine fumaride). 
 
4.2.3 Synthesis of Phenylalanine Modified Poly (L-Lysine Fumaride) 
 
 
The grafting of L-phenylalanine onto PLF was achieved using the standard DCC 
promoted amide-coupling chemistry (Haslam, 1980). The experimental procedure 
followed the process described in CHAPTER 2, Section 2.2.3 Synthesis of Amino Acid- 
Modified Poly (L-Lysin Iso-Phthalamide) except for reducing all chemicals and solvents 
used by six-fold. The molar ratio of L-phenylalanine to available carboxylate group on 
PLF used in this study was 1:2 to create FP-50. Deprotection and purification steps were 








Polymers were dissolved in DMSO-D6 and characterised by Bucker Advance 500 MHz 
NMR spectroscopy (Bruker Biospin GmbH, Germany). The 1H-NMR spectrum was 
processed through peak picking and integration with MNova software (Mestrelab 
Research, Spain). The data was used to confirm polymer structure and calculate grafting 






Absorption spectrum of PLF was collected using a Thermo Nicolet Nexus 870 
spectrometer (Waltham, MA, USA) as the average of 32 scans with a wavenumber 
resolution of 4 cm-1 in the 600-4000 cm-1 range. 
 
 
4.2.4.3 Measuring Polymer Transition pH by Turbidity 
 
 
Polymers were each dissolved in DI water to make 10 mg/mL polymer stock solution. PB 
at different pHs were prepared by first making 0.1 M PB with corresponding amount of 
phosphoric acid, sodium phosphate monobasic and sodium phosphate dibasic. The pHs 
of the stock solutions were measured by a pH meter (n=3). The polymer solutions were 
added to PB buffer at various pH in a 1:10 dilution to make 1 mg/mL final concentration 
in clear Eppendorf semi-micro Vis cuvette (Eppendorf, UK). The UV spectra of the 





4.2.4.4 Circular Dichroism 
 
 
Stock solution of the polymers were prepared by dissolving lyophilised polymers in their 
sodium form in DI water at 1 mg/mL. Phosphate Buffer (PB) at different pHs were 
prepared by first making stock solution of 0.1 M PB with corresponding amount of 
phosphoric acid, sodium phosphate monobasic and sodium phosphate dibasic. The pHs 
of the stock solutions were measured by a pH meter (n=3) before diluted with DI water 
into 10 mM PB solution. Stock polymer solution were added to 10 mM PB at the 
corresponding pH for CD measurements with a final polymer concentration of 0.05 mg/mL 
for PLF and 0.1mg/mL for PLP. Spectra were recorded at 25ºC on an Aviv model 410 
circular dichroism spectrophotometer (Aviv Instruments, Lakewood, NJ). Far UV-spectra 
were scanned from 185 nm to 260 nm while near UV-spectra were scanned from 260 nm 
to 320 nm. Data was collected for every 1-nm interval and averaged for 5 seconds. Each 
of the final spectra was the result of averaging three scans. All spectra were baseline 
corrected and smoothed with Aviv 540 software (Aviv Instruments, Lakewood, NJ). 10 
mM PB of the tested pH were measured and used as blank for baseline correction. Mean 
Residual Ellipticities (MRS) were calculated with the following formula. 
 
[𝜃]𝑀𝑅𝑊,𝜆  = 𝑁 × 𝑀𝑅𝑊 × 𝜃𝜆/10 × 𝑐 × 𝑑 Function 4-1 
 
The  is the ellipticity measured in millidegrees at a given wavelength, d is the length of 
the cell in centimeters, c is the polymer concentration in grams per liter. The Mean 
Residue Weight (MRW) is the polymer subunit molecular weight. N is the number of 
peptide bonds in the PLP or PLF per subunit. 
 
 
4.2.4.5 Small Angle Neutron Scattering (SANS) 
 
 
SANS experiments were conducted in the same condition as described in CHAPTER 2, 




4.2.5 Biological Activities 
4.2.5.1 Cell Culture 
 
 
Cells were handled and maintained as described in CHAPTER 2, section 2.2.5.1 Cell 
Culture using the same reagents if not otherwise specified. 
 
4.2.5.2 Determining Intracellular Delivery of Calcein by Confocal Microscopy 
 
 
HeLa cells were incubated in supplemented DMEM for 48 hours before the experiment in 
a 4-well 1.8 cm2 chambered cover glass system (Nunc, UK) at 5x104 cells/well and 500 
L/well. Cells were first washed twice with PBS and incubated with phenol red-free DMEM 
in the presence or absence of 2 mM calcein for 24 hours with or without polymers. Cells 
were then washed twice with PBS and incubated with 5 g/mL Hoecht 33342 and 5 g/mL 
propidium iodide (PI) in phenol red- and FBS-free DMEM for 20 minutes. Cells were 
washed again twice with PBS before phenol red- and FBS-free DMEM was added to each 
well and imaged under confocal microscopy. 
 
 
4.2.5.3 Determining Intracellular Delivery of Calcein by Flow Cytometry 
 
 
Calcein (a membrane impermeable fluorophore) was used as a tracer molecule to monitor 
the effect of polymer intracellular delivery efficiency. Disodium calcein salt was dissolved 
in PBS to make 200 mM stock solution. HeLa cells were seeded in 24-well plates at 5x104 
cells/mL in 0.5 mL supplemented DMEM to full confluence in 24 hours followed by 
incubation with 0.22 µm filter-sterilised supplemented media and 2 mM calcein in the 
presence or absence of polymers. Cells were washed twice with PBS, trypsinised and 
resuspended in phenol red-free DMEM supplemented with FBS spun down at 0.2 g for 5 
minutes. The supernatant was removed and the cell pallets were resuspended in phenol 
red- and FBS-free DMEM and transferred into a Titertube 1 mL micro test tube (Bio-Rad, 
UK). Cells were analysed by Cytek DxP8 cell sorter (Cytek Bioscience, USA) with 10,000 




wavelengths. The results were processed by FlowJo software (Cytek Bioscience, USA) 




4.2.5.4 Measuring Cytotoxicity of polymers 
4.2.5.4.1 Cell metabolic activity determined by MTS assay 
 
 
The MTS tetrazolium compound is reduced by metabolically active cells to a colored 
formazan product that could be quantified at an absorbance of 490 nm by a 
spectrophotometer. The absorbance of the formazan product and viable cells within the 
range of the cell concentrations was a linear relationship. Therefore, the reduction of 
cellular metabolic activity of HeLa cells, followed by polymer or chemical exposures, was 
determined by MTS assay. The assay was performed according to the manufacturer’s 
protocol. Experiments were performed in six repeats. The spectra were recorded using a 
BMG Labtech SPECTROStar Nano (Allmendgruen, Germany). 
 
 
4.2.5.5 Cell apoptosis study determined by AnnexinV/PI staining 
 
 
HeLa cells were seeded in 24-well plates at 5x104 cells/well in 500 L supplemented 
media for 48 hours. Cells were then incubated with supplemented media with or without 
polymers for 24 and 48 hours. Cells were then washed with PBS twice, trypsinised, and 
then re-suspended in phenol red-free DMEM containing FITC-AnnxinV and PI. Untreated 
cells were used as a negative control. HeLa cells incubated with 1% saponin in DMEM 
for 10 minutes were used as a positive control for apoptosis. The apoptosis assay was 
then performed with Cytek DxP8 cell sorter (Cytek Bioscience, USA). The results were 





4.3 Results and Discussion 
4.3.1 Synthesis and Characterisation of PLF 
 
 
After synthesis and purification, a yellow polymer was obtained. Synthesis of PLF was 
performed in a smaller scale and the yield of the initial methylated polymer poly (L-lysine 
methyl ester fumaride) PLMF was 33.2 % over two batches. In comparison, typical PLMP 
yield was 66.2%. The main reason that contributed to the difference could be the solvent 
for the chloride di-acid in the synthesis process of PLF. Instead of using water soluble 
acetone, chloroform was used to dissolve fumaryl chloride as it is not soluble in more 
polar solvents. Additionally, the scale of the reaction for PLF was 10-fold smaller than the 
PLP reaction conducted in this study. As chloroform is less soluble in water where L- 
lysine methyl ester was dissolved in, there would be less contact between the chloroform 
and water interface making the reaction less efficient. Despite the yield of PLMF being 
two-fold lower than PLP the synthesis yielded enough polymer for further analysis. PLF 
was characterised via 1H-NMR and FTIR to confirm its chemical structure. 
 
 
4.3.1.1 PLF Characterisation by 1H-NMR 
 
The NMR spectrum of PLF in DMSO-d6 is shown in Figure 4-2 with the appropriate 
assigned proton depicted in a chemical drawing. Peak assignment: 6.78-6.92 ppm (a, - 
HC=CH-), 8.36-8.39 ppm (b, f, -NH-), 3.10-3.12 ppm (c, -CH2-) 1.29-1.73 ppm (d, -(CH2)3- 
). The spectrum confirmed the PLF contains the di-amide, ethylene and long amine chain 
structures. The result confirmed that even with the new chemical synthesis process, the 






Figure 4-2: Chemical structure and 1H-NMR Spectrum of poly (L-lysine fumaride) in DMSO-D6. The 
protons on the chemical structure of PLP were each assigned to a legend and labelled on the 1H-NMR 
spectrum. DMSO peaks at 2.5 ppm were removed for better visualisation of the spectra. 
 
 
4.3.1.2 PLF Characterisation by FTIR 
 
 
The FTIR spectra of PLF was compared to PLP in Figure 4-3 to compare the difference 
and similarity in functional groups and chemical structure. The spectra of PLF showed a 
number of similar characteristics as PLP including the carboxylate C=O stretch (1710 cm- 
1), amide C=O stretch (1630 cm-1), amide N-H bend (1530 cm-1) and the hydroxy group 
O-H stretch (3300 cm-1). The difference in structure could be observed in unique peaks 
of PLF spectra at the C-H out-of-plane bend (1450 cm-1) and trans-C-H out-of-plane bend 
for alkene groups (970 cm-1). Additionally, the slightly lower intensity at 1530 cm-1 for PLF 
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Figure 4-3: FTIR spectrum of poly (L-lysine fumaride). The spectrum of PLP was included below the 




The FTIR data complimented the 1H-NMR result discussed in the earlier section as 
evidence that PLF had similar functional groups including amide and carboxylic acid 
compared to PLP. The two techniques could confirm that PLF, like PLP, is a poly-amides 
with pendant carboxylic acid groups. The major difference in the primary structure in PLF 
is that the fumaride group replaced the iso-phthalamide. This opens up the question on 
how the change would affect the secondary structure and function of the polymer which 
would be discussed in later sections. 
 
 
4.3.1.3 Measuring Transition pH of PLF by Turbidity 
 
 
It was previously determined that PLP undergoes conformational change as the 
environmental pH decreases and that was what contributed to the membrane disruptive 
activity of the polymer (Eccleston et al., 2000, 2005). Since PLF was determined to have 
similar poly-amide and carboxylate structure, it may also adopt the pH responsive and 
membrane disruptive characteristic. In order to determine whether PLF respond to 
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change in environmental pH shift, the turbidities of PLF in various phosphate buffer (0.1 
M) was measured by recording the transmittance at 460 nm. This technique has been 
previously reported for the determination of pH dependence of PLP and PLP-based 
polymers (Eccleston et al., 2005; Yue, Eccleston and Slater, 2005; Chen, 2007). 
Precipitation of the polymers caused drastic decrease in transmittance at a specific pH. 
 
Consistent with the result reported in previous chapters and work done previously, PLP 
had transition pH at 4.3 (Chen, 2007). As shown in Figure 4-4, the transition pH of PLF 
was determined to be at pH 3.5. This value is significantly lower than that of the PLP. This 
could be explained by the lack of aromatic group in PLF compared to PLP. It was 
previously reported that the precipitation of PLP as the pH decreases was caused by the 
protonation of carboxylate group and consequently weakening of the ionic repulsion 
between polymer subunits (Chen, 2007). This event caused the - interaction of 
aromatic ring and the hydrophobic interaction to become the dominant force over ionic 
repulsion. As suggested in the previous chapters, PLP polymer rods bundle into a larger 
cylindrical structure. Since PLF lacks aromatic rings compare to PLP, the hydrophobic 
interaction is the sole force that drives the polymer to aggregate once protonated, a 
lower transition pH for PLF is, therefore, expected. The turbidity experiment confirmed 
that PLF, which precipitates at low pH, indeed has pH responsive characteristic like PLP. 
The structural and functional differences of the two polymers were determined through 
other techniques and discussed in the following sections. 
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Figure 4-4: Variation of the turbidity of PLF and PLP in different pH conditions. The turbidity of 
polymers at 1 mg/mL in 0.1M phosphate buffer at pH between 2.5 and 7.8 were measured at λ = 460 nm. 
Estimated transition pH determined for PLF was 3.5 and for PLP was 4.3. 
 
 
4.3.1.4 Circular Dichroism of PLF 
 
 
Far-UV CD spectra from PLF showed that it, like PP-50, it had a CD spectrum with an 
inverse sign compared to that of PLP’s. CD spectrum of PLF had a positive peak at 215 
nm rather than the negative observed on the spectrum of PLP. Additionally, the absolute 
signal strength of PLF at 215 nm was twice as strong as that was observed in PLP and 
the change in cotton effect at different pH was more prominent with PLF (Figure 4-5). 
Interestingly, the strongest signal for PLF was observed at pH 6.1, which is far from the 
transition pH of 3.6 determined for PLF. The CD spectrum at pH 6.1 for PLF was twice in 
strength compared to PLF at physiological pH. Although the change was not as intense 
as the three-fold increase observed in PLP at pH 4.0 and pH 7.4, the overall strength of 
the PLF CD spectra was significantly more intense than that of PLP. PLP, on the other 
hand, had the strongest CD signal at pH 4.0 which is relatively close to its transition pH. 
Whether this observation was of significance would later be determined and discussed 
by the intracellular delivery efficiency experiment determined by using a membrane 
impermeable fluorophore, calcein. 















Figure 4-5: Circular Dichroism spectra of A) PLF and B) PLP at various pHs. Polymers were analysed 
at 0.1 mg/mL in phosphate buffer at the specified pH between 185 and 260 nm. 
 
 
4.3.1.5 SANS Data Analyses for PLF 
 
 
SANS is a non-destructive and high-resolution technique to study the structure of 
macromolecules in solution. The technique could provide the shape of dimension of the 
macromolecule of interest in great detail and, as shown in previous chapters, ideal for the 
study of pH responsive polymers. To understand the structure difference between PLF 
and PLP, PLF was characterised by SANS in three different pHs, specifically 7.4, 6.1, 
and 4.1. 
 
As shown in Figure 4-6, the SANS spectra of PLF did not change significantly as pH 
decreases. This phenomenon is interesting since PLF was determined by the turbidity 
experiment to be pH responsive and precipitate from phosphate buffer at pH 3.6. It could 
be argued that PLF has not reached its transition pH, therefore, did not express a 
observable difference in its SANS spectra at the three studied pHs. By the slope of the 
intermediate region of the spectra, PLF was projected to be a cylindrical structure with 
length of 1000 Å and diameter of 14 Å. The length of the rod is significantly longer than 
that of PLP at approximately 200 Å. The diameter for PLF at pH 7.4 is very similar to the 
diameter of PLP at the same pH. In comparison to PLP, the diameter recorded by 
SANS of PLF does not increase as pH decreases. Whether these differences between 
the two polymers would contribute to difference in biological activities would be explored 
in later sections of this chapter. 
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Figure 4-6: SANS spectra of PLF at pH 7.4, 6.1 and 4.1 in deuterated phosphate buffer solution. 
Deuterated phosphate buffer at selected pH was used as background. Spectra were fitted with the best 
matching models to determine the shape and dimensions of the polymer in solution. 
 
 
4.3.2 Intracellular Delivery Efficiency of PLF compared to PLP 
 
 
The intracellular delivery of PLF, like PLP, was assessed both in terms of increased 
calcein fluorescent signal and endosomal escape by flow cytometry and confocal 
microscopy. As shown in Figure 4-7A, PLF was able to increase intracellular calcein 
concentration in HeLa cells at polymer concentration as low as 0.5 mg/mL when 
incubated for 24 hours with similar level compared to PLP. Dose-dependence of the 
increase in intracellular calein concentration could be observed in both PLF and PLP. At 
5 mg/mL PLF was able to increase the calcein concentration by 48% compared to 
calcein only. This result clearly demonstrated that PLF was able to increase the 
intracellular calcein concentration at an efficiency comparable to PLP despite lacking 
the aromatic ring. Interestingly, the transition of PLF was considerably lower than that of 
PLP but did not play a significant role on the intracellular delivery of calcein in HeLa 
cells. This observation may be related to the CD data obtained for PLF where the 
strongest signal 
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was observed at pH 6.1 rather than the transition pH 3.6 which indicate that the PLF 
polymer formed the most organised secondary structure at pH 6.1. This result could well 
affect how transition pH was defined for pH-responsive polymers. On the one hand, the 
transition pH of a polymer could be set at the pH where it aggregated. On the other hand, 
the transition pH of a polymer could be set at a pH where it had the most organised 
secondary structure and membrane disruptive activity. Setting a consistent definition 
could provide a more informative guidance when characterising these polymers. 
 
 
Figure 4-7: Flow cytometry analyses and confocal microscopy image of HeLa cells incubated in the 
presence and absence of PLF and PLP for 24 hours. A) Flow cytometry analyses of calcein uptake in 
HeLa cells in the presence or absence of PLF and PLP polymers after 24-hour incubation at various 
concentrations. Fluorescence was obtained using a FACScan flow cytometer. Data were derived from three 
replicates. Error bars represent standard error. B) Confocal microscopy image of cells incubated with or 
without polymer. Cells were incubated with 2 mM calcein (green fluorescence) in the presence or absence 
of polymer and subsequently stained with 5 μg/ml Hoechst H33342 (blue fluorescence). 
 
 
The ability for PLF to facilitate endosomal escape was determined by confocal 
microscopy and compared to PLP. As shown in Figure 4-7B, HeLa cells incubated in the 
presence of 1 mg/mL PLF had slightly increased calcein fluorescence intensity compared 
to calcein alone. There are also more HeLa cells that had caclein distributed evenly in 
cells compared to calcein alone. The calcein distribution in HeLa cells observed in the 
presence of PLF is similar to that of the PLP. The two analyses provided evidence that 
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PLF could facilitate intracellular delivery of membrane impermeable calcein at a similar 
level to PLP and the delivery occurs at a dose-dependent manner. 
 
 
4.3.3 Cytotoxicity of PLF Compared to PLP 
 
 
Although it was previously demonstrated that PLP was well tolerated by immortalised cell 
lines such as HeLa and SAOS-2 osteosarcoma cells (Eccleston et al., 2000; Mercado 
and Slater, 2016). The main concern with PLP was that the breakdown product, iso-
phthalic acid, is water insoluble and not present in natural systems. It may pose long-
term cytotoxic or undesirable effects when introduced to more sensitive cell lines such 
as stem cells or at the tissue level. Thus, the rationale of creating an intracellular 
delivery polymer with soluble natural occurring components. To compare the 
biocompatibility of PLF and PLP, MTS and AnnexinV/PI assays were performed on 
HeLa cells at different polymer concentration and incubation time to assess the short-
term cytotoxicity effects. 




Figure 4-8: Evaluating the cytotoxicity of PLF and PLP by measuring metabolic and apoptotic 
activity of HeLa cells after incubation with PLF or PLP at various concentrations by flow cytometry. 
A) Metabolic activity of HeLa cells after 24-hour incubation with or without polymers at different 
concentrations. B) Metabolic activity of HeLa cells after 48-hour incubation with or without polymers at 
different concentrations. C) Apoptotic activity of HeLa cells after incubation with or without polymers for 24 
hours measured by AnnexinV-FITC assay. D) Apoptotic activity of HeLa cells after incubation with or 
without polymers for 24 hours measured by PI staining. Data were normalised to cells incubated in the 
absence of polymer at the same incubation time. Data were derived from three replicates. Error bars 
represent standard error. 
 
 
As shown in Figure 4-8A, metabolic activities determined by commercially available MTS 
assay of HeLa cells after 24-hour incubation with PLF and PLP were compared. The 
decrease in metabolic activity was in a dose dependent manner for PLF and PLP (above 
2 mg/mL). Overall, PLF increased the metabolic activity of HeLa cells by on average 25% 
after 24-hour incubation at concentration below 5 mg/mL. HeLa cells incubated with 10 
mg/mL of PLF had the same metabolic activity as the control without polymers. PLP, on 
the other hand, had more variable effects on the metabolic activity of HeLa cells, but was 
overall well tolerated at concentration as high as 10 mg/mL. 
 
When HeLa cells were incubated with PLF for 48 hours, however, the polymer started to 
induce adverse effect on HeLa cells at concentrations above 5 mg/mL (Figure 4-8B). The 
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metabolic activity of HeLa cells decreased in a dose-dependent manner to PLF 
concentration. The metabolic activity was 9.5% below the control at 5 mg/mL of PLF and 
31% at below at 10 mg/mL while PLP did not negatively impact the metabolic activity 
even at 10 mg/mL. The cytotoxicity of polymers, however, could not solely be determined 
through MTS assays. Past publications indicated that the MTS assay heavily relies on the 
enzymatic activity of components in the mitochondria and endoplasmic reticulum (ER) 
that are prone to a number of interferences (Vistica et al., 1991; Van Tonder, Joubert 
and Cromarty, 2015). Additionally, exogenous fumarate was previously reported to 
induce redox-dependent senescence that reduces the proliferation of mammalian cells in 
vitro (Zheng et al., 2015). 
 
To more accurately depict the cytotoxic effects of PLF compared to PLP, AnnxinV-FITC 
and PI were used to determine the number of cells undergoing apoptosis and the 
membrane integrity of cells after 24-hour incubation with polymers at different 
concentrations. As shown in Figure 4-8C, PLF increased AnnexinV-FITC staining in HeLa 
cells in a dose dependent manner. At 10 mg/mL, PLF increased the fluorescent intensity 
by 56% compared to the 36% increase by PLP. However, PLP did induce on average 
30% of the fluorescent intensity across different polymer concentrations. The two 
polymers induced significantly less fluorescent intensity compared to the positive control 
induced by saponin, which increased AnnexinV-FITC staining by more than 260%. The 
membrane integrity of HeLa cells incubated with the polymers was examined using PI, a 
membrane impermeable DNA-binding fluorescent dye. As shown in Figure 4-8D, PLF 
did not significantly affect the membrane integrity of HeLa cells after 24-hour incubation. 
It increased the PI staining by 17% at 10 mg/mL compared to the 68% PLP induced. 
PLP significantly affected the membrane at concentrations above 5 mg/mL. At 10 
mg/mL PLP induced same membrane permeability at approximately 65% as the 
saponin control. The result indicated that PLP negatively impacted the membrane 
integrity of HeLa cells at concentrations above 5 mg/mL after 24-hr incubation while PLF 
had a more moderate impact at a concentration of 10 mg/mL. 
 
The cytotoxicity results obtained through MTS and AnnexinV/PI assays concluded that 
PLF exhibited a dose-dependent toxicity profile and is well tolerated by HeLa cells at 
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concentrations below 5 mg/mL. Despite more negatively affecting HeLa cell metabolism 
at concentrations above 5 mg/mL after 48-hr incubation, PLF induced less apoptosis and 
membrane integrity compared to PLP. These results confirmed that PLF is well tolerated 
by HeLa cells and overall exhibited a similar, if not better, safety profile compared to PLP. 
 
 
4.3.4 Effect of Amino Acid Modification on PLF 
4.3.4.1 Synthesis and Characterisation of PF-50 
 
 
As shown previously in this chapter, PLF has the pH responsiveness and intracellular 
delivery characteristics similar to PLP. FTIR and NMR results also confirmed that PLF is 
a poly-amide with pendant carboxylate groups that could easily be modified. Following 
similar logic to modifying PLP with hydrophobic amino acids to increase intracellular 
delivery efficiency, PLF could also be modified using the same strategy to potentially 
increase intracellular delivery significantly (Figure 4-9). In this study, L-phenylalanine was 
chosen as the hydrophobic amino acid to be grafted onto free carboxylate groups on PLF 
at a molar ratio of 1:2 to create PF-50. Phe was chosen as the modifier is due to the fact 
that it was the most established and effective entity for modifying PLP. After synthesis 
and purification following same protocol as PP-50 synthesis, a yellow solid was acquired. 




Figure 4-9: Reaction scheme for the synthesis of L-phenylalanine grafted poly (L-lysine fumaride). 
The reaction was achieved through standard DCC/DMAP coupling. The L-phenylalanine group is denoted 




4.3.4.2 Characterisation of PF-50 
 
 
After synthesis and purification, PF-50 was characterised by 1H-NMR and FTIR to 
determine the chemical composition and functional structure. As shown in Figure 4-10, 
the 1H-NMR spectrum revealed that the successful grafting of phenylalanine onto the PLF 
backbone confirmed by the unique peak at 7.13 ppm. The peak represents five protons 
on the phenyl group which was not seen on the 1H-NMR spectrum of PLF (Figure 4-2). 
The grafting percentage of Phe was calculated to be 41.6% by comparing the integrated 
area of peaks at 6.56 ppm (two protons on the alkene group on the PLF backbone) and 
7.13 ppm (five protons on the phenyl group). However, PF-50 has limited solubility in 




Figure 4-10: Chemical structure of PF-50 and 1H-NMR Spectra of PF-50 in DMSO-D6. The protons on 
the chemical structure of PF-50 were each assigned to a legend and labelled on the 1H-NMR spectrum. 
The two protons on the trans alkene were assigned a while the five protons on the phenyl group of the 
grafted Phe were assigned b. The PLF 1H-NMR could be found in Figure 4-2 in the section “PLF 
characterization by 1H-NMR.” 
 
 
As shown in Figure 4-11, the FTIR spectrum of PF-50 revealed that the polymer 
contains key functional groups including trans-C-H out-of-plane bend for alkene groups 
(970 cm-1), C-H out-of-plane bend (1450 cm-1), amide C=O stretch (1630 cm-1), amide 




groups of PF-50 on the FTIR spectrum were similar to PLF shown in Figure 4-3 except 
the peak at 1550 cm-1 (between 1530 and 1630 cm-1 on the figure) for PF-50, as the 
























Figure 4-11: FTIR spectrum of PLF and PF-50. The spectrum of PLF was included above the PF-50 




4.3.4.3 SANS Analyses of PF-50 
 
 
SANS was applied to characterise PF-50 to study the structure and determine the 
underlying pH-responsiveness. As shown in Figure 4-12, PF-50 adopted a rod like 
structure due to the slope of the intermediate region (0.01 Å-1 < q < 0.1 Å-1) of the PF-50 
SANS spectra at pH 7.4, 6.1 and 4.1. According to the analysis of the spectrum at pH 7.4, 
PF-50 is a cylinder with approximately length of 1500 Å and diameter of 35 Å. The 
increase in diameter compare to PLF’s diameter of 14 Å was expected as the modification 
added pendant groups to the PLF backbone. The increase in length, however, was 
unexpected as the modification shouldn’t have modified the length of individual PLF rods. 
It is very likely that the modification caused the uneven stacking of smaller cylinder into a 
































of PF-50 at pH 6.1 and 4.1 indicated that PF-50 adopted a cylindrical structure but with 
more stacking and aggregation compared to PF-50 at pH 7.4. 
 
 
Figure 4-12: SANS spectra of PF-50 at pH 7.4, 6.1 and 4.1 in deuterated phosphate buffer solution. 
Deuterated phosphate buffer at selected pH was used as background. Spectra were fitted with the best 
matching models to determine the shape and dimensions of the polymer in solution. 
 
 
PF-50 adopting a cylindrical form across the three pH was somewhat unexpected. As in 
previous chapters, modification of PLP with Phe resulted in a polymer that could form a 
lamellar structure usually at the lower pH. The studies in the previous two chapters 
suggested that the adoption of a lamellar structure was important to the intracellular 
delivery characteristic of PLP-based pH-responsive polymers. The fact that PF-50 did not 
form a lamellar structure at lower pH tested in this study could affect its ability to facilitate 
the intracellular delivery of membrane impermeable molecules in mammalian cells. In the 




4.3.4.4 Intracellular Delivery Activity of FP-50 
 
 
As a proof of concept, intracellular delivery capacity of the phenylalanine modified PLF, 




was incubated with HeLa cells in the presence or absence of FP-50 for 2 or 24 hours. As 
shown in Figure 4-13, at 2 hours incubation, PF-50 was not able to increase the 
intracellular calcein concentration of HeLa cells at 0.5 or 1 mg/mL. After 24-hour co- 
incubation with calcein and 0.5 mg/mL or 1 mg/mL of PF-50, the intracellular calcein 
concentration of HeLa cells increased by 10.9 and 13.5% respectively. The increase in 
intracellular calcein concentration for PF-50 was very similar to that of PLF and PLP but 
significantly lower than PP-50. This result suggested that although the Phe modification 
of PLF was successful, the effect of the modification on intracellular delivery efficiency 
was not as significant as the one observed between PLP and PP-50. It was determined 
in the previous section that PF-50 respond to pH changes and aggregates at lower pH, 
but it could not form lamellar structures at pH as low as 4.1. This may be problematic for 
endocytosis-dependent transmembrane transport as if the pH of the endosome falls 
below pH 4.0 it may merge with other vesicles to for lysosomes. The lysosome contains 
various enzymes that could digest any potential molecules that PF-50 could transport into 
the cell. The result suggested that the Phe modification of PLF could not increase the 
intracellular delivery efficiency and the resulting polymer PF-50 does not have the same 
characteristic as Phe modified PLP. 
 
 
Figure 4-13: Intracelluar calcein concentration of HeLa cells with or without PF-50 polymers 
determined by flow cytometry. HeLa cells were incubated with 2mM of calcein in the presence or absence 
of 0.5 or 1 mg/mL of polymer for 2 or 24 hours. Cells without calcein incubation were used as control. The 
fluorescent signal was normalised to calcein only without polymer. Data were derived from three replicates. 




4.4  Conclusion 
 
 
In this chapter, the reason for finding a more biocompatible polymer than PLP but with 
similar characteristic was discussed. As one of the building components of PLP, iso- 
phthalic acid, is water insoluble and may cause long-term adverse effect to the biological 
system, a natural occurring di-acid was chosen for the synthesis of a new PLF polymer. 
PLF was proven to be pH-responsive but has a transition pH3.5 which is lower to PLP’s 
4.3 (Figure 4-4, Ch 4 Measuring Transition pH of PLF by Turbidity). Additionally, CD and 
SANS determined that PLF adopts an organised cylindrical secondary structure similar 
to PLP but approximately five times longer (Ch 4 SANS Data Analyses for PLF). Despite 
these differences, PLF was able to facilitate intracellular delivery of membrane 
impermeable calcein in HeLa cells with the same efficiency as PLP (Figure 4-7, Ch 4 
Intracellular Delivery Efficiency of PLF Compared to PLP). Cytotoxicity data of PLF and 
PLP in HeLa cells suggested that PLF was well tolerated at a comparable level to PLP 
up to concentration as high as 10 mg/mL for 24-hour incubation but had less effect on 
the membrane integrity (Figure 4-8, Ch 4 Cytotoxicity of PLF Compared to PLP). The 
results indicated that PLF was a strong candidate that warrants further development as 
a biocompatible intracellular delivery agent. 
 
Modification of PLP with Phe resulted in a polymer, PP-50, that had much higher 
intracellular delivery efficiency and the same modification was explored in PLF. The Phe- 
modified PLF polymer, PF-50, had a moderate grafting efficiency of 83.2% and contains 
all the key functional groups. PF-50 adopted a cylinder secondary structure but, unlike 
PP-50, it does not form any lamellar structure at pH as low as 4.1 (Ch 4 SANS Analyses 
of PF-50). In vitro experiment with membrane impermeable calcein in HeLa cells 
suggested that PF-50 had only comparable intracellular delivery efficiency as PLF 
(Figure 4-13, Ch 4 Intracellular Delivery Activity of PF-50). The Phe modification did not 
result in an enhance delivery efficiency of the polymer. The failure to enhance efficiency 
with the modification could be due to the fact that PF-50 could not form a lamellar 
structure. The modification strategy did not work on PLF but as it was a preliminary 





be used as modifier. As PLF was proven to be well tolerated and was as efficient as PLP 





Chapter 5 SYNTHESIS AND CRYOPRESERVATION 





Cell therapy has made drastic advancements and is estimated to become a $5 billion 
industry in the US alone (Ram-Liebig et al., 2015). With the recent approval from the US 
Food and Drug Administration (FDA) and European Medicines Agency (EMA) of CAR T-
cell therapies namely Kymriah and Yescarta from Novartis and Gilead respectively, cell 
therapies would inevitably take a more important role in future medical treatments. 
Despite having several well-established cryopreservation protocols, cells remain 
subjective to cryo-damage with altered cell physiology. These damages include lipid and 
protein oxidation, which could adversely affect cell proliferation and function (Best, 
2015). In more severe cases, oxidative stress could lead to apoptosis or necrosis in a 
number of cell types decreasing the overall cryosurvival rate (Bilodeau et al., 2001; 
Wolkers et al., 2001; Zhang et al., 2015). Thus, it is critical to reduce the oxidative stress 
throughout the cryopreservation process for successful long-term cell storage. 
 
For cells to survive the prolonged period of storage at critically low temperatures, the 
presence of cryoprotective agents (CRAs) such as dimethyl sulfoxide (DMSO) or glycerol 
are required (Anchordoguy et al., 1987; Chen et al., 2001; Liseth et al., 2005; Luo, Li 
and Wang, 2008). DMSO is one of the most commonly used and effective CRAs to 
date, however, the cytotoxicity on cells and systemic adverse effects have prevented it 
from further advancement in the field of medicine (Galmes et al., 2007; Jahnukainen et 
al., 2007; Li et al., 2010). Non-toxic components such as sugars are becoming the more 
promising reagent for cryopreservation protocols while the success have been 
hampered by the limited transmembrane transportation mechanisms (De Antoni et al., 
1989; Lynch, Chen and Slater, 2011). For example, disaccharides such as trehalose 
was proven to be an effective CRA during the freezing-thaw process. The molecule was 
shown to be able to maintain membrane structure and prevent undesirable membrane 
fusion which could occur during dehydration caused by freezing of water (Rudolph and 
Crowe, 1985). Trehalose is required to be present on both sides of the cell membrane 




and Slater, 2011; Mercado and Slater, 2016). Several methods have been studied to 
increase intracellular disaccharide concentration including introduction of ATP receptor 
channels or engineering membrane pores but deemed incompatible due to their 
irreversible damaging effect to the cell membrane (Chen et al., 2001; Fyles et al., 2001; 
Richard et al., 2003; Alvarez-Lorenzo and Concheiro, 2013). 
 
One recently developed method that successfully increases intracellular disaccharide 
transport in mammalian cells involves the application of amphiphilic polymers that 
increase the membrane permeability. Some of these polymers contains amphiphilic and 
charged domains designed to mimic the permeablising effect of viral and bacterial 
peptides (Brogden, 2005). A pH-responsive poly-amide, namely poly (L-lysine iso-
phthalamide) or PLP, was previously developed by Eccleston et al. as a drug delivery 
system. The polymer was shown to increase the intracellular concentration of a 
membrane-impermeable fluorophore, calcein, while being biocompatible in vitro 
(Eccleston et al., 2000, 2005). The delivery efficiency of PLP was further improved by 
Chen et al. after applying hydrophobic amino acid as a modifier of the pendant 
carboxylate group (Chen et al., 2009). One of the most effective of such polymers, PP-
50, was synthesised by reacting 50% molar ratio of L-phenylalanine with free 
carboxylate groups on PLP. Despite the successful loading of trehalose into mammalian 
cells including erythrocytes and SAOS-2 osteosarcoma cells by PP-50, limited success 
in cryopreservation was observed potentially due to the inability to alleviate effects of 
oxidative stress (Mercado and Slater, 2016). 
 
This study was motivated by the attempt to create a dual functional polymer with effective 
intracellular delivery and anti-oxidative characteristics. As previously mentioned, 
intracellular transport efficiency of PLP could be further improved by hydrophobic amino 
acids. It is logical to assume that the modification with other hydrophobic molecules not 
limited to amino acids could achieve similar effects. There is a variety of naturally 
occurring hydrophobic molecules that could be explored and an application-specific 
design approach should be taken to maximise the effectiveness of the selection 
process. In this study, cryopreservation with disaccharide as cryoprotectant was 
selected as the target application with clear objectives. Firstly, using a drug delivery 




effectively protect cells during cryostorage. Secondly, utilising anti-oxidative agents to 
alleviate oxidative stress throughout the cryopreservation process to improve cell survival 
and post cryostorage recovery. (±)-α-Tocopherol (vitamin E), a natural occurring 
hydrophobic molecule with antioxidative properties was selected to modify PLP. Vitamin 
E is a lipophilic molecule that can commonly be found in biomembranes with extreme 
potency for scavenging free radicals and is more effective in preventing lipid oxidation 
than vitamin C (Tappel, 1962; Packer, Slater and Willson, 1979; Burton and Traber, 
1990). Chemically, vitamin E contains long alkyl chains with an aromatic ring structure 
that makes it ideal to interact with lipid membranes. The anti-oxidative and membrane 
interactive characteristics make vitamin E the ideal modifier for PLP. Furthermore, 
vitamin E cannot be delivered independently because it is insoluble in water. 
 
Whether vitamin E could act as an effective modifier of PLP and whether the resulting 
polymer could act as a potent antioxidant will be explored in this chapter. Similar to 
previous chapters, the polymer will be fully characterised by various techniques to confirm 
the chemical structure. Subsequently, the vitamin E-modified PLP will be examined in 
vitro on its intracellular delivery efficiency and anti-oxidative effectiveness. Finally, the 
polymer will be used to test a trehalose-based cryopreservation protocol. 
 
 




Chemicals were purchased from Sigma Aldrich and biological reagents for cell culture 





5.2.2 Synthesis and Characterisation of PVitE-25 
5.2.2.1 Synthesis of PVitE-25 
 
 
Poly (L-lysine iso-phthalamide) (PLP) was synthesised as previously reported by 
Eccleston et al. (Eccleston et al., 2000, 2005). Vitamin-E was grafted onto PLP 
backbone at 25% molar ratio of available carboxylate group through esterification with 
standard DCC coupling reaction (Neises and Steglich, 1978). The reaction scheme of 


















































Figure 5-1: Reaction scheme of PVitE-25 synthesis. Standard DCC esterification using DMAP as 





Polymers were dissolved in DMSO-D6 and characterised by Bucker Advance 500 MHz 
NMR spectroscopy (Bruker Biospin GmbH, Germany). The 1H-NMR spectrum was 









Absorption spectrum of polymers were collected using a Thermo Nicolet Nexus 870 
spectrometer (Waltham, MA, USA) as the average of 32 scans with a wavenumber 
resolution of 4 cm-1 in the 600-4000 cm-1 range. 
 
 
5.2.3 Biological Activities of PVitE-25 
5.2.3.1 Cell Culture 
 
 
HeLa cells were cultured and maintained as mentioned in the Materials and Methods 
Section of Chapter 2. The cells were maintained and cultured using the same protocol. 
 
 
5.2.3.2 Cytotoxicity of polymers characterised by MTS assay 
 
 
HeLa cells were seeded in 96-well plates at 5x103 cells/well in 100 L of supplemented 
media for 48 hours. Cells were then incubated with phenol red free DMEM supplemented 
FBS with or without PVitE-25 for 24 or 48 hours at different concentrations. The MTS 
assay was performed according to the manufacturer’s recommendation. Data was 
collected at 480 nm with a SPECTROstar Nano plate reader (BMG Labtech Ltd., UK). 
 
 
5.2.3.3 Cytotoxicity of polymers characterised by AnnexinV/PI staining 
 
 
HeLa cells were seeded in 24-well plates at 5x104 cells/well in 500 L supplemented 
media for 48 hours. Cells were then incubated with supplemented media with or without 
PVitE-25 for 24 and 48 hours. Cells were then washed with PBS twice, trypsinised, and 
then re-suspended in phenol red-free DMEM containing FITC-AnnxinV and PI. Untreated 
cells were used as a negative control. HeLa cells incubated with 1% saponin in DMEM 
for 10 minutes were used as a positive control for apoptosis. The apoptosis assay was 
then performed with flow cytometry to determine the cytotoxicity of the polymers. 
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5.2.3.4 Characterisation of Polymer-mediated Intracellular Delivery of Calcein 
 
 
Calcein (a membrane impermeable fluorophore) was used as a tracer molecule to monitor 
the effect of polymer intracellular delivery efficiency. HeLa cells were seeded in 24-well 
plates at 5x104 cells/mL in 0.5 mL supplemented DMEM to full confluence in 24 hours 
followed by incubation with 0.22 µm filter-sterilised supplemented media and 2 mM 
calcein in the presence or absence of 1 mg/mL PVitE-25 polymer. 
 
 
5.2.3.5 Anti-Oxidative Activity of PVitE-25 Determined by DCFH-DA 
 
 
HeLa cells were incubated in supplemented DMEM for 48 hours before the experiment in 
4-well 1.8 cm2 chambered cover glass system (Nunc, UK) at 5x104 cells/well and 500 
L/well. Cells were washed twice with PBS and incubated with phenol red- and FBS-free 
DMEM in the presence or absence of 1 mM H2O2 for 2 hours with or without polymer. 
Cells were then washed twice with PBS and incubated with 10 M DCFH-DA, 5 g/mL 
Hoechst 33342, 5 g/mL PI in phenol red- and FBS-free DMEM for 20 minutes. Cells 
were washed again twice with PBS and DMEM was added to each well and imaged by 
confocal microscopy. 
 
Image were processed using Image J. Fluorescent intensity per cell was calculated by 
the dividing total image fluorescent intensity by the total cell number. Cell numbers were 
determined by counting cells that had Hoechst 33342 stained nuclei. 
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5.2.4 Cryopreservation Utilising PVitE-25 and Trehalose Protocol 
 
 
HeLa cells were seeded in 6-well plates at 5x105 cells/mL in 1 mL of supplemented media 
for 24 hours. Cells were then incubated with phenol red-free DMEM media supplemented 
with 10% FBS with or without 200 mM of trehalose in the presence or absence of 1 mg/mL 
PVitE-25 for 4 hours. After the incubation, cells were washed three times with PBS, 
trypsinised and spun down. Cells were then resuspended in 10% (v/v) DMSO in FBS or 
100 mM trehalose in 10% (v/v) phenol red free DMEM media in FBS at 106 cells/well. The 
solution containing cells was transferred into cryovials and cooled at 1 ˚C/min in a Mr. 
Frosty container in a -80 ˚C freezer overnight. The vials were then transferred into a 
liquid nitrogen cell bank and stored for at least 3 days before thawing. Experiments 
were performed in triplicate. 
 
During the thawing process, each vial of 1 mL HeLa cells were diluted with 9 mL of 
supplemented DMEM and seeded in 96-well plates. Metabolic activities were assessed 
by MTS assay 24 and 48 hours after thawing. For the 48-hour timing, media was changed 
with supplemented DMEM 24 hours after thawing. MTS assay was performed as 
manufacturer’s recommendation. Experiments were performed in six repeats. 
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5.3 Results and Discussion 
 
 
PVitE-25 was synthesised by modification of PLP with vitamin E and characterised. The 
resulting polymer was tested for its effectiveness in intracellular delivery efficiency 
compared to PLP using membrane impermeable calcein. The anti-oxidative characteristic 
was determined by using the free-radical responsive fluorescence of 2’,7’- 
dichlorofluorescin diacetate (DCFH-DA) in hydrogen peroxide challenged HeLa cells. 
After confirmation of the intracellular delivery efficiency and antioxidative characteristic 
of PVitE-25, the polymer was used to develop a trehalose-based cryopreservation 
protocol and compared to the industrial DMSO standard. The metabolic activity of cells 
post cryostorage was determined by MTS to evaluate the effectiveness of the protocols. 
 
 
5.3.1 Synthesis and Characterisation of PVitE-25 
 
 
PVitE-25 polymer was synthesised by grafting vitamin E onto PLP through the standard 
DCC esterification reaction. After purification and lyophilisation, a white porous solid was 
obtained. The polymer was characterised by 1H-NMR and FTIR to determine the grafting 
percentage and the chemical structure. 
 
As shown in Figure 5-2, the NMR spectrum of PVitE-25 had additional peaks before 4 
ppm compared to the PLP spectrum, the most notable being the triplet peak at 2 ppm 
which corresponded to the three –CH3 groups on the benzene ring of vitamin E (b). Since 
vitamin E, like PLP, contains aromatic ring structures, the high chemical shift regions used 
for calculating the molar number of monomers would no longer be accurate. Therefore, 
the single hydrogen on the beta carbon of L-lysine in the PLP backbone (δ = 4.33) was 
used as a reference instead. The grafting percentage of PVitE-25 was calculated by 
comparing the integrated area of the two peaks at δ = 2.01 and δ = 4.33 respectively 
with a 9:1 ratio which was 18.93%. This grafting percent of vitamin E translates to 
75.72% reaction efficiency and there were no observed stability issues with the polymer 
during the purification and experiments. 






















Figure 5-2: Chemical structure and 1H-NMR Spectrum of PLP and PVitE-25 in DMSO-D6. The proton 
(a) on the chemical structure of PLP and the three methyl groups (b) on vitamin E were each assigned to a 
legend and labelled on the 1H-NMR spectrum. DMSO peaks at 2.5 ppm were removed for better 
visualisation of the spectra. 
 
 
The molar ratio of vitamin E to pendant PLP carboxylate group for the reaction was 
selected at 25% because vitamin E is more hydrophobic than phenylalanine and it 
contains no carboxylate group which reduces the overall solubility of the resulting 
polymer. 
 
Additionally, PVitE-25 was characterised by FTIR to confirm the polymer structure by 
identifying the key functional groups. The spectrum of PPVitE-25 showed a number of 
similar characteristics to PLP including the amide C=O stretch (1680 cm-1), amide N-H 
bend (1550 cm-1), aromatic C-H stretch (2940 cm-1) and the hydroxy group O-H stretch 
(3300 cm-1) (Figure 5-3). The lack of carboxylate C=O stretch (1710 cm-1) in the PVitE- 
25 spectrum demonstrated the reduced carboxylate as it is partly replaced by ester C=O 
stretch while the intensified C-H stretch (2940 cm-1) reflects the additional C-H groups on 
vitamin E. 
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Figure 5-3: FTIR spectrum of PVitE-25. The spectrum of PLP was included below for comparison. Peaks 
labelled were assigned to the appropriate functional groups of the polymers. 
 
 
Both NMR and FTIR confirmed the successful modification of PLP by vitamin E and the 
resulting polymer contains the key functional groups. Further characterisation of the 
interaction of PVitE-25 in vivo will be discussed in the following sections. 
 
 
5.3.2 Cytotoxicity of PVitE-25 
 
 
To determine the biocompatibility of PVitE-25, HeLa cells incubated with the polymer for 
various duration at different concentrations were characterised with commercially 
available MTS assay and AnnexinV-PI apoptosis assay. As shown in Figure 5-4A, PVitE- 
25 did not exhibit any cytotoxic effect to HeLa cells below 1 mg/mL up to 48 hours 
according to MTS assay. In fact, there was a slight increase in cell metabolic activity when 
PVitE-25 was incubated with cells below 1 mg/mL for 24 hours. The only time where 
cytotoxic effect was observed was when PVitE-25 was incubated with HeLa cells at 2 
mg/mL for 48 hours. However, cells incubated in the condition still retained approximately 
78.94%  4.33% of metabolic activity that of untreated cells. 
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AnnexinV apoptosis assay showed that up to 2 mg/mL, PVitE-25 did not induce apoptosis 
in HeLa cells after 24-hour incubation (Figure 5-4B). The increased signal was on average 
27% across different concentrations of PVitE-25 compared to the negative control of 
untreated cells, whereas the positive control with saponin increased by 15-folds. These 
results suggest that PVitE-25 was well tolerated by HeLa cells with a 24-hour incubation 
period at 2 mg/mL. 48-hour incubation with PVitE-25 induced measurable apoptosis 
activity compared to the negative control group. However, the induced apoptosis activity 
of HeLa cells was significantly lower than the positive control suggesting that PVitE-25 
was tolerable to HeLa cells. 
 
As shown in Figure 5-4C, HeLa cells incubated with PVitE-25 at 2 mg/mL for 24 hours 
was relatively intact compared to saponin, a strong cell permeabilising agent, treated cells 
(Seeman, Cheng and Iles, 1973). PVitE-25 slightly increased the membrane 
impermeable PI staining of cellular DNA regardless of the concentration after 24-hour 
incubation, suggesting the polymer only minimally affected the membrane integrity. At 
48-hour incubation, PVitE-25 increase the PI staining slightly higher which was 
expected as AnnexinV staining indicated PVitE-25 induced high apoptosis activity with 
longer polymer incubation time. 
 
The three assays all suggested that PVitE-25 was well tolerated by HeLa cells at 2 mg/mL 
with 24-hour incubation. PVitE-25 was slightly toxic with 48-hour incubation but still 
tolerable by HeLa cells. The application with PVitE-25 would not require an incubation 
time longer than 24 hours, therefore, the toxicity beyond that would not be a concern. 
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Figure 5-4: The cytotoxicity of PVitE-25 at different incubation period and concentration. A) 
Metabolic activity of HeLa cells after 24- and 48-hour incubation with PVitE-25 determined by MTS assay. 
Untreated cells were used as control and the measurements were set to be 100% relative metabolic 
activity. B) Annexin V staining of HeLa cells after 24- and 48- hour incubation with PVitE-25 polymer at 
different concentrations. Control (-) and control (+) were untreated cells and cells incubated with 1% 
saponin for 10 minutes. C) PI staining of HeLa cells after 24- and 48- hour incubation with PVitE-25 
polymer at different concentrations. Control (-) and control (+) were untreated cells and cells incubated 
with 1% saponin for 10 minutes. 
 
 
5.3.3 Intracellular delivery activity of PVitE-25 
 
 
To evaluate the intracellular delivery activity of PVitE-25, the polymer was co-incubated 
with membrane impermeable calcein with HeLa cells. The delivery efficiency of PVitE-25 
was shown in Figure 5-5A where it induced a significantly higher intracellular delivery 
efficiency of calcein compared to PLP. The PVitE-25-induced increase in intracellular 
calcein concentration behaved in a dose-dependent manner. The result suggested that 
the modification with vitamin E was successful and the resulting polymer could be an 
efficient intracellular delivery agent. The delivery kinetic of the calcein with the polymer 
was also characterised to provide information for the estimation of polymer incubation 
time for future delivery applications. Incubation of 4 hours with calcein and PVitE-25 was 
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able to generate a difference in intracellular calcein concentration in HeLa cells while 




Figure 5-5: Intracellular calcein concentration of HeLa cells with or without PVitE-25 polymers 
determined by flow cytometry. A) Intracellular delivery of calcein by co-incubation with PVitE-25 or PLP 
for 24 hours at different polymer concentration. B) Intracellular delivery of calcein at different incubation 
length with 1 mg/mL of PVitE-25. 
 
 
The increase in intracellular calcein concentration is a good indicator for the intracellular 
delivery activity, but the distribution of intracellular calcein should also be determined. 
Previous publication suggested that modified PLP polymers facilitate intracellular delivery 
through endocytosis pathways (Mercado et al., 2016). The distribution of intracellular 
calcein delivered by PVitE-25 was characterised by confocal microscopy (Figure 5-6). A 
slight increase in calcein concentration was observed after 2-hour incubation and calcein 
was distributed throughout the cytosol. With 6-hour incubation, similar to 2-hour 
incubation, calcein could be observed throughout the cytosol but with a larger increase in 
intracellular calcein. These results are evidence that PVitE-25 was able to efficiently 
deliver membrane impermeable fluorescent dye into the cell cytosol and could be used 
as an intracellular delivery vehicle. 
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Figure 5-6: Confocal image of HeLa cells after co-incubation with calcein and PVitE-25. Calcein 
distribution was used to assess endosomal escape efficiency of PVitE-25. Cell nuclei were stained with 
Hoechst 33342 (blue). A) 2-hour incubation. B) 6-hour incubation. 
 
 
5.3.4 Anti-oxidative activity of PVitE-25 
 
 
To assess the anti-oxidative characteristic of PVitE-25, dichloro-dihydro-fluorescein 
diacetate (DCFH-DA), a fluorometric probe to measure oxidative species was used 
(Aranda et al., 2013). As shown in Figure 5-7A, DCFH-DA emits blue fluorescence and 
as it is oxidised into DCF, the fluorescent becomes green. The probe has been used as 
a reliable assay to quantify reactive oxygen species. In order to determine the optimal 
probe to reactive oxygen species concentrations, a preliminary experiment was carried 
out incubating DCFH-DA with HeLa cells at different concentration with subsequent 
incubation with hydrogen peroxide. Results proved that DCFH-DA was able to generate 
measurable difference in fluorescent signal with 10 M of DCFH-DA and 0.5 mM of H2O2 
(Figure 5-7B). To ensure the reliability of the assay, 10 M of DCFH-DA and 1 mM of 
H2O2 were selected for assessing the anti-oxidative characteristic of PVitE-25 in HeLa 
cells. 
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Figure 5-7: Chemical structure and emission spectrum of oxidation-reactive fluorophore, DCFH-DA. 
A) Chemical structure of DCFH-DA and the emission spectrum before (depicted in blue) and after (depicted 
in red) oxidisation. B) DCF, a fluorophore after DCFH oxidization, fluorescent signal at different DCFH-DA 
and hydrogen peroxide, an oxidising agent, concentration. 
 
 
After the appropriate setting for the DCFH-DA assay was selected to measure reactive 
oxygen species in HeLa cells, polymers were introduced for the study of anti-oxidative 
effects. As shown in Figure 5-8A, hydrogen peroxide (1 mM) was able to induce a 
significant fluorescent signal in HeLa cells and could be observed under confocal 
microscopy. When the cells were pre-incubated with PLP before the reactive oxygen 
species (ROS) induction, the DCFH-DA fluorescence was decreased by 14.0  9.2 % (p 
> 0.05, ns). However, when HeLa cells were incubated with hydrogen peroxide in the 
presence of PVitE-25 (1 mg/mL) for 2 hours, the amount DCFH-DA fluorescent signal 
was significantly reduced by 85.4  7.3 % (Figure 5-8B, p < 0.05). The result suggested 
that the vitamin E moiety retains its antioxidative activity when incorporated into PVitE-







Figure 5-8: Assessment of anti-oxidative activity of PVitE-25 in HeLa cells by DCFH-DA assay. A) 
Confocal images of HeLa cells incubated with ROS-reactive dye DCFH-DA to assess the level of ROS. The 
green fluorescent represents DCF which was oxidised from DCFH. Higher fluorescent level corresponds to 
higher ROS levels. ROS production was induced by incubation with 1 mM H2O2 for 2 hours in the presence 
of PVitE-25 or PLP. B) Quantification of cellular ROS level using DCF fluorescent intensity by image 
processing with Image J (n=3). 
 
 
5.3.5 Cryopreservation of Mammalian Cells Utilsing Trehalose/PVitE-25 Protocol 
 
 
The effectiveness of PVitE-25 was further tested in the cryopreservation of HeLa cells. In 
this study, PVitE-25 was used in conjunction with trehalose as a cryostorage protocol to 
compare with the standard DMSO protocol. The viability of HeLa cells after different 
cryopreservation protocols was determined by MTS assay 24 and 48 hours after 
reconstitution with supplemented DMEM. As shown in Figure 5-9, cells preserved using 
PVitE-25 combined with the trehalose treatment protocol reached 82.7  5.5% viability 24 
hours after thawing compared to the standard DMSO preservation method. Additionally, 
cells preserved with the PVitE-25-based protocol were able to reach comparable 









Figure 5-9: Metabolic activity of HeLa cells 24 and 48 hours after reconstitution from cryostorage 
determined by MTS assay. HeLa cells were treated with different cryopreservation protocols. Untreated 
HeLa cells were used as a reference while positive control was DMSO-based protocol and negative control 




It is believed that the successful cryostorage in this study was achieved for the following 
two reasons: Firstly, PVitE-25 delivered the membrane impermeable trehalose into the 
cell cytosol and enabled trehalose to be an effective cryoprotectant (Rudolph and 
Crowe, 1985; Chen et al., 2001; Lynch et al., 2010). Secondly, the anti-oxidative 
property of PVitE- 25 alleviated the detrimental effects induced by ROS to cells during 
the freeze thaw cycle and improve the survival of cells undergoing cryopreservation 
(Tampo et al., 2003; Mishra et al., 2009; Li et al., 2010). The cryopreservation result 
highlighted the successful development of the first synthetic cell permeating polymer 
system with an anti-oxidative property and the potential for it be an effective system for 






In this chapter, a novel design and development of a biocompatible intracellular delivery 
polymer with antioxidative property was discussed. The modification of PLP with an anti- 
oxidative agent, vitamin E, produced a functionally active aqueous soluble form of the 
antioxidant that retained the ability to enhance the transport of hydrophilic molecules such 
as trehalose into cells while retaining biocompatibility. 
 
With vitamin E modification, the resulting PVitE-25 polymer had enhanced intracellular 
delivery efficiency compared to unmodified PLP. The intracellular concentration of 
membrane impermeable calcein was increased by over 100% when co-incubated with 
PVitE-25 at 2mg/mL while PLP co-incubation at the same concentration only resulted in 
a 10% increase. Confocal microscopy showed that the PVitE-25 delivered payload was 
equally distributed in the cytosol, verifying that the polymer was capable of causing 
membrane permeabilisation or endosomal escape. This result supported that 
modification with hydrophobic molecules containing aromatic groups could increase PLP 
delivery effectiveness. Additionally, PVitE-25 was able to achieve high intracellular 
calcein delivery with a lower grafting percentage compared to Phe modification. This 
indicated that there may be other natural occurring hydrophobic molecules, especially the 
ones known to be present in the cell membrane, that could further enhance PLP 
delivery efficiency. 
 
The vitamin E modified PLP retained its biocompatibility profile and was well tolerated by 
HeLa cells at 24 and 48-hour incubations. PVitE-25 did not induce measurable apoptosis 
or compromise membrane integrity in HeLa cells after 24-hour incubation even at 2 
mg/mL. Even with 48-hour incubation, PVitE-25 was tolerated by HeLa cells. As 
biocompatibility is the important differentiating factor of PLP-based polymer compared to 
other methods such as lipofectamine, it is essential to retain this characteristic while 




Another key characteristic that PVitE-25 polymer exhibited in the study was the anti- 
oxidative functionality that neutralised ROS generated from 1 mM H2O2 challenge in HeLa 
cells. ROS-responsive, membrane permeable DCFH-DA, would be oxidised into 
fluorescent DCF and used to measure the amount of ROS present. In this study, H2O2 
was able to induce high DCF intensity when incubated with or without PLP, but in the 
presence of PVitE-25 fluorescent intensity was reduced by 85.4  7.3 %. The result 
supported that, PVitE-25 obtained the functionality, similar to vitamin E, to neutralise ROS 
and protected cells from H2O2 challenge. This is the first instance that a modifying agent 
could enhance intracellular delivery and enable additional functionality of PLP. 
 
It was suggested that cells face ROS during the freezing and thawing process during 
cryopreservation and would cause detrimental results (Mishra et al., 2009; Li et al., 
2010; Tatone et al., 2010). Although trehalose, was a proven cryoprotectant that 
exhibited potential anti-oxidative benefit, it was clearly not enough when combined with 
PLP-based polymer to sustain high cell survival rate after cryopreservation (Luo, Li and 
Wang, 2008; Mercado and Slater, 2016). In this study, PVitE-25 with enhanced 
intracellular delivery efficiency and anti-oxidative functionality was further assessed for 
the cryopreservation of HeLa cells. When the polymer was used in conjunction with 
trehalose as a protocol to cryopreserve HeLa cells, it was as effective as the DMSO 
standard protocol judging by the metabolic activity of the reconstituted cells. This result 
highlighted the effectiveness of PVitE-25 as a dual functional delivery system and the 
importance of intelligent design when developing drug delivery system for the 








This thesis presented experimental studies to understand the structure of biocompatible 
pH responsive polymers and their interaction with the biological system in order to design 
more effective entities for biomedical applications. More specifically, using synthetic 
methods to create variations of the PLP polymers and determine which polymers were 
more effective drug delivery system. The main outcome of this study was the 
development of a PLP-derivative that act as a both an intracellular delivery system and 
an anti-oxidative agent that successfully applied for the cryopreservation of mammalian 
cells. 
 
A proper design of any system would require in depth understanding of the components. 
There was limited information available on the structure and intracellular delivery 
mechanism of PLP and its derivatives. Firstly, CD and SANS were applied for the first 
time to characterise the structure of PLP. It was revealed that PLP forms an optically 
active helical secondary structure that is 200 Å by length. As pH decreases from 
physiological norm, the length of PLP remains the same while the macrostructure of the 
polymer changes. SANS results supported the theory that PLP forms a larger bundle 
with multiple rods as pH decreases. This contradicts the previous hypothesis that PLP is 
a flexible polymer chain at pH 7.4 and condense into a globular structure at lower pH. 
 
Modification of PLP with hydrophobic amino acids was previously reported as an 
effective strategy to enhance polymer intracellular delivery efficiency. PP-50, a Phe, 
grafted PLP was determined by CD to have a significant different secondary structure 
compared to PLP. Moreover, PP-50 was determined by SANS to forms a lamellar 
macrostructure at lower pH rather than a rod structure compared to PLP. Therefore, the 
ability to form a larger macrostructure may be an important factor for PP polymers to be 





To further understand the difference between PLP and PP polymers, three PLP and four 
PP-50 enantiomers were synthesised and characterised using lysine and phenylalanine 
isomers. The different enantiomers were used to explore the different characteristics to 
provide a better understanding of the polymer behavior, intracellular delivery mechanism, 
and cytotoxicity. 
 
CD spectroscopy showed that PLP-L and PLP-D adopted similar helical secondary 
structures but with the opposite sense. It was also confirmed by CD that PLP-L-D overall 
did not exhibit optical activity, but the optical inactivity was possibly caused by the 
destructive signal addition of co-existing clockwise and counterclockwise helical domains. 
SANS data further supported that all three PLP enantiomers adopted rod-like structures 
which form larger stacked rods as pH decreases. In terms of intracellular delivery 
efficiency and cytotoxicity, the three PLP polymers have very similar profiles. These 
results indicated that the mammalian cell does not discriminate against the three PLP 
enantiomers and all three polymers were well tolerated. 
 
After PLP enantiomers were characterised, PLP-L and PLP-D were modified by 
phenylalanine of different chirality, more specifically L- or D-, to yield four PP-50 
enantiomers. The four PP-50 enantiomers were determined to be chemically similar, pH 
responsive, and had distinctive CD spectra in different pH environments. Although the 
four PP-50 enantiomers had slightly different SANS spectra, all the polymers were able 
to form lamellar structures at pH below 6.1. Unsurprisingly, the four polymers had very 
similar intracellular delivery efficiency of membrane impermeable calcein in HeLa cells. 
The result provided additional evidence that the ability of polymers to form lamellar 
structures would determine the ability to deliver payload intracellularly. 
 
Experimental results supported that using amino acids of different chirality to synthesise 
pH-responsive polymers did not affect the overall structure and characteristics. The 
chirality of the material also did not contribute to any observable impact to the polymer 
interaction with HeLa cells as the intracellular delivery profile and cytotoxicity profile of 





After systematically studying the effect that chiral molecule and pendant modification 
have on PLP characteristics, an attempt was made to further explore the possibility to 
replicate PLP with all naturally occurring components. Fumarate, a di-acid important for 
the Krebs cycle, was selected for the synthesis of a biocompatible polyer. The resulting 
PLF polymer was proven to be pH-responsive but has a transition pH of 3.5 which is 
lower than PLP’s 4.3. Additionally, CD and SANS determined that PLF adopts an 
organised cylindrical secondary structure similar to PLP but approximately five times 
longer. Despite these differences, PLF was able to facilitate intracellular delivery of 
membrane impermeable calcein in HeLa cells with the same efficiency as PLP. 
However, Phe modified PLF did not result in enhanced membrane activity. SANS 
determined that PF-50 adopted a cylinderical secondary structure but, unlike PP-50, 
does not form any lamellar structure at pH as low as 4.1. In vitro experiment with 
membrane impermeable calcein in HeLa cells suggested that PF-50 had only 
comparable intracellular delivery efficiency as PLF. The modification strategy did not work 
on PLF but as it was a preliminary experiment, perhaps other amino acids such as 
tyrosine (Tyr) or tryptophan (Trp) could be used as modifier. As PLF was proven to be 
well tolerated and was as efficient as PLP in delivering calcein in HeLa cells, modification 
of PLF could still be an option worth further exploration. 
 
With a better understanding of PLP and pH responsive polymers as drug delivery 
systems, an application specific new design approach was adopted. Cryopreservation 
with the delivery of membrane impermeable cryoprotectant was selected as a pilot 
application to test the effectiveness of this approach. Previously, PP-50 was used as a 
delivery system to transport trehalose as cryoprotectant into osteosarcoma cells but only 
achieved 64% cryosurvival rate compared to the standard DMSO protocol (Mercado and 
Slater, 2016). The shortfall may not be due to the delivery efficiency of PP-50 but 
potentially other aspects, such as the oxidative stress that cells encounter during the 




oxidative agent, vitamin E, was selected as a modifier to produce a functionally active 
PLP polymer with enhanced ability to transport membrane impermeable molecules. 
With vitamin E modification, the resulting PVitE-25 polymer had enhanced intracellular 
delivery efficiency compared to unmodified PLP with the ability to distribute payload in the 
cytosol. Additionally, PVitE-25 was able to achieve comparable intracellular calcein 
delivery with 25 grafting percentage compared to the 50% of Phe modification. While 
PVitE-25 had enhanced intracellular delivery efficiency, the polymer retained its 
biocompatibility profile and was well tolerated by HeLa cells at 24 and 48-hour 
incubations. Finally, PVitE-25 polymer exhibited anti-oxidative functionality that 
neutralised ROS generated from 1 mM H2O2 challenge in HeLa cells. 
 
In this study, PVitE-25 with enhanced intracellular delivery efficiency and anti-oxidative 
functionality was further assessed for the cryopreservation of HeLa cells. When the PVitE- 
25 was used in conjunction with trehalose as a protocol to cryopreserve HeLa cells, it was 
able to achieve cyrosurival rate comparable to the DMSO standard protocol. This result 
highlighted the effectiveness of PVitE-25 as a dual functional delivery system and the 
importance of intelligent design when developing drug delivery system for the prospective 
biomedical application. With enhanced understanding of PLP structure and how different 
modification would affect the polymer functionality and characteristic, PLP could be 




6.2 Future Work 
6.2.1 Further Characterisation of PLP 
 
 
In this thesis, circular dichroism spectroscopy and small angle neutron scattering were 
applied for the first time to provide important structural information of PLP and modified- 
PLP polymers. The data supported that PLP adopted a helical secondary structure at pH 
7.4. The sense of the helix, however, was not able to be determined. In other words, 




Characterisation methods including single-crystal X-ray crystallographic analysis and 
atomic force microscopy (AFM) could provide a more comprehensive picture of PLP 
structure. Single-crystal X-ray crystallographic analysis was described as a reliable and 
versatile method to determine the helical structure at an atomic level including the sense 
of the helix (Yashima, 2010). The method would require uniformed oligomers to be 
isolated and crystallised which could be challenging for PLP with higher polydispersity. 
AFM, a common technique for probing the structure of macromolecules, could potentially 
be a more suitable method for it is not limited by the polydispersity of the sample. The 
method utilises a very fine needle that comes into contact with the samples to map out 
the structure at atomic resolution (Butt, Cappella and Kappl, 2005). Kumaki et al. were 
able to use AFM to determine the helical sense and dimension of selected polymers 
(Kumaki, Sakurai and Yashima, 2009). The technique could potentially provide a more 




6.2.2 Circular Dichroism spectroscopy of PLP polymers with GUV 
 
 
CD spectroscopy is a versatile technique to provide macromolecule secondary structure 
in solution. In this dissertation, PLP and PP-75 were characterised with CD in the 
presence of GUV and yielded interesting preliminary results. PLP and PP-75 CD spectra 
did not change at pH 7.4 in the presence of GUV. However, the CD spectrum of PP-75 
was observed to be less prevalent in the presence of GUV at pH 5.1 and lead to the 
hypothesis that PP-75 interacts with the lipid lamellar at lower pH. However, the CD 
spectrum of PLP in the presence of GUV at pH 5.1 remained unchanged. This could 
potentially be due to the fact that pH 5.1 was above the transition pH of PLP and it had 
weak interaction with the GUV membrane. Therefore, to confirm whether PLP and other 
PLP-derived polymers interact with the lipid membrane more preferably at lower pH or 
their transition pHs, polymers could be experimented with GUV at different pHs 
including the polymer’s transition pHs. The study could also provide information on how 
PLP polymers interact with lipid membranes and the structural information could help 




6.2.3 Long-term and in vivo toxicity studies of PLP and PLP-derived polymers 
 
 
Biocompatibility of PLP and its derivatives was only studied in vitro and by studying cell 
metabolism, membrane integrity, and apoptosis activity. Studies characterising the long- 
term effect of PLP in vivo have yet to be conducted. To fully assess the biocompatibility 
of PLP and its derivatives, more comprehensive studies on cell morphology or protein 
expression after exposure to PLP polymers should be determined. 
 
PP-75 was previously applied as a drug delivery system for siRNA to treat cancer by 
Khormaee et al. in immunocompromised mice (Khormaee et al., 2013). It was the first 
instance that a PLP derivative was experimented in vivo. The more complex system in 
multicellular organism such as metabolism, renal clearance, and the immune system 
could all affect the polymers. For PLP derivatives to be used as a drug delivery system in 
clinical applications, how polymers interact with different tissue would have to be fully 




6.2.4 Modification of PLF with other amino acids containing aromatic rings 
 
 
As discussed in Chapter 4, PLF was determined to be as potent as PLP in delivering 
membrane impermeable calcein and was well tolerated by HeLa cells. Modification of 
PLF with Phe did not result in a polymer with enhanced intracellular delivery. Additional 
amino acids such as Typ or Trp could potentially be more suitable modifiers for PLF to 
enhance membrane activity. Characterisation of the resulting polymer with SANS could 
provide additional data points to support whether lamellar structure formation is correlated 
to the enhanced intracellular delivery of Phe modified PLP. 
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6.2.5 Modification of PLP with other membrane interactive molecules 
 
 
Vitamin E was not the only lipophilic molecule that has affinity towards the plasma 
membrane. Cholesterol is one of the most important components in the lipid membrane 
that determines the membrane fluidity of mammalian cells. Modification with cholesterol 
could potentially increase PLP interaction with the cell membrane and increase the 
intracellular delivery efficiency. Additionally, due to the importance of cholesterol for 
alternating membrane fluidity, the cholesterol modified PLP could potentially exhibit 
membrane modification properties and affect membrane signalling. For example, T 
lymphocytes from the human immune systems are stimulated through the recruitment 
of membrane T-cell receptors into a concentrated region (Montixi et al., 1998). The 
recruitment of T-cell receptor that are normally evenly distributed on the cell membrane 
to a concentrated area would depend on the regional membrane fluidity. Any major 
disruption of membrane fluidity could modify the T-cell receptor recruitment could alter 
the activation of T lymphocytes. Therefore, cholesterol may become a functional 
modifier for PLP that is beyond enhancement of intracellular delivery efficiency similar 
to Vitamin E. Further studies on how cholesterol modification could be accomplished 
and how the resulting polymer would interact with biological membranes could be an 
interesting topic for future investigation. 
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